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Effective host responses to injury and infection require both rapid recruitment 
of neutrophils into tissues and timely inflammation resolution.  Research efforts 
have primarily focused separately on the initiation and resolution phases of 
inflammation and on how neutrophil survival responses determine the duration 
and extent of the inflammatory response.  Less focus has been placed on 
mechanisms retaining viable neutrophils at inflamed sites and thus contributing 
to ongoing inflammation. This may be of therapeutic importance given the 
numerical dominance of viable over apoptotic neutrophils in inflamed tissue, 
even during inflammation resolution.  
Semaphorins were originally identified as chemo-repulsive molecules for 
axonal growth cones. They have since been implicated in cell motility in the 
context of vascular growth, tumour progression and in immune signalling and 
immune synapse formation. Recently the class 3 Semaphorin, Sema3A, was 
shown to act as an attractant for tumour-associated macrophages (TAM), 
regulating their localization and retention within hypoxic tumour areas.  
Previous unpublished work from our group found neutrophils express the class 
3 Semaphorin, Sema3F, with differential expression observed in hypoxia.  
Whether neutrophil expression of Sema3F can directly regulate recruitment to 
inflamed sites is currently unknown. Semaphorins can interact both directly 
with Plexins and in complexes with Neuropilin co-receptors, leading to 
activation of protein kinase and (guanosine triphosphate-ase) GTPase 
signalling pathways. This affects actin cytoskeletal re-organisation following 
oxidation of actin filaments leading to modifications of neutrophil shape and 
migration. In light of emerging evidence that neutrophils also undergo a 
process of reverse migration away from inflamed tissue, I propose neutrophil 
expression of Sema3F regulates neutrophil retention within the tissues. Where 
autocrine production of neutrophil Sema3F induces neutrophil F-actin 
disassembly, acting as a cytoskeletal brake to cell movement and is thus a 
 
ii 
determinant of both the magnitude and duration of the innate immune 
response. To investigate this, in vivo experiments were performed in murine 
models of acute lung injury, using both wild type and neutrophil specific 
Sema3F knockout mice. Complementary in vitro experiments were performed 
in human peripheral blood neutrophils. 
Inflammatory neutrophils express sema3F. Sema3F protein expression is 
seen in the recruited neutrophils found in tissue from patients with chronic 
inflammatory lung disease (COPD). In vivo modelling showed Sema3F 
expression is regulated at a transcriptional level during inflammation, with 
induction of Sema3F mRNA in neutrophils recruited to the airways following 
Lipopolysaccharide (LPS) challenge and a parallel increase in Sema3F protein 
expression in Ly6G positive cells within the alveoli. Similarly, the surface 
expression of Neuropilin 2 (NRP2), the obligatory co-receptor to Sema3F, is 
increased in both human and murine neutrophils following an inflammatory 
stimulus. In a murine model of LPS-induced lung injury, intra-tracheal 
instillation of Sema3F at 24 hours increases retention of airway recruited 
neutrophils at 48 hours. Furthermore, neutrophil specific knockout of murine 
Sema3F in an LPS-induced lung injury model increases both recruitment and 
clearance of neutrophils found in the bronchoalveolar lavage but does not alter 
apoptotic responses. The Sema3F deficient neutrophils migrate, to and away 
from the site of tissue injury rapidly and are not retained within inflamed murine 
lung tissue. The retention phenotype seen in the Sema3F knockout mouse 
appears neutrophil specific as macrophage numbers were unchanged 
throughout the inflammatory response.  
In human peripheral blood neutrophils Sema3F treatment inhibits neutrophil 
chemotaxis to the bacterial product N-Formyl-Met-Leu-Phe (fMLF). Using a 
microfluidic chip assay, neutrophils responded to Sema3F in a dose 
dependent manner. Following Sema3F treatment there was a reduction in 
neutrophil migration. This was observed in neutrophils migrating up an 
increasing Leukotriene B4 (LTB4) gradient (chemotaxis). After the neutrophils 
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had reached the chamber and the highest concentration of LTB4, the rate of 
neutrophil migration out of the chamber and against the gradient (retrotaxis) 
was reduced. Effectively the neutrophils were retained within the chamber for 
90 minutes. Sema3F treated neutrophils have preserved functions including 
phagocytosis of opsonised Zymosan granules and fluorescently labelled 
Escherichia coli (E. coli) particles. Following Sema3F treatment neutrophils 
produce increased intra-cellular levels of radical oxygen species (ROS). 
Increased ROS has been shown to promote F-actin disassembly and result in 
cytoskeleton rearrangement. Sema3F not only inhibits neutrophil chemotaxis, 
but also affects neutrophil rounding and regulates exogenous 
myeloperoxidase and elastase activity. It is evident that Sema3F signalling 
could selectively modulate diverse neutrophil functions related to neutrophil 
cytoskeletal dynamics. 
Using cultured murine lung slices and real-time confocal imaging neutrophils 
treated with Sema3F are slower than controls. On delivery of intra-tracheal (IT) 
Sema3F to the murine ALI model the retained neutrophils are found in the 
alveoli space and are not retained by a rate-limiting interaction with the barriers 
to neutrophil lung transmigration. Following IT Sema3F, these neutrophils 
retained in the murine airway are more spherical and undergo increased F-
actin disassembly. These results for the first time identify a role for Sema3F as 
a neutrophil specific retention signal in acute lung injury. Thus, revealing a 
novel mechanism by which neutrophils are recruited to and maintained at the 
site of tissue injury. I therefore propose that Sema3F and the co-receptor 
NRP2 are potential therapeutic targets in acute lung injury and lung diseases 











Neutrophils are a type of white blood cell and are essential for tissue healing 
after injury and protection against infection. Neutrophils contain toxic 
substances which they can release in a controlled way to kill bacteria. They 
can also eat debris, bacteria and foreign particles clearing the way for tissue 
repair and inflammation resolution when there is full recovery and the process 
is over. The number of neutrophils present at the injury site, in part, determines 
when the resolution of the injury and inflammation happens. However, in 
certain situations neutrophils overreact staying at the injury site too long or too 
many arrive in response to the injury. In these situations, the helpful infection-
fighting responses of the neutrophils spill over and can begin to harm the 
patient’s own tissues. In this way excessive neutrophil numbers, activity or 
neutrophil lifespan can cause diseases such as Chronic Obstructive 
Pulmonary Disease (COPD), asthma and acute lung injury (ALI). The extent 
of help, or harm, neutrophils cause is determined partly by how long these cells 
live within the site of injury. Neutrophils usually die in a controlled manner 
called “apoptosis” or programmed cell death and are eaten by another cell type 
found in the blood, macrophages. More recently there is evidence that the 
control over neutrophil driven inflammation is not only through apoptosis 
(organised neutrophil death), but even before this happens, there are signals 
that instruct neutrophils to “go” or “stay” at the injury site. One such potential 
signal is Sema3F, which is part of a family of proteins called Semaphorins, 
named after the flag signalling system used by ships to direct traffic. We know 
neutrophils make different levels of the signal Sema3F themselves and can 
respond to their own Sema3F signal, this is a process called “autocrine” 
signalling. We have shown in animal models that neutrophils without Sema3F 
move into the injury site faster than the neutrophils producing Sema3F and 
they also move away from the injury site quicker. In another animal model the 
opposite is true: giving excess Sema3F after a lung injury retains the 
neutrophils within the injury site. It is known that Semaphorins cause changes 
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in the cytoskeleton of cells, which is the scaffolding that allows cells to do many 
functions including change shape and move. It appears that Sema3F causes 
neutrophils to disassemble their scaffolding and therefore the neutrophils 
cannot move as well. Sema3F acts as a “brake” to neutrophil movement and 
“migration”. It may be that, in the future, we can harness Sema3F signalling to 
control neutrophil migration in the context of disease, to move neutrophils to 
the injury site when this would be helpful but away when they are responsible 
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1 Introduction 
1.1 Neutrophils in the innate immune response: initiation and 
resolution 
Neutrophils are the most abundant type of granulocyte forming 40-75% of the 
circulating population, the remaining cell types being basophils and 
eosinophils. They form a crucial component of the innate immune system. 
Neutrophils are recruited to the site of tissue damage or infection by 
chemoattractants these are released from damaged cells, activated 
macrophages or the early-recruited neutrophils themselves. They are able to 
transmigrate from the circulation, through the endothelial and epithelial layers, 
to reach the site of injury promptly. After developing from pluripotent 
hematopoietic cells within the bone marrow, they are very short-lived cells. 
Neutrophils mature within 1 week and are present in the circulation for a further 
6-8 hours they usually they undergo constitutive apoptosis following 
transmigration.1 They have efficient cytotoxic abilities including phagocytosis, 
the “respiratory burst” and the release of granules.2-5 Neutrophil apoptosis 
(programmed cell death) is a series of highly regulated biological events that 
leads to cell changes and death. Apoptosis ensures neutrophils maintain 
membrane integrity and thus retain their cytotoxic granule contents; it also 
reduces chemotaxis, phagocytosis and the respiratory burst.6 Apoptosis 
promotes the recognition and safe removal of neutrophils and their cytotoxic 
content by macrophages. It is a major route of neutrophil clearance which is 
vital in the resolution of inflammation and infection to maintain tissue 
homeostasis.1 Typically, the survival of neutrophils is extended in the 
inflammatory environment found at site of tissue damage or infection. 
Neutrophils have an enhanced survival in response to bacteria and bacterial 
products, hypoxia and cytokines.7-9 This unique robustness, in the face of 
inhospitable surroundings, allows these cells to defend the organism against 
pathogens and tissue injury. 
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1.2 Neutrophilic inflammation in lung disease 
ARDS is a severe and common cause of respiratory failure. This clinical 
syndrome is defined by an acute onset of hypoxia (PaO2:FiO2 of < 40 kPa) 
associated with diffuse bilateral chest infiltrates seen on x-ray consistent with 
non-cardiogenic pulmonary oedema.10 The dysregulation of the resolution 
phase leading to persistent neutrophilic inflammation is implicated in the 
pathogenesis of many lung diseases. In acute respiratory distress syndrome 
(ARDS) neutrophils predominate in the pulmonary oedema fluid and 
bronchoalveolar lavage fluid obtained from affected patients.11 Histological 
findings include diffuse alveolar damage, disruption to the hyaline membranes 
and capillary injury. This results in a protein rich oedema fluid in the alveolar 
spaces and disruption of the alveolar epithelium.12 ARDS has been observed 
in neutropenic patients, suggesting that in this minority of cases, neutrophilic 
inflammation is not responsible for the clinical findings. Yet, in the most part, it 
cannot be refuted that neutrophils have the both the proximity and ability to 
produce this distinctive pattern of cellular damage.13  
There are a variety of injuries which can lead to the characteristic and 
deleterious excessive neutrophil recruitment and activity seen in ARDS. 
Moreover, the degree of neutrophil recruitment correlates with increasing 
disease severity and morbidity.14-16 Mortality from this syndrome is high (> 
40%) and following recovery survivors often endure significant and chronic 
sequalae.17 As such ARDS can levy a considerable burden upon resources 
within both hospitals and the wider community. Neutrophil recruitment and 
migration are central in the generation of the harmful neutrophilic response 
seen following injury. BAL taken from patients with ARDS is highly chemotactic 
for neutrophils and contains many of the potent neutrophil chemoattractant 
signals including interleukin-8 (IL-8). There is further enhancement of 
neutrophil chemotaxis through synergy between signals.14 The initial exudative 
phase is heralded by a deluge of recruited neutrophils and release of their 
histotoxic contents. These bactericidal agents (for example myeloperoxidase, 
elastase and free radicals) contribute to catastrophic diffuse alveolar damage 
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and loss of lung architecture and the ability to perform gaseous exchange 
resulting in organ failure and often death.18,19 The instigating injury can occur 
at a distant site and these primed neutrophils may relocate to the lung and 
once there cause an acute lung injury without a clear or direct insult to the lung 
itself.20-24 
1.2.1 Neutrophilic inflammation in chronic pulmonary disease  
The destructive presence of inflammatory neutrophils is responsible for the 
chronic inflammatory changes seen in the airways of patients with Chronic 
Obstructive Pulmonary Disease (COPD). This is characterised by airway 
thickening and constriction, increased secretions and ultimately non-reversible 
airway obstruction with airflow limitation. Patients with COPD suffer from 
breathlessness, fatigue and respiratory failure.25  
While ARDS and COPD are very different clinical entities they are both 
underpinned by neutrophilic inflammation. In the case of COPD, it is often a 
result of exposure to environmental factors such as cigarette smoke and coal 
fires. The inflammation leads to a largely non-reversible narrowing of the 
airways and airflow restriction. Symptomatically the patient will experience 
shortness of breath and as the disease progresses, respiratory failure 
associated cardiovascular complications. The disease progression is 
characterised by exacerbations, where the gradual decline and background 
inflammation is punctuated by acute periods of either infection or increased 
inflammation. Following resolution of an exacerbation there is often a 
progression of the background damage to the lung architecture and over time, 
worsening of the chronic symptoms. The neutrophil is central in the 
propagation of this pathological inflammation and is a dominant cell-type 
present in the lung BAL fluid, found in larger numbers in diseased than in 
healthy lung. This is attributed to the inflammatory signals produced in the 
COPD affected lung.26 
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The neutrophil is implicated in other respiratory diseases, it appears to be the 
dominant cell type in non-atopic and severe forms of asthma.27 In addition, the 
generation of oxidative stress by activated neutrophils is proposed as a 
potential mechanism in the pathogenesis of lung fibrosis.28 The ongoing 
release of neutrophil proteases, such as elastase, generate the bronchiectatic 
changes seen in patients with cystic fibrosis. These proteases may go on to 
dysregulate neutrophil cytotoxic abilities promoting infection, such that 
elastase is present early in the life of these patients and appears as a 
biomarker of progression throughout.29 
 
1.3 Neutrophil recruitment 
Tissue injury releases a variety of chemoattractants; neutrophils are able to 
sense these signals and navigate rapidly to the site of damage. The first 
neutrophils to arrive at the site of injury amplify the recruitment signal, thus 
ensuring a prompt delivery of neutrophils from the blood stream. Acutely, 
damage-associated molecular patterns (DAMPs) are released from injured or 
necrotic cells these include: DNA, proteins, N-formyl peptides, extracellular 
matrix components, ATP and uric acid.30 Neutrophils detect early signals, such 
as DAMPs, by G protein-coupled receptors (GPCRs).31 At the site of injury, the 
detection of DAMPs results in the local production of a hydrogen peroxide 
(H2O2). In larval zebrafish the release of H2O2  starts at 3 minutes post injury 
and the gradient peaks at 20mins.32 This rapid signal is sensed by a proto-
oncogene tyrosine-protein kinase Lyn a member of the Src family kinases 
(SFKs) which have been shown to produce chemotaxis of human and murine 
neutrophils in vitro. 33 SFK activation results in the activation of PI-3 Kinase, 
the Rac subfamily of the Rho family of GTPases and extracellular signal-
regulated kinases (ERK) to mediate directed migration.33,34 Locally DAMPs 
stimulate the release of CXC-chemokine ligands such as CXCL8 and CXCL2, 
interleukin 1 beta (IL-1b) and LTB4 from both immune cells and non-immune 
cells, such as epithelium and endothelium.35,36  
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Amplification of the chemoattractant signal is further augmented by the early-
recruited neutrophil itself. The migrated neutrophils are activated and this 
promotes both directly, and indirectly, additional secretion of CXCL8 and 
LTB4.37,38 The role of CXCL8 family–CXCR signalling in neutrophil migration 
has been confirmed in zebrafish, mice and humans.39-41 Neutrophil chemotaxis 
and activation is also triggered by N-formyl peptides, such as fMLF. Whilst 
these N-formyl peptides can be derived from bacterial proteins, they are also 
released from mitochondria after tissue damage and activate human 
neutrophils by binding to the GPCRs fMLF receptor 1 (FPR1), FPR2 and 
FPR3.42 In addition to early-recruited neutrophils, DAMPs attract pro-
inflammatory monocytes and macrophages. Neutrophils also produce 
chemokines that directly recruit macrophages, and in response recruited 
macrophages release further stimuli that perpetuate this feed-forward loop. 
Thus exponentially more neutrophils are drawn into the inflammatory site often 
termed “neutrophil swarming” (figure 1.3-1).36 
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Figure 1.3-1 The phases of neutrophil recruitment leading to neutrophil swarming 
Damage-associated molecular patterns (DAMPs) are released at a tissue injury site and promote the release of hydrogen peroxide (H2O2). Following 
detection of chemoattractant cues (DAMPs & H2O2) recruited neutrophils undergo actin polymerisation and chemotaxis. DAMPs also induce the production 
of CXC-chemokine ligand 8 (CXCL8) family chemokines and leukotrienes from surrounding tissue cells to further recruit neutrophils. Early-recruited 
neutrophils are then activated, which directly and indirectly promotes further secretion of CXCL8 family chemokines and leukotriene B4 (LTB4) to induce 
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1.4 Neutrophil Transmigration 
For circulating neutrophils to gain access to the site of inflammation they must 
be notified of the insult, locate the damaged tissue and exit the vascular 
compartment, to arrive accurately and promptly. This is in part achieved 
through the leukocyte adhesion cascade. Capture and rolling of circulating 
leukocytes is mediated by L-selectin, P-selectin and E-selectin.43 These 
interact with P-selectin glycoprotein ligand 1 (PSGL1). PSGL1 was first 
described as a receptor for P-selectin, however it does interact with all three 
selectins.44 Most leukocytes express L-selectin where it mediates leukocyte to 
leukocyte interactions, whilst E- and P-selectins are found on damaged 
endothelial cells; the latter is also found on activated platelets. E-selectin can 
bind to both glycosylated CD44 and E-selectin ligand 1 (ESL1).45 Leukocyte 
arrest occurs usually under conditions of high flow. Following the binding of 
selectins with their ligands, they work cooperatively with integrins to promote 
firm leukocyte adhesion. For example, the lymphocyte function-associated 
antigen 1 (LFA1), also known as α1β2-integrin, undergoes affinity change 
when interacting with E-selectin. This allows LFA1 to transiently bind to its 
substrate, the inter-cellular adhesion molecule 1 (ICAM).46 Likewise, the rolling 
of human lymphocytes is enhanced and slowed when ICAM1 is co-expressed 
with L-selectin ligands in a human vascular endothelial cell line.47 Chemokines 
and chemoattractants are produced by a variety of sources, leukocytes 
themselves, endothelial cells or by-standing cells such as platelets or mast 
cells. They trigger arrest of leukocytes through GPCRs receptors and are 
powerful mediators of integrin adhesion. Integrins most relevant to leukocyte 
arrest belong to the β1-integrin and β2-integrin subfamilies. The most studied 
of these are the β1-integrin, Very Late Antigen-4 (vLA4) and the β2-integrin, 
LFA1. The effect of chemoattractants on integrin binding appears to be cell 
and ligand specific. Chemoattractants affect integrin valency and affinity 
employing inside-out signalling pathways and generating internal signals. As 
a result, under physiological conditions, integrin binding can be an 
instantaneous event.48,49 The current literature identifies 47 proteins that are 
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implicated in the regulation of integrin-mediated adhesion by 
chemoattractants.50 The arrest of leukocytes depends on the balance between 
chemoattractants, integrin expression and selectins. This combination may 
define the subtype of leukocyte and its availability in certain environments.  
Transmigrating neutrophils must traverse distinct barriers to gain access to the 
inflamed compartment. These are the endothelial cells, the endothelial-cell 
basement membrane, the interstitium, the epithelial layer and at times, the 
pericyte sheath. Transmigration is controlled, in part, by the ratio of these 
barriers which varies within the organism. The whole process can be 
completed within 15mins, with the basement membrane providing the greatest 
challenge. Initially neutrophils crawl inside the blood vessel in an ICAM1 
dependent manner.51 There the neutrophil may take either the paracellular or 
transcellular route. Inflamed endothelial cells can redistribute junctional 
molecules in a way that favours transendothelial cell migration.52 
Immunoglobulin superfamily members actively mediate leukocyte 
transendothelial migration. Examples include Platelet endothelial cell adhesion 
molecule (PECAM)1, ICAM1, ICAM2, Junction adhesion molecule (JAM)-A, 
JAM-B, JAM-C and endothelial cell-selective adhesion molecule (ESAM), as 
well as the non-immunoglobulin molecule CD99.  In response to IL-1β, but not 
Tumour Necrosis Factor-a (TNF-a), PECAM1, ICAM2 and JAM-A mediate 
leukocyte transmigration.53 Direct activation of leukocytes by TNF, fMLF or 
LTB4 appears to bypass the need for these molecules and actively mediates 
leukocyte transendothelial migration. The transcellular route is taken by the 
minority of emigrating leukocytes, largely seen within the central nervous 
system and during inflammation. Leukocyte transcellular migration starts with 
the extension of membrane protrusions into endothelial cells.54,55 Ligation of 
ICAM1 triggers cytoplasmic signalling events that leads to the translocation of 
apical ICAM1 to regions high in caveolae (small lipid rafts 50-100nanometer) 
and rich in F-actin. This results in the eventual transport of the apical ICAM1 
with caveolin-1 (a scaffolding protein) to the basal plasma membrane.54,55 
The Role of Semaphorin3F in Neutrophilic Inflammation 
Chapter 1 Introduction  19 
These responses collectively result in the formation of channels through which 
leukocytes can transmigrate migrate.55,56 Finally, leukocytes reach the 
endothelial-cell barrier, largely formed by the endothelial basement-membrane 
comprising vascular laminins, collagen IV and connecting molecules and 
intermittently the pericyte sheath.57 Variations in the constituents of the 
basement membrane, in relation to the density of the pericyte population, may 
favour neutrophil transmigration.58 Integrins are the main receptor for laminins 
and during transmigration there is a mobilization of internal stores. There 
appears to also be an interaction between integrins and cell surface proteases, 
for example there is evidence that α6β1-N integrin works synergistically with 
neutrophil elastase.58,59 
Within the lung transmigrating neutrophils face specific challenges. Due to the 
small diameter of the capillary, transmigrating neutrophils must deform, 
referred to as margination, which increases transit time even under resting 
conditions.60,61 Neutrophils may reside in the capillary bed for a time, pausing 
in intravascular pools, although the extent of this remains a controversial topic. 
In the venules, initially adhesion-molecule independent rolling can occur and 
in response to chemokines, neutrophils sequester to the capillary endothelium 
where they later adhere.62,63 Alveolar macrophages and type II pneumocytes 
produce CXC chemokines, thus promoting transendothelial migration, 
neutrophils journey through the endothelium, interstitial space, and epithelium 
to reach the alveolar space. Compared with transendothelial migration, the 
molecular details of transepithelial migration into large or the small airways and 
the alveolar epithelia, remain mostly unknown. Only recently are proteins 
emerging that might be involved such as the receptor TREM-1. TREM-1 
deficient neutrophils effectively migrate across primary endothelial cell 
monolayers but fail to migrate across primary airway epithelia.64 This highlights 
that within the lung, neutrophil recruitment can by altered at multiple levels, 
including those less well described such as transepithelial migration. These 
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may not only provide new and interesting areas of study but give rise to novel 
mechanisms prime for therapeutic manipulation.   
1.5 Neutrophil Chemotaxis 
For the directional migration of neutrophils termed ‘chemotaxis,’ the 
polarisation of the cell is obligatory. This is achieved with formation of the 
leading edge by actin rich lamella and at the opposite pole, the uropod, a tail 
like projection.65 Phosphatidylinositol-4,5-bisphosphate 3-kinases (PI-3 
kinases) have been identified down stream of G-protein-coupled receptors and 
are stimulated by chemoattractants. PI-3k activity regulates the establishment 
of cell polarity, whilst inhibition of PI-3 kinase, results in defective formation of 
the leading edge and suppression of neutrophil chemotaxis.66-68 PI-3 Kinase 
phosphorylates phosphatidylinositol 4,5-bisphosphate [PI{4,5}P2] to generate 
PIP3, which stimulates guanine nucleotide exchange factors (GEFs). GEFs are 
small GTPases; they act as a molecular switch promoting the activity of Rho-
GTPases such as Rac and Cell division control protein 42 homolog (Cdc42). 
Rac and Cdc42 induce localised actin polymerisation through Actin-Related 
Proteins2/3 (Arp2/3) pathway amongst other mechanisms.  
Rac and Cdc42 appear to have complementary but divergent roles. Rac 
participates in the feed-forward generation of PIP3 at the leading edge of the 
migrating cell. This is perhaps to amplify subtle external chemoattractive 
gradients into larger internal signals. Whereas Cdc42 is responsible for 
maintaining the location of the leading edge, by signalling the  ‘backness’ of 
the polarised cell, thus stabilising polarity.69 Negative feed-back pathways are 
essential to produce effective chemotaxis. GTPase-activating proteins (GAPs) 
directly antagonise the action of GEFs as they catalyse the conversion of 
active (GTP-bound) Rac/Cdc42 to inactive (GDP-bound) Rac/Cdc42. 
Phosphatase and tensin homolog (PTEN) generates PI(4,5)P2 a negative 
regulator of PI-3 kinase pathways and has a reciprocal location to the leading 
edge. In contrast, SH2-domain-containing inositol 5-phosphatase (SHIP), a 5′ 
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inositol polyphosphatase, is active both at the leading edge and at the tail and 
is thought to terminate PI-3 kinase activity.70 Whilst PTEN maintains PIP3 
accumulation at the anterior end, SHIP1 has been shown to inhibit integrin 
activated PIP3 gradients. Loss of SHIP1 results in defective chemotaxis 
probably due to enhanced adhesion and loss of PIP3 polarity.71 The interplay 
of these complementary pathways regulate cell motility, such that cells can 
appropriately migrate in variety of environments, in a precise and rapid 
manner. 
1.6 Reverse migration 
At the site of injury neutrophils may undergo cell death by either apoptosis or 
necrosis, with clearance occurring through phagocytosis by macrophages.72 
Alternatively they transmigrate into the airway and are expectorated. Most 
recently there is evidence that they are also retained within the tissues, or may 
undergo reverse migration away from the injury site.73,74 Reverse migration is 
a term to describe the phenomenon of leukocytes migrating in an 
unconventional direction within tissues and  organs. 75 For example, 
leukocytes moving in the opposite direction from the net leukocyte population 
or moving away from a known chemotactic stimulus. Less is known regarding 
the underlying mechanisms of reverse migration or retention of neutrophils 
within inflamed tissue; despite this it is clear that they are important factors in 
controlling inflammation resolution.76 Reverse migration has been observed in 
zebrafish models of inflammation.77 These models of neutrophil inflammation 
have distinct advantages namely, larvae are transparent allowing excellent 
visualisation of fluorescent proteins in vivo. Zebrafish neutrophils (Heterophils) 
are identifiable early after fertilisation and the innate immune system remains 
separate from any adaptive immune system. There exists a wide range of tools 
for genetic manipulation of this model. Thus zebrafish provide a simplified, 
genetically tractable model, where fluorescent neutrophils can be used to track 
the immune response.78 In one such a transgenic zebrafish model neutrophils 
express green fluorescent protein (GFP) under control of the myeloperoxidase 
The Role of Semaphorin3F in Neutrophilic Inflammation 
Chapter 1 Introduction  22 
(MPO) promoter (zMPO:GFP). In this model, following recruitment to the site 
of tail fin injury fish neutrophils have been shown to later undergo retrograde 
chemotaxis away from the injury site. It is postulated this is an additional 
mechanism of inflammation resolution.73,79 The pro-inflammatory compound 
Tanshinone 11A in a zebrafish model increased reverse migration.79 The 
relevance of reverse migration to mammalian systems is controversial.77   
In physiological conditions at resting state, neutrophils are seen to “patrol” 
vessels crawling along the luminal surface but do not transmigrate into tissue, 
termed abortive emigration.80 As discussed, neutrophils are recruited by 
release of chemoattractants from activated macrophages, epithelial cells and 
bacteria and then transmigrate across capillary epithelium to enter the site of 
injury.81,82 Hughes et al. (1997) demonstrated in a rat model of 
glomerulonephritis, that the majority of neutrophils recruited to the injured 
glomerular did not undergo apoptosis. Interestingly these neutrophils were 
observed to return to the circulation.83 In this study radiolabelled neutrophils 
were obtained from an identical rat strain and were infused prior to glomerular 
injury. Histological analysis of apoptosis, cell counts and flow cytometry were 
used to delineate the magnitude of neutrophil migration from the site of injury 
into the circulation after 0, 4 and 24 hours. These data were then compared 
with the corresponding peripheral neutrophil counts and reverse migration of 
the radiolabelled neutrophils detected. It must be conceded that vascular leak 
in the injured glomerular may also play a part in neutrophils returning to the 
circulation following recruitment to the injury site. 
Similar reverse migration has been shown in humans. Buckley et al. (2006) 
observed that in patients with rheumatoid arthritis 1-2% of their peripheral 
blood neutrophils had undergone retrograde transmigration or reverse 
migration. In healthy controls this is still seen but represents less than 0.25% 
of the total neutrophil population. Neutrophils that had returned to the 
circulation were identified by unique cell surface expression of CD54 with low 
levels of expression of the CXC chemokine receptor 1 (CXCR1low). This 
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pattern is seen on neutrophils that have migrated through an endothelial layer. 
In these patients, this neutrophil subpopulation appeared phenotypically 
altered compared to other non-recruited circulating neutrophils.74 The 
neutrophils that had undergone reverse migration demonstrated more 
resistant to apoptosis in subsequent assays.  
To date reverse migration has been visualised in zebrafish,79,84-86 mice87,88 and 
humans.77,89 Reverse transmigration of neutrophils has implications in both 
immune surveillance and dissemination of systemic inflammation as seen in 
ARDS.87,90 The mechanisms behind reverse migration remain are not fully 
understood. Interactions between neutrophils and endothelial cells are key in 
controlling neutrophil migration and ultimately leukocyte transmigration. The 
signals involved are probably organ specific, for example neutrophil migration 
into the lung parenchyma can be both selectin- and b2-integrin-independent.91 
There is evidence that neutrophils can crawl along the walls of blood vessels 
against the direction of blood flow. This is termed reverse luminal crawling 
(rLC).92 rLC of neutrophils contributes to trans-endothelial migration (TEM) 
sites in stimulated murine cremasteric venules. rLC has also been seen in 
natural killer (NK) cells and monocytes; it is thought to contribute to immune-
surveillance in multiple murine models.80,93,94 Reverse transmigration of the 
endothelial layer by leukocytes is decreased when either endothelial cell 
junctional molecule C (EC-JAM- C) or neutrophil elastase is genetically 
knocked down in murine models.74,95,96 As part of the reverse transmigration 
of any tissue the leukocyte must undergo reverse interstitial migration. This 
may require the migrating cell to dynamically re-prioritise the ongoing 
chemoattractant cues. There may be distinctive repellent signals turned on 
during resolution and these could be released from other sources including 
neighboring cells such as macrophages. 97 Also, the concentration of the 
chemoattractant may change during the course of tissue injury. In this way the 
response of the neutrophil could changed over the time despite the injury 
persisting. For example, a high dose (verses lower dose) of CXCL8 changes 
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the nature of the signal from chemoattractant, to chemorepellent. A proposed 
mechanism for this, is the desensitization of the neutrophil to the ongoing 
stimulus.98 The environment itself may alter the direction of neutrophil 
migration. Osmolarity differences between interstitial fluid and the external 
environment have been shown to mediate rapid leukocyte recruitment to sites 
of tissue damage.99 Other environmental cues may regulate the migration of 
neutrophils, for example in injured and hypoxic tissue the subsequent 
activation of Hypoxia-inducible factor (HIF) pathway increases the number of 
neutrophils at the site of injury.84,98  
Neutrophils can move away from an established chemoattractant gradient 
termed retrotaxis (can also be referred to fugetaxis); this is the specific ability 
of a neutrophil to move against a chemoattractant gradient for long distances 
and may form part of the process of reverse migration. 79,97,100 A microfluidic 
model of neutrophil chemotaxis revealed 90% of chemotaxed neutrophils 
subsequently underwent retrotaxis and this was enhanced by lipoxin A4, a 
known antioxidant.101 There is evidence of crosstalk between macrophages 
and neutrophils, whereby macrophage autocrine redox-SFK signalling is an 
important step in the reverse migration of companion neutrophils.86 The type 
of recruiting stimulus may alter the propensity for reverse migration, exposure 
of neutrophils to Zymosan yeast particles has been shown to reduce 
transmigration.89,101 Lipid mediates such as LTB4, have been shown to 
increase reverse migration in an ischaemia-reperfusion model. 102 LTB4 
induced proteolytic cleavage of JAM-C by neutrophil elastase, enables 
neutrophils to migrate back into the circulation.96 It is also possible that the 
reverse migration of neutrophils is a passive process and is based on diffusion 
rather than active migration.103  
Reverse migration is not simply chemoattraction followed by chemorepulsion; 
it is a far more complicated series of events which involve: multiple tissues 
layers, the comprising cells, cell receptors and signalling molecules. The 
recruited neutrophil is exposed to a plethora of contrasting and potentially 
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confusing signals which results in coordinated response. This could also 
represent a point of weakness that could generate dysregulation of the 
neutrophil response and subsequent disease. As per the definition of 
neutrophil reverse transmigration only a small proportion of the migrating 
neutrophil population undergoes reverse migration. This might suggest that 
this represents a pathological response rather than a novel form of neutrophil 
injury response. This evidence taken together suggests that accumulation of 
neutrophils at the inflammatory site is due to a balance between many factors. 
Neutrophil migration is determined by: chemotaxis, retrotaxis, the structure of 
the traversed cells and the environment at the site of injury. It is likely that there 
is an equally complex reverse migration cascade at play that is likely to include 
signals that retain neutrophils at the injury site. The lung has been shown to 
be a secondary site for neutrophils that have undergone reverse 
transendothelial migration (rTEM) as defined by the up regulation of ICAM 1 
with a greater ability to generate ROS. After pancreatitis and ischaemic-
reperfusion injuries rTEM neutrophils are found in the lung.82-84 From this it 
could be concluded that the resolution of inflammation is determined, not only 
by apoptosis and necrosis, but by the balance and patterns of neutrophil 
migration including neutrophil retention.  
Neutrophil migration could be manipulated to alleviate the damaging effect of 
neutrophilic inflammation. As such, neutrophil migration signals are a target for 
new therapies to prevent ischemic reperfusion injuries and to disrupt neutrophil 
migration to prevent disease.104 For example, CXCR2 antagonists have been 
shown to reduce both neutrophil numbers and elastase activity in the sputum 
of health volunteers following an inhaled LPS lung challenge.105 To date there 
is limited research on signals that specifically arrest neutrophil migration and 
maintain their presence and activity in areas of inflammation. 
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1.7 Cell motility and the actin cytoskeleton 
Cooperatively divergent signalling pathways produce a distinct polarity within 
the migrating cell. 69 In response to external chemoattractant gradients, and by 
using internally manufactured gradients, neutrophils self-regulate the 
machinery required for polarisation and motility. 106 Small GTPases such as 
Rho, Rac and Cdc42 can trigger the nucleation of actin and determine specific 
patterns of actin polymerisation. 107 Actin polymerization occurs directly below 
the cell membrane taking two forms, either a branching structure termed 
filopodia, or lamellipodia composed by sheet like protrusions. 108 Arp2/3 
complex is a member of the Wiskott-Aldrich Syndrome Protein (WASP) family 
of proteins. 109 This family of proteins detects signals and translates these into 
the nucleation of new actin branches, which are initiated from pre-existing 
filaments to construct lamellipodia.110 Filopodia are produced in two ways, 
either by branches formed by the actin bundling protein fascin, or directly 
nucleated by formin.111 Lipids and proteins within the plasma membrane may 
also direct actin dynamics. There are many actin binding proteins that 
modulate both form and function of the actin network. Actin polymerisation is 
the initiating step in a complicated and sophisticated network of pathways that 
produce orchestrated shape change and cell motility, through dynamic 
changes within the actin cytoskeleton. 
Following nucleation by Arp2/3, the formation of an actin filament sees an actin 
monomer unit added to the barbed end of the structure, whilst units are 
detached from the rear. This process is intimately related to the hydrolysis of 
Adenosine triphosphate (ATP), where G-actin-ATP is preferentially added to 
the barbed end paired with simultaneous loss of F-actin-GDP. The hydrolysed 
phosphate group remains non-covalently attached to the actin unit, leading to 
possibly three types of actin within the filament: ATP, ATP+Pi or Adenosine 
diphosphate (ADP). The actin filament is in constant flux termed “treadmilling” 
and it is the proportions of these three types of actin monomer unit that 
determine the growth pattern of the filament. Two proteins control this process; 
actin depolymerizing factor ADF (Cofilin) and capping proteins. These are 
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examples of proteins that bias the treadmilling, for example Cofilin increases 
treadmilling while capping prevents barbed end growth and increases the 
addition of units at non-capped ends. Only when acting together can these 
proteins dramatically increase the growth at the barbed end. This is seen in 
the filaments facing the leading edge in a developing lamellipodia.112 
1.8 The Resolution Phase  
The induction of inflammation resolution is initiated relatively early in the 
inflammatory process and a myriad of signals begin the termination sequence. 
These signals largely pertain to the reduction in active neutrophils at the injury 
site. Initially, granulocyte cells switch the production of arachidonic 
prostaglandins and leukotrienes to lipoxins.113 Neutrophils undergo apoptosis 
and are phagocytosed by accompanying macrophages, providing major route 
by which neutrophils cleared.114  
Apoptosis is crucial for the removal of potentially harmful material in the 
inflammatory environment and fostering resolution. Apoptosis is precisely 
controlled and augmented, a small increment in the percentage of apoptosis 
can greatly increase the rate and ultimately the clearance of neutrophils and 
consequently resolution. 115 Classically apoptosis is triggered by either intrinsic 
or extrinsic pathways. Mitochondria are central in the intrinsic apoptotic 
pathway, where permeabilisation of the mitochondria causes release of 
cytochrome c into the cytoplasm. Cytochrome c then forms a multi-protein 
complex known as the ‘apoptosome’ and initiates activation of the caspase 
cascade through caspase 9.116 Extrinsic signals include ligation of receptors 
by the (first apoptosis signal) Fas ligand (FasL), TNF-related apoptosis 
including ligand (TRAIL) and under certain conditions, TNF-a induce neutrophil 
apoptosis via generation of the death-induced signalling complex (DISC) and 
subsequent caspase 8 activation. The death-receptor ligand TRAIL has also 
been shown to accelerate neutrophil apoptosis.78 Moreover, TRAIL deficient 
mice demonstrate an enhanced inflammatory response but normal constitutive 
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apoptosis.117 The inflammatory microenvironment can further manipulate 
apoptosis, inflammatory cytokines present at the site of injury, such as IL-1b, 
interferon-gamma (IFN-g), Granulocyte-colony stimulating factor (C-CSF) and 
Granulocyte-macrophage colony-stimulating factor (GM-CSF) can delay 
apoptosis.118 Likewise, hypoxia found at sites of inflammation, has been shown 
to regulate apoptosis through the HIF oxygen-sensing pathway. This pathway 
has a major effect on the susceptibility of neutrophils to apoptosis. HIF 
expression and transcriptional activity are regulated by the oxygen-sensitive 
prolyl hydroxylases (PHD1-3); mice deficient in PHD3 had associated 
upregulation of the pro-apoptotic mediator Siva1 and loss of its binding target 
B-cell lymphoma-extra large (Bcl-xL).119 This resulted in increased levels of 
neutrophil apoptosis and was protective in a mouse model of colitis. Other 
extrinsic signals modulate neutrophil apoptosis, for example cyclin-dependent 
kinase inhibitors have been shown to enhance the resolution of inflammation 
by promoting apoptosis.115  
Extravasated neutrophils are also cleared mechanically for example though 
expectoration of sputum, or in faeces and urine. A family of lipid mediators, 
generated from omega-3 polyunsaturated fatty acid called resolvins 
(resolution-phase interaction products) and (pro-resolving mediators) 
protectins also regulate this phase.120,121 More recently, it has been postulated 
that neutrophils from the inflammatory site might then re-enter the circulation 
through a process of reverse migration, which in turn may promote the 
resolution of inflammation.75   
1.9 Semaphorins  
Semaphorins are a family of secreted and transmembrane molecules that 
have well-described chemotropic roles essential for growth cone collapse and 
neuronal development.122 They are also implicated in regulating cell motility in 
the context of vascular growth, tumour progression, immune signalling and 
immune synapse formation.123,124 The first Semaphorin protein to be identified 
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was called Collapsin, to reflect its effect upon developing axonal growth 
cones.125 This molecule was identified as a repulsive cue through a motility 
modulating ability. Collapsin (Semaphorin D) and Fasciclin (Semaphorin 1) led 
to the discovery of a larger family of related proteins.126 Over 20 mammalian 
Semaphorin proteins are known: they are divided into eight subclasses 
according to their structural features. Semaphorins are either secreted or 
transmembrane glycoproteins, classes 1 & 2 represent the invertebrate 
classes, whilst 3-7 are vertebrate and class 8 contain viral Semaphorins.123,127 
Subclass 3 are secreted and can form steep tissue gradients. Individual 
proteins are designated by their class and an accompanying letter, for example 
Sema4D. All Semaphorins contain a highly conserved Sema domain formed 
of a 400 amino acid sequence. The central feature of this structure is a seven-
blade β-propeller fold, with overall a degree of similarity to the β-propeller 
repeats of α integrins.128 They can range in size between 400 and 1000 amino 
acids; their size depends on which domains are added to the prerequisite 
phenotypic Sema domain and PSI domain (Plexins, Semaphorin and 
integrins). In classes 2-4 and class 7 a single immunoglobulin (IG) like domain 
is found, whereas class 5 Semaphorins have 5 thrombospondin domains. The 
highly conserved Sema domain and the PSI domain share familiarity with other 
important cell proteins such as integrins. This shared structure suggests that 
Semaphorins like integrins, may have an important role throughout the 
organism. 
1.9.1 Semaphorins and their receptors 
Semaphorins largely signal through Plexins, grouped A-D coded with both a 
letter and number to signify an individual receptor, such as PlexinA3. They 
were first identified through a role in cell adhesion.129 As with Semaphorins, a 
feature of the Plexin receptor is a Sema domain, extracellularly Plexins have 
three PSI domains and three multiple (Ig-like, Plexins and transcription 
factors). Interestingly they have GTPase- binding domain, this can interact 
Cdc42/ Rac, RhoD, RND1 and may also bind Ras proteins.130 
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Dimers of Sema4D and Sema6A have been shown to bind dimers of their 
Plexin receptors (B and A respectively). 131 Class 3 Semaphorins, with one 
exception, require Neuropilins as essential co-receptors to signal through class 
A Plexins (see figure 1.9.1-1).132 Dimeric Sema3A, two copies of plexinA2 and 
two copies of Neuropilin 1 are arranged as a dimer of heterotrimers. 133 The co 
receptor Neuropilin 1 (NRP 1) stabilises this structure by cross bracing the 
connection between sema domains of the Sema3A and Plexin A2 subunits 
from two heterotrimers (see figure, 1.9.1-1). Neuropilins also act as co-
receptors for the vascular endothelial growth factor (VEGF).134 
Semaphorin binding relieves Plexin auto-inhibition. When the sema domain is 
lost from Plexin-A1 the receptor becomes constitutively active.135 Most Plexin–
Semaphorin interactions are mediated through the sema domains of both 
proteins. Plexin A1 ectodomains are autoinhibited through intermolecular cis-
interactions prior to ligand binding. 136  Prior to ligand binding Plexin A1 may 
exist in a pre-formed cluster to facilitate rapid signalling. When Semaphorin 
dimers then bind, the cytoplasmic domains of the Plexin undergo a 
conformational change. This leads to a reduction in the intermolecular cis-
interactions of the Plexin A ectodomains that impose pre-signaling 
autoinhibition and outside-in signalling occurs. 136  
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Figure 1.9.1-1 The Semaphorin-Plexin-Neuropilin complex 
There are four classes of Plexin A-D, class 3 Semaphorins such as Sema3F require co-
receptors Neuropilin 1 or 2 to bind the Semaphorin ligand forming a complex with the 
transmembrane Plexin receptor which has a large intracellular component formed of a GTPase 
activating protein (GAP). The crystalline structure of the Plexin ectodomain is a ring like and 
generates cis-interactions between neighboring plexins. This is thought to prevent 
dimerization and allow clustering. 131 The obligatory co-receptor Neuropilins 1 and 2 have no 
intracellular component and serve to stabilise the binding between the sema domains of 
adjacent Plexins and Sema ligands as part of a heterotrimeric receptor complex. 136  
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1.10 Neuropilins 
Neuropilins are a family of pleiotropic receptors with roles in the 
cardiovascular, nervous and immune systems.137 Neuropilin (NRP) 1 and 2 are 
type 1 transmembrane proteins of ~ 900 amino acids with short intracellular 
domains that lack intrinsic enzymatic activity and share 44% homology.138 
Neuropilins are obligatory a co-receptors binding the exogenous class 3 
Semaphorin ligand, with the larger Plexin transmembrane receptor then 
transducing this signal intracellularly.138 Neuropilin 2 and the Plexin A family 
have been identified as receptors for Sema3F.139 NRP2 is a high affinity 
receptor for Sema3F, both NRP1 and 2 are ligand-binding partners in co-
receptor complexes for not only Plexins, but also vascular endothelial growth 
factor receptors (VEGFRs).115,116 Soluble forms of NRPs are created by 
alternate splicing or by ectodomain shedding of the transmembrane 
proteins.140,141  
NRP1 signalling is relevant to the immune system and has been shown to be 
involved in inhibitory T-cell activation, tumorigenesis and the regulation of 
tumour associated macrophages within the hypoxic niche.142,143 Recently the 
class 3 Semaphorin, Sema3A, was shown to act as an attractant for tumour-
associated macrophages (TAM) and its expression was found to be up 
regulated in hypoxic areas. NRP1 is essential for TAM attraction to hypoxic 
regions and unlike Sema3A, Neuropilin 1 was down regulated in hypoxia. This 
demonstrates how Neuropilins and Semaphorins can be individually and 
differently regulated by one stimulus (hypoxia) and this is turn regulates TAM 
localization and retention within hypoxic areas.144 There would be many 
potential outcomes of a single stimulus depending on the unique combination 
of individually regulated co-receptor and ligand. Similarly, Plexin A3 was also 
down regulated in hypoxic conditions however both receptors’ down-regulation 
appeared partially reversed when stimulated with TNF-a or IL-1b. Likewise, 
pro-inflammatory cytokines TNF-a and IL-1b also overcame observed hypoxic 
suppression of Sema3F seen in human neutrophils. Furthermore, surface 
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expression of NRP1 is down regulated on retinal neurons following Sema3A 
treatment through receptor mediated endocytosis.145 Therefore, any effect 
Sema3F has on cell motility is likely to be manipulated by the cells’ 
environment through both Sema3F and receptor expression.  
NRP2 is expressed by thymocytes, macrophages and dendritic cells with a 
clear role in controlling cell migration.146-148 Immormino et al. (2018) 
demonstrated in a murine model following LPS induced lung injury, myeloid 
specific ablation of NRP2 resulted in increased chemokine (C-C motif) ligand 
2 (CCL2) and leukocyte infiltration into the lung.149 Human alveolar 
macrophages were found to up regulate NRP2 in response to LPS dependent 
upon Myeloid differentiation primary response 88 (MyD88) signaling and 
nuclear factor kappa-light-chain-enhancer of activated B cells (NFkB). 
Whether neutrophils also upregulated NRP2 in the inflammatory niche remains 
unknown. 
NRP2 is an obligatory co-receptor for Sema3F and forms the receptor complex 
with a plexin (A1-A4), through which class 3 Semaphorins signal. Sema3F has 
higher affinity for NRP2 over NRP1. Alterations in Neuropilin expression may 
determine the outcome of Sema3F signaling and account for a degree of the 
plasticity seen in Semaphorin signalling across contexts, times and locations. 
For example, Sema3F has been shown to promote cell detachment through 
loss of cell-to-cell attachments and lamellipodia. In the MC57 breast cancer 
cell line this occurs exclusively through NRP1, whereas in the C100 breast 
cancer cell line this is through NRP2 signaling.150 NRP1 and NRP2 can be 
expressed on the same cell type and their stimulation by different class 3 
semaphorins may work synergistically to regulate complex biological patterns 
of neuronal growth seen in gangliogenesis.151  
 
1.10.1 Class A Plexins 
Currently most research on Semaphorin-Plexin signalling focuses on class A 
Plexins mediating downstream effects such as growth cone collapse and the 
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regulation of cell motility. Class A Plexins regulate the kinases Fes and Fyn. 
The binding of Sema3A to PlexinA1 results in an association between 
PlexinA1 and Fes. Fes then phosphorylates both the Plexin receptor and a 
complex of collapse response mediator protein-2 (CRMP-2) and CRMP-
associated molecule (CRAM).152 Through this pathway, Fes has been shown 
to promote Sema3A-induced collapse of COS-7 cells [CV-1 (simian) in Origin, 
and carrying the SV40 genetic material - cells], which contributes to the 
collapse of neuronal growth cones.152 CRMP-2 is thought to be related to 
microtubule dynamics whereas Plexins regulate Rho GTPases including Rho, 
Rac and Cdc42.153  
The involvement of Rac1 in class A Plexin signalling has been confirmed by 
various means.154,155 Rac1 has recently been shown to interact directly with 
PlexinA1 Sema3A growth cone collapse requires Rac activity, yet a 
constitutively active form of PlexinA1 did not require Rac to affect growth cone 
collapse.154 This is surprising on two counts, firstly Rac is usually involved in 
the generation of membrane protrusion and secondly this may identify a role 
of Rac upstream of Plexin signalling. Similarly, Rac1 not Cdc42 or Rho, 
mediated Sema3D induced growth cone collapse.155 Within the developing 
nervous system Semaphorins and their co-receptors Neuropilins, have an 
established role as repulsive signals essential for the formation of the neuronal 
network.156 PlexinA3 is required for the reduction of hippocampal mossy fibres 
and pyramidal axons needed to sculpt the pattern of neuronal connections;  
Sema3A and Sema3F appeared to be likely candidates triggering this 
function.157 Sema3A inhibits branching of cortical neurons by de-polymerising 
actin filaments.158 Sema3A was shown in culture to promote dendrite growth 
while reducing axonal growth thus determining early neuronal morphogenesis 
and polarising neurons. 159 PlexinA1 and other type A Plexins are expressed 
by endothelial cells, as are many of the class 3 Semaphorins. Semaphorin-
mediated autocrine signalling facilitates vascular re-modelling, by reducing 
endothelial cell adhesion and promoting cell movement.160 Semaphorins and 
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their receptors are not only involved in angiogenesis and vascular re-
modelling, they also play a role in morphogenesis in the nervous system, the 
heart and skeleton.161 
1.10.2 Other Plexins and direct Semaphorin signaling 
PlexinB1 can function as a GAP for the Ras-family GTPase, R-Ras. Following 
Plexin-B1 interacting with RND1, a small GTP-binding protein of the Rho 
family, there is down regulation of R-Ras activity by the Plexin-B1-RND1 
complex. This is essential for the Sema4D-induced growth cone collapse in 
hippocampal neurons.162 Integrin inactivation has been shown to be an early 
event in Sema4D-induced COS cell collapse and is crucial in the cell 
movement that is regulated by Semaphorins.160,163 It has therefore been 
proposed by Oinuma et al. (2004) that the GAP activity of Plexins decreases 
active R-Ras, leading to the detachment of cells from the extracellular matrix. 
136,137 Whilst most Semaphorin signalling occurs through interactions with 
Plexins and Neuropilins, CD72 and T cell immunoglobulin and mucin domain 
containing protein-2 (Tim2) have been found to interact functionally with 
transmembrane Semaphorins in the immune system.164 Sema7A binds directly 
to Plexin-C1 displaying Plexin-independent activity that is mediated by 
integrin-β1.139,140 Class 3 Semaphorin, Sema3E, is unusual in its class as it 
does not require a NRP co-receptor for Plexin mediated signalling.165 
1.10.3 Semaphorins in disease 
Viral Semaphorins and Sema7A are found in the genome of pox viruses and 
the wildebeest herpes virus, alcelaphine. Sema7A is also expressed by 
activated T cells, the shared homology with the viral Semaphorin Vaccina virus 
semaphorin (A39R) is not surprising, as Sema7A binds to PlexinC1 to induce 
a pro-inflammatory response by monocytes.166 It also suppresses the 
migration of dendritic cells and monocytes towards the virus infected cells and 
may interfere with phagocytosis.167,168 This prevents the acquisition and 
processing of viral antigens by dendritic cells, a mechanism of immune evasion 
by the pox virus. A39R decreases integrin-mediated attachment of dendritic 
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cells and in PlexinC1–/– mice integrin inactivation by A39R is abrogated.169  It 
is intriguing that a pox virus has evolved to utilise their signalling pathways to 
manipulate immunity and this probably reflects their prominence with the 
immune system. 
The 3p21.3 homozygous deletion in small cell lung cancer was found to 
contain genes for Sema3B and Sema3F.170 In lung tissue, a reduction in 
Sema3F seen in the epithelial layer, with a predominance of localisation to the 
cytoplasmic membrane, correlated with a higher stage of lung cancer.171 When 
metastatic human melanoma cells were transfected with Sema3F and 
implanted into mice, the resultant tumors did not metastasize.172 In this model 
tumour cells expressing Sema3F had diminished ability to adhere and migrate 
on fibronectin. They were chemorepulsive for vascular and lymphatic 
endothelial cells expressing NRP2 and the repulsive activity was abrogated by 
NRP2 RNA interference. Semaphorin signalling in the transfected tumour cells 
appears to be autocrine, this has also been observed in endothelial cell 
Semaphorin signalling.160 
 
1.10.4 Sema3F regulates motility in a zebrafish model 
Published work from my group found neutrophils express the class 3 
Semaphorin, Sema3F, with differential expression observed in hypoxia.119 This 
is interesting as neutrophils migrate to injury sites that are far more hypoxic 
than the circulatory system. Little is known about the role of Sema3F within the 
immune system. To investigate this further my group used a Sema3F knockout 
zebrafish model, where a Sema3F mutation was induced by TALENs genome 
editing. In this Sema3F knockout fish, whole body neutrophil counts remained 
unchanged compared to wild type, as was neutrophil recruitment to the site of 
injury (figure 1.10.4-1, graphs A-C) (unpublished work completed by Dr Suttida 
Eamsamarng, this work was supervised by Professor Moira Whyte, Dr Sarah 
Walmsley and Dr Andrew Furley). Intriguingly, accelerated neutrophil 
resolution was observed. In contrast, in a Sema3F whole-animal 
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overexpression model, neutrophil recruitment was reduced, and inflammation 
resolution delayed (graphs D & E). Sema3F modulates cell behaviour through 
both directly signalling with Plexins and also in complexes with NRP1 or NRP2. 
This leads to activation of protein kinases and GTPase signalling pathways, 
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Figure 1.10.4-1 Sema3F expression in a transgenic Zebrafish model alters both 
recruitment and resolution in a tail fin injury model  
Whole-fish Sema3F knockout was achieved using TALEN in situ genome editing, results are 
shown graphs (A-C). Semaphorin3Fa or semaphorin3Fb mutated F1 fish were incrossed and 
compared to myeloid-specific peroxidase (mpx): GFP fish. Tailfin transection was performed 
at 2 days post fertilisation (dpf), neutrophils were counted at 6 hours post injection (hpi) 
[recruitment phase] and 24 hpi [resolution phase]. (A) Neutrophils counted at 24 hpi. Data 
shown are mean ± SEM, n= 50 performed as 4 independent experiments, *P<0.01, 
***P<0.001. (B) TALENs had no effect on the whole-body neutrophil numbers. Whole body 
total neutrophil numbers were counted at 3dpf, n= 50 performed as 4 independent 
experiments.  (C) Neutrophils counted at 6 hpi. Data shown are mean + SEM, n= 50 performed 
as 4 independent experiments, *P<0.01, ***P<0.001. Semaphorin3Fa or Semaphorin3Fb RNA 
(50ng/μl) was injected into 1-cell stage zebrafish mpx: GFP embryos, with 50ng/μl mCherry 
RNA used as a negative control, to create a Sema3F whole-fish overexpression model. Tailfin 
transection was performed at 2dpf, and neutrophils counted at 6 and 24 hpi. (D) 6 hpi time 
point neutrophil counts (recruitment) and (E) 24 hpi time point neutrophil counts (resolution). 
Data shown are mean + SEM, n= 30 performed as 3 independent experiments, P values were 
calculated using one-way ANOVA, with a post-test correction for multiple comparisons 
(Bonferroni), ***P<0.001. 
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1.10.5 Semaphorin signaling and chemotaxis 
During chemotaxis directional migration of neutrophils requires polarisation of 
the cell with formation of the leading edge formed by actin rich lamella and at 
the opposite pole the uropod a tail like projection.65 PI-3 kinases have been 
identified down stream of G-protein-coupled receptors and are stimulated by 
chemoattractants, PI-3k activity regulates the establishment of cell polarity.67 
The cytoplasmic region of Plexin have been shown to interact with 20 different 
proteins, of which some are GEFs (Guanine nucleotide exchange factors). 175 
One such GEF is FARP2, this is a Dbl-family guanine nucleotide exchange 
factor (GEF) that contains a 4.1, ezrin, radixin and moesin (FERM) domain, a 
Dbl-homology (DH) domain and two pleckstrin homology (PH) domains. 176 
This may link Plexin signalling to the leading edge of a migrating cell. 
Recruitment of pleckstrin homology (PH) domain containing proteins bind to 
phosphoinositides (PIs) such as P1(3,4,5)3 leading to pseudopodia 
production.177  PH domain containing proteins are concentrated at the leading 
edge of neutrophils undergoing chemotaxis.178 Production and regulation of 
P1(3,4,5)3 is controlled by PI-3 kinases and PI-3 phosphatases. Inhibition of 
PI-3 Kinase activity results in defective formation of the leading edge and 
suppression of neutrophil chemotaxis.66 In addition accumulation of a major 
lipid product of PI-3 kinase namely PIP3 is a key event in in direct downstream 
cell signalling augmenting cell polarity and chemotaxis.68 PI-3 Kinase activity 
determines the level of PIP3, AKt binds directly to PIP3 at the PH domain 
situated at the membrane, therefore levels of Akt indirectly reflects PI-3K 
activity.  
My group measured dynamic PI-3 kinase activity using a transgenic zebrafish 
line: lyz/PHAkt-EGFP. Sema3F overexpression was induced by injection of 
Semaphorin3Fa or Semaphorin3Fb RNA and enhanced green fluorescent 
protein (EGFP). Fluorescence intensity was compared between the leading 
edge and the trailing edge of migrating neutrophils. Localisation of PHAkt-
EGFP in neutrophils was observed during recruitment to a tail fin injury site. 
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Both the level and localisation of PHAkt-EGFP were similar between wild-type 
and in overexpression of Sema3F, there was clear formation of a distinct 
leading edge, polarity of the cell was maintained, but they appeared rounder. 
This suggests that Sema3F signalling is acting downstream of both Akt and 
PI-3K. This initial data suggests that Sema3F affects chemotaxis via changes 
in the neutrophil cytoskeleton. Furthermore they demonstrated that 
Semaphorin induced F-actin disassembly in the zebrafish line 
Tg(mpx:LifeActRuby). This is where LifeAct is 17 amino acid bioprobe originating 
from yeast bound to a Ruby fluorochrome which binds all F-actin. Following 
injection with Semaphorin3Fa and Semaphorin3Fb, neutrophils from this 
transgenic zebrafish appear “rounder” and the area of the F-actin detected was 
diminished in the Sema3F treated cells. Barberis et al. (2004) observed that 
Sema4D-PlexinB1 signalling caused cell rounding.163 The PlexinB1 activation 
resulted in disassembly of integrin-based adhesion followed by F-actin 
depolymerisation. These results highlight the importance of Sema3F signalling 
in neutrophil actin dynamics. Sema3F unlike Sema3A,  has no evident affect 
on heterophil polarisation but does result in cell rounding. Sema3F may signal 
downstream of the of Akt and PI-3K promoting actin depolymerisation leading 
to “cellular collapse”.  
The pathway linking Plexin signalling and actin dynamics has not been fully 
described. Hung et al. (2010) demonstrated convincing evidence the multi-
domain cytosolic protein MICAL1 (microtubule associated monooxygenase, 
calponin and LIM domain containing 1) provides the physical link between 
Semaphorin-Plexin signalling and cytoskeletal response. Associated with 
PlexinA4 these proteins have redox activity, which in turn is responsible for the 
destabilisation of F-actin directly.173 Distinct temporal spatial activation of small 
GTPases of the Rho subfamily manifest in dynamic changes within the 
cytoskeleton and it is possible Sema3F signalling may interact with members 
of this pathway. Key effectors in this pathway include Rho GTPases (Rho, Rac, 
and Cdc42) which are prominent downstream targets of PI-3 Kinase and are 
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activated by rising PIP3 levels. Semaphorin-induced cell rounding may 
demonstrate global actin depolymerisation. Certainly it been shown that 
Sema3A signalling results in loss of branched F-actin mesh works. 179 This 
may also be a result of altered or inhibited cross-talk between the front and 
back of a polarised neutrophil. It is known that RhoA and its downstream 
effector, myosin II, mediate the ‘‘back-ness’’ response, which locally inhibits 
the ‘‘front-ness’’ response and constrains its location to one part of the cell.180 
Roundness and cellular collapse may result from a lack of protrusions, 
achieved through inhibition of Rac signalling as this is essential for the 
protrusion of lamellipodia and forward movement. Other members of the Rho-
family may be implicated in cell rounding such as: Cdc42. This maintains 
polarity through directing spatial orientation of lamellipodia and intracellular 
organs, or Rho which promotes adhesions during movement, or indeed Ras 
signalling as this regulates focal adhesions and dynamic stress fibre 
responses.181 How Semaphorin-Plexin signalling mediates cell rounding and 
cell motility remains a challenging puzzle, certainly it appears redox signalling, 
the Rho-super family and actin dynamics are key players. 
Sema3F evidently has an important role in controlling neutrophil migration to 
the injury site and as a consequence the magnitude of the inflammatory 
response. Neutrophils have differential expression of Sema3F in hypoxia, 
similarly the expression of Neuropilin 1 at hypoxic sites is reduced. Both in 
transfected tumour cells and endothelial cell Semaphorin signalling occurred 
in an autocrine manner.160 Whether neutrophil autocrine expression of 
Sema3F can directly regulate neutrophil recruitment to inflamed sites is 
currently unknown. In light of emerging evidence that neutrophils also undergo 
processes of reverse migration away from inflamed tissue I propose neutrophil 
expression of Sema3F regulates neutrophil retention within the lung 
parenchyma and is thus a determinant of the intensity of the innate immune 
response. The varying response of cells to class 3 Semaphorins may in part 
be accounted for by the heterogeneity of receptor expression. Following signal 
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transduction, the mechanism by which Sema3F regulates cell motility is not 
through a disruption of cellular polarity, with preservation of a leading edge, it 
is downstream of this involving the signalling pathways and cross-talk that 
control dynamic cytoskeletal organisation within a neutrophil. 
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1.11 Hypothesis and aims 
 
My specific hypothesis is that loss of neutrophil autocrine expression of 
Sema3F enhances neutrophil recruitment and resolution in acute lung injury 
through alterations in F-actin dynamics leading to reduced neutrophil retention. 
Aims: 
1. Characterise neutrophil specific expression of Sema3F and its co-
receptors in both human and murine neutrophils in response to 
inflammation. 
2. Investigate the role of Sema3F in neutrophil mediated acute lung injury 
through the study of whole animal and transgenic mice. 
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2 Materials and Methods 
2.1 Ethical approval 
The healthy human blood donation was obtained under the University of 
Edinburgh ethics protocol of the project entitled: The Role of inflammation in 
Human Immunity AMREC Reference number 15-HV-013. This has been 
reviewed and approved by: 
 1) The Blood Resource Management Committee, Medical Research Council 
(MRC) Centre for Inflammation Research (CIR), Queens Medical Research 
Institute, Little France, Edinburgh (appendix XIV); 
 2) The ACCORD medical research ethics committee, AMREC (ACCORD is 
the Academic and Clinical Central Office for Research and Development, a 
joint office of the University of Edinburgh and NHS Lothian).  
Similarly, human lung tissue was obtained from biopsy through the Edinburgh 
tissue bank which has also been reviewed and approved by the Edinburgh 
Tissue Bank ethics committee and AMREC. The NHS Lothian Bio-resources 
provided lung tissue from non-tumour regions of lung following biopsy was 
used for immunohistochemistry in this project (application number: SR451). 
2.2 Human neutrophil isolation 
Neutrophils were isolated from peripheral blood using Dextran sedimentation 
with discontinuous plasma-Percoll gradients.182 Initially, blood was drawn 
using a 21-gauge needle and then decanted into a 50ml polypropylene falcon 
(Corning B.V. Life Sciences, MA USA, 352098) and 4.4ml of 3.8% sodium 
citrate (Sigma-Aldrich, UK 00526) added to 35.6ml blood. The whole blood 
was then centrifuged at 350g for 20 minutes, at 20°C, with Brake 5, 
Acceleration 5. The platelet rich plasma (PRP) phase was aspirated into 10ml  
narrow  neck  glass vial (Fisher-Scientific, UK, 11563680) and 200μl of 1M 
CaCl2 added. Then the vial was incubated at 37°C for 1 hour to produce 
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autologous serum. Using the cell-rich lower layer remaining, leukocytes were 
then separated from erythrocytes by Dextran sedimentation using a 6% 
Dextran solution (Dextran T500, Pharmacosmos, Denmark 5510 0500 9006) 
and 0.9% saline to warm in 37°C incubator. When a clear interface was 
achieved the leukocyte, rich layer was aspirated into 50ml falcon and 
centrifuged at 350g for 6 minutes, at 20°C, with Brake 9, Acceleration 9. 
Discontinuous plasma-Percoll (GE Healthcare, UK, 17089102) gradients were 
prepared by overlaying 2 ml of 81% Percoll/9% phosphate buffered saline 
(PBS. Gibco, 14190250) onto 68% Percoll/32% PBS in a 15ml falcon tube. 
After spinning the leukocyte rich cell suspension, the cell pellet was re-
suspended with a 1 ml of 55% Percoll/45% PBS and this carefully layered over 
the gradient. The gradients were then centrifuged at 700xg, for 20 minutes, at 
20°C, with Brake 0, Acceleration 0. The erythrocytes pellet is formed at the 
bottom of the tube, between 68% and 81% Percoll layer are the neutrophils 
and eosinophils. A further band is seen above and lies the between the 81% 
layer and 55% cell suspension, these are the PBMCs and were removed 
before the PMCs using a Pasteur pipette. The neutrophil layer transferred to 
RPMI 1640 media (Thermo Fisher Scientific, UK, 11875-085) and counted 
using a haemocytometer (C-CHIP, Cambridge BioScience, UK, DHC-F01-50). 
Granulocytes were then centrifuged at 250g for 6 minutes, at 20°C, with Brake 
9, Acceleration 5. Supernatant was discarded, and the cells were re-
suspended to give 5x106 neutrophils per ml in RPMI 1640 containing 1% 
penicillin, 1% streptomycin (Sigma-Aldrich, UK, P0781) and 10% autologous 
serum or 10% heat -inactivated foetal calf serum (FCS, Sigma-Aldrich, UK, 
N4762). Neutrophils were cultured 150 μl of 5x106 neutrophils per well on a 
96-well polypropylene plate (Corning Costar plates, Sigma-Aldrich, UK, 6551). 
Neutrophil purity was measured by examination of cytocentrifuge slides using 
freshly isolated cells and was routinely >95% with eosinophils as the main 
contaminant cell type.  
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2.3 Human Neutrophil Culture 
Human neutrophils were cultured at a concentration of 5x106 neutrophils per 
ml of media on a 96-well polypropylene plate at 37°C in a humidified incubator 
with 5% supplemental CO2 (BB15 incubator, ThermoScientific, UK). 
Neutrophils were cultured in RPMI 1640, with 10% heat-inactivated FCS in the 
presence or absence: of 10 ng/ml LPS from E coli, (Enzo Life Sciences New 
York, USA, ALX-581-010-L001) fMLF [10-100nM] (Sigma-Aldrich, UK, F3506), 
IL-1b[100nM] (AMS Biotechnology, Oxford, UK, 6460-10) IL-8 [100nM] (Life 
technologies, UK, 10098H01H2U25), human recombinant Sema3F 
protein[10-1000nM] and (R&D Systems Inc, UK, 3237-S3-05), TNF-a [100nM] 
(AMS Biotechnology, UK, 1050-10).7 
2.4 Western Blotting 
2.4.1 Preparation of human neutrophil lysates for protein 
separation 
Following culture for the appropriate time period, neutrophils were gently 
harvested into 2ml Eppendorfs from the culture plates and spun at 300g for 2 
minutes at 4°C.The cells were combined so that 1x106 cells per condition were 
in each 1.5ml Eppendorf and washed in ice cold phosphate buffered saline 
(PBS, Gibco®, Invitrogen Ltd, UK 10010015). They underwent a second wash 
in 1ml of sonication lysis buffer (Appendix I). The supernatant was discarded, 
and cells re-suspended in 100 μl of sonication lysis buffer and incubated on 
ice for 10 minutes. Cells were then sonicated in a BioruptorPLUS™ iced water 
bath (Diagenode Europe SA, Liège, Belgium) using 30 second on-off high 
power cycles for 10 minutes. The whole cell lysates were centrifuged at 12,000 
g for 10 minutes at 4°C. The supernatant was removed into fresh 1.5ml tubes 
and an equal volume of 2X SDS lysis buffer was added to each aliquot (see 
appendix II). Samples were boiled for 5 minutes at 100°C then stored at -80°C. 
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2.4.2 Protein separation 
Proteins were separated by sodium dodecyl sulphate polyacrylamide 
electrophoresis (SDSPAGE) using the Bio-Rad mini PROTEAN®II 
electrophoresis cell system (Bio-Rad laboratories, UK 1658000). Precast 7.5 
% gels from (Bio-rad laboratories, 5671023) were loaded with preheated 
neutrophil cell lysates (100°C for 2-5 minutes) containing rainbow markers 
(Bio-Rad Laboratories). Proteins size ranged from 38-120 kDa therefore 7.5% 
gels were appropriate for all proteins studied. The gel was run at 180 volts 
(PowerPac 300, Bio-Rad Laboratories) in a tank containing running buffer (see 
appendix III) until the blue dye front reached the bottom of the gel. 
2.4.3 Protein Transfer 
Following separation by SDS-PAGE as described above, the gel apparatus 
was disassembled. A piece of PVDF Immobilon-FL transfer membrane (Life 
technologies, UK, 22860) was activated by soaking in methanol for 2 minutes 
and then placed in transfer buffer (see appendix IV). In a tray containing 
transfer buffer, a gel-holding transfer cassette was opened, and a fibre pad 
soaked in transfer buffer was placed on the black side of the cassette. Two 
pieces of blotting paper (Whatman®3mm chromatography paper, Whatman 
International, Maidstone, UK) were then placed on top of this followed by the 
resolving gel and then the activated membrane. Two further pieces of blotting 
paper and another fibre pad were applied on top before the gel holding 
cassette was closed and placed in a tank filled with ice-cold transfer buffer. 
Transfer of protein to the membrane was performed using a Bio-Rad Mini 
Trans-Blot® cell at 100 volts for 90 minutes. 
2.4.4 Immunoblotting and Detection 
After transfer, the membrane was blocked in blocking buffer (Odyssey buffer 
(PBS), Li-Cor, Lincoln, USA) for 1 hour on an orbital shaker. This minimised 
non-specific binding of antibodies to the membrane. The membrane was 
transferred to a 50 ml tube and the primary antibody, diluted in 2 ml of Li-cor 
Odyssey blocking buffer, was added. The dilutions at which the antibodies 
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were used are shown in appendix V. The membrane was incubated overnight 
at 4˚C on a rolling platform. After incubation with the primary antibody, the 
membrane was washed for 30 minutes in PBS with 0.1% Tween20 before 
being incubated for one hour at room temperature with the appropriate 
fluorophore-conjugated secondary antibody diluted in 2 ml of blocking buffer 
(IRDyeÒ Donkey anti-Rabbit IgG, Li-cor Bio-sciences UK, 925-32213). The 
membrane was then washed again as before. Labelled proteins were detected 
using the Li-cor Fc-Odyssey System (Li-Cor, Lincoln, USA). 
2.5 Immunohistochemistry 
Immunohistochemistry was kindly performed by Lyndsey Boswell, Service 
Manager at the Shared University Research Facilities (SuRF) department of 
the Edinburgh University, Queen’s Medical Research Institute. Following cull, 
lungs were instilled via a cannulated trachea with 10% formalin under 20 cm 
H20 and lungs dissected en bloc. They were then submerged in 10% formalin 
for 1 hour at room temperature, then at 4˚C for 4 hours. After this they were 
placed in 70% ethanol until used. Tissue was paraffin-embedded and sections 
cut at 3-5 microns. 
 
2.5.1 Staining of tissue sections 
Slides were then loaded onto Leica Bond-Max automated immunostainer 
(Leica Microsystems GmbH, Ernst-Leitz-Straße, Wetzlar, Germany). Epitope 
retrieval was performed on board Bond-Max using DAKO Proteinase k 
solution (DAKO, Glostrup, Denmark). Primary antibodies used are listed in 
appendix VI alongside the matched isotype control (using a non-immune 
immunoglobulin of the same type at an identical concentration) and was 
applied to sections at room temperature for one hour. The presence of antigen 
was visualized with Bond Polymer refine detection kit (Leica Microsystems 
GmbH, Ernst-Leitz-Straße, Wetzlar, Germany). The nuclei of the tissue were 
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counterstained using the heamatoxylin from the refine detection kit. Slides 
were removed from bond max, dehydrated and mounted.  
2.6 Assessment of neutrophil function 
2.6.1 Neutrophil chemotaxis assay 
Neutrophil chemotaxis was assessed using Neuro Probe ChemoTxÒ 
microplates with a 5μm filter (Neuro probe, Inc. Receptor Technologies Ltd., 
UK). Plates are molded from tissue culture grade transparent polystyrene. PVP 
Treatment –PCTE membranes are available pre-treated with the wetting agent 
polyvinylpyrrolidone (PVP) which makes the surface hydrophilic. Neutrophils 
do not adhere well to PVP treated membranes and drop off after migrating 
when quantifying cell numbers in the end well this is an key advantage.  
Microplate wells were filled in duplicate with 29μl of test solutions containing 
various concentrations of recombinant Sema3F[10-100nM] (R&D Systems, 
Abingdon, UK 3237-S3-025) and fMLF. A negative control (RPMI 1640) and a 
positive control (25μl of cells at a concentration of 2x106/ml) were also added 
to the microplate. The framed filter was firmly applied to the microplate so that 
the fluid in the wells made contact with the filter and there were no air bubbles. 
Cells (25μl of cell suspension) were added to each site on the filter except for 
the positive control well and allowed to migrate for an hour. Chemokinesis 
controls were prepared, cells were suspended with either recombinant 
Sema3F or fMLF in the microplate and the same reagent added to the 
corresponding well below. After incubation, any remaining cells on the top of 
the filter were carefully removed and the cells in the microplate wells counted 
using a haemocytometer. The number of cells in the microplate wells is 
expressed as a percentage of the positive control and the chemokinesis 
controls shown for clarity and not deducted from the chemotaxis values. The 
percentage of neutrophil chemotaxis was calculated as follows:  
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(Average* number of neutrophils in well / Average* number of 
neutrophils in control well) x 100 = Percentage chemotaxis 
*Average is calculated of mechanical repeats of condition 
2.6.2 Microfluidic chemotaxis assay 
 
Transwell assays have significant limitations to assess neutrophil migration yet 
are relatively easy and therefore widely used. It gives an endpoint readout only 
and provides no further information on the pattern of cell migration. To 
investigate further the effect of Sema3F on neutrophil migration I collaborated 
with Dr Felix Ellett a Clinical Fellow at Harvard medical school. The 
chemoattractant LTB4 is loaded into the chamber and washed through the 
channels creating a stable gradient for up to eight hours.89 The narrow 8µm 
diameter channels replicate the pulmonary capillaries. A drop of whole human 
blood is placed on the opposing pole and only the neutrophils population are 
able to migrate to the start of the channels through the first section of the chip 
assay (figure 2.6.2-1). Real-time light microscopy is used to monitor the 
neutrophil journey to the chamber and retrotaxis (against the preserved 
gradient, away from the chamber). Every ~5min the percentage of maximal 
recruitment to the chamber was calculated. The inflection point represents 
maximal recruitment; after this point declining percentages represent retrotaxis 
and not apoptosis as these cells can be viewed actively leaving the chamber 
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Figure 2.6.2-1 A microfluidic chip for the investigation of neutrophil migration 
A chip assay was used to assay the migration of human neutrophils in response to LTB4 [100nM] shown 
in the diagram. Only neutrophils can exit the blood and progress to the migration channels. The 
neutrophils are then recorded in real-time as they migrate to the loading chamber and the maximal 
concentration of the chemotactic stimulus. 
  
The Role of Semaphorin3F in Neutrophilic Inflammation 
Chapter 2 Materials & methods  53 
 
2.6.3 Neutrophil Phagocytosis  
2.6.3.1 Phagocytosis of opsonized Zymosan A 
Zymosan A is prepared from the cell wall of Saccharomyces cerevisiae 
(Sigma-Aldrich, 58856-93-2), initially 1g of Zymosan was boiled in 20ml of 
sterile PBS for 30 minutes then allowed to cool. Aliquots of this mixture were 
centrifuged (1200rpm for 10 minutes at 4°C) and washed three times with 
sterile PBS. The Zymosan was then pooled into a final volume of 20ml of sterile 
PBS and aliquots transferred into Eppendorf tubes. These aliquots were spun 
at 3000 rpm for 5 minutes and the supernatant discarded before storing at -
20°C. On the day of use the Zymosan was opsonized by adding 1 ml of foetal 
bovine serum to 10mg of Zymosan and agitating for 1 hour at 37°C. Particles 
were then washed three times in PBS before re-suspending in PBS to give a 
stock suspension of particles of 50mg/ml. Prepared in this way Zymosan forms 
a fine suspension of particles around 3μm in diameter. 
Neutrophils were incubated with 0.2mg/ml of opsonized Zymosan A particles 
for 15 minutes at 37°C. Cytocentrifuge slides were then prepared and uptake 
of the yeast particles assessed. In excess of 300 cells were counted and the 
phagocytic index was calculated as follows: 
PI = (Mean number of particles per neutrophil) x (% of neutrophils 
containing particles) 
2.6.3.2 Phagocytosis of Escherichia Coli 
Neutrophils were incubated with heat-inactivated fluorescein isothiocyanate-
conjugated Escherichia Coli O55:B5 (Sigma-Aldrich, 297-473-0) at a 
multiplicity of infection of 1 for 30 minutes at 37°C. The cells were then placed 
on ice to stop phagocytosis, washed in PBS and re-suspended in 
fluorescence-activated cell sorting buffer (FACS buffer: PBS without 
Ca2+/Mg2+, Bovine Serum Albumin 1% (BSA, Sigma-Aldrich, A8412), 2 mM 
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EDTA). Samples were processed using a flow cytometer (BD FACSCaliburÔ, 
BD Biosciences, Becton Dickinson Ltd., Oxford, UK). Results were analysed 
using FlowJo software (version 9.0, Tree Star Inc., Ashland, USA). 
2.7 Operetta High Content Imaging System  
Nunc™ MicroWell™ optical bottom 96 well plates (ThermoFisher, 265301) 
were pre-coated with Corningä Cell-tak (Fisher Scientific Ltd., 354240). 
Isolated human neutrophils from healthy volunteers were incubated in media 
and autologous serum at the optimized density of 2x105 cells per 100µl well 
with recombinant Sema3F [10nM, 100nM]. Each condition had 4-8 replicates 
on the plate. The plate was then centrifuged at 300g for 2 minutes and fMLF 
[100nM] added after 40 minutes of culture at 37°C The neutrophils were then 
fixed with 4% paraformaldehyde (ThermoFisher, UK, 28906) for 15 minutes at 
room temperature in a laminar flow cabinet. PBS was also added at the same 
volumes as fMLF for the vehicle control. The plate was then carefully washed 
twice with PBS and a 0.1% Triton® X-100 (Sigma-Aldrich, 9002-93-1) in PBS 
solution added to the well for 15 minutes at room temperature. Following two 
more washes with PBS the HCS CellMask™ Green stain (Thermofisher, 
H32714) was added for 30 mins at room temperature. Once removed, Alexa 
Fluor® 594 conjugated Phalloidin (Thermofisher, A12381) was added for 45 
minutes. Finally, this was removed and DAPI (4',6-Diamidino-2-Phenylindole 
Dihydrochloride, ThermoFisher, D1306) added for 15 minutes. The plate was 
washed 2 more times in PBS and sealed with para-film and protected from 
light. Images of the neutrophils at x20 magnification were acquired using 
Operetta High-Content Imaging System; each well was analysed using a 
minimum of 20 fields. Analysis of cell roundness was performed by the 
Columbus image analysis software (PerkinElmer, UK). Nuclei were first 
identified in the DAPI channel. Nuclei were quality controlled for size (<70µm2) 
and DAPI intensity (<5000) with passing nuclei used to seed a cytoplasmic 
segmentation algorithm in the 488 channel (Cell Mask™). Intensity of pixels in 
the 594 channel (Phalloidin) and the shape distribution were then measured 
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inside the predefined cytoplasmic boundary region for each cell. All cells 
imaged were analysed individually and mean of each well calculated and 
reported.183 Roundness was determined on a scale where 0 is a straight line 
and 1 a perfect circle. The pipeline used to measure neutrophil roundness is 
summarised in appendix VII. 
2.8 Project and Personal Animal Work Licence 
2.9 Murine Colonies 
2.9.1 Wild type mice 
Male and female C57BL/6 mice were purchased from Harlan (Oxon, UK) aged 
6-8 weeks. They were then rested in standard housing for 1 week prior to 
commencing experiments. 
2.9.2 Sema3Fflox/flox MRP8Cre-/- and Sema3Fflox/flox MRP8Cre+/- 
colonies 
A tissue specific Cre-LoxP system was used to delete Sema3F. MRP8 driven 
Cre recombinase (MRP8Cre) was used to target Sema3F (Sema3Fflox/flox 
MRP8Cre+/-) in neutrophils (Sema3F KO). Sema3Ffloxflox mice were generated 
via the MRC IMPC consortium and was crossed with MRP8 Cre heterozygous 
mice to generate neutrophil-specific knockouts.  
Details can be found at http://www.informatics.jax.org/allele/MGI:5692585 
[Sema3f_HEPD0570_6_A04, allele type Tm1c]. 184,185 Animals were 
backcrossed to a C57BL/6 background. C57BL/6 mice (Harlan, Oxon, UK) or 
littermate Sema3Fflox/floxMRP8Cre-/- mice were used as controls. All animal 
experiments were conducted in accordance with Home Office Animals 
(Scientific Procedures) Act of 1986 with local ethics approval. MRP8 (Myeloid-
related protein 8) is a member of the family of S100 calcium binding proteins. 
186 MRP8 driven Cre recombinase has been shown to delete the targeted gene 
in ~80% of neutrophils, with little deletion in macrophages/monocytes, 
dendritic cells, natural killer cells, mast cells, basophils or eosinophils.187  
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2.9.3 CatchupIVM-RED;Lifeact GFP transgenic mice 
CatchupIVM-RED;Lifeact-GFP mice were provided by Dr Leo Carlin and generated 
by crossing lines available at the Beatson Institute animal facilities, for use 
during ex-vivo lung imaging experiments. Mice were culled, and tissue 
prepared within this facility under local licences. Ly6G is expressed exclusively 
by neutrophils in mice.159,160 Mice were obtained where Cre recombinase and 
the fluorescent protein tdTomato were targeted to the Ly6G promotor 
sequence creating a murine model where neutrophils could be detected 
through expression of tdTomato termed  “catchup mice”.161188. While the 
neutrophils in the catchup mouse can be identified by flow cytometry the 
tdtomato in this construct is not bright enough for microscopy, therefore these 
mice were crossed with a transgenic mouse containing tdTomato under the 
control of the constitutively active promotor Rosa26 (Rosa26.LSL.tdTomato) 
producing CatchupIVM-RED. Termed “IVM-Red” as these mice allow intravital 
microscopy of red-fluorescent endogenous neutrophils. 188 CatchupIVM-
RED mice were then crossed with another transgenic animal where the peptide 
lifeact is used to report the dynamics of filamentous actin (F-actin) in a tissue 
specific manner (‘floxed-lifeact). In this mouse the promotor is the X-linked Hprt 
gene and the peptide lifeact is attached to green fluorescent protein (GFP) for 
detection (Hprt.LSL.lifeact-GFP). The term CatchupIVM-RED;Lifeact-GFP will be 
used for these mice moving forward. 
 
2.9.4 Genotyping for Murine Colonies 
Genotyping of the mice during breeding of the Sema3Fflox/floxMRP8Cre+/- 
colony and cross was initially performed by Transnetyx (Tennessee, USA) 
using protocols provided to us by the MRC Harwell (MRC IMPC consortium). 
There three probes used LIL2-Bact-P MD (the promotor driver cassette), 
Sema3F-3 WT (Sema3F gene) and Cre recombinase. Once the lines 
Sema3Fflox/floxMRP8Cre+/- and Sema3Fflox/floxMRP8Cre-/- had been established 
in-house genotyping was performed based on the Cre-recombinase 
expression. This was performed by Dr Lauren Melrose (MRC Centre for 
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Inflammation Research, Queen’s Medical Research Institute, UK) using 
primers, mastermix and cycling conditions detailed in Appendix VIII. An 
example of the genotyping results for animals from these colonies are shown 
in figure 2.9.4-1. Every 3 months samples would be sent to Transnetyx for 
more detailed genotyping to ensure the maintenance of the genotypes of the 
colony. For the CatchupIVM-RED;Lifeact-GFP mice samples were also sent to 
Transnetyx and propriety probes sets were used to confirm genotypes. 
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Figure 2.9.4-1 Example of PCR gel used for murine colony genotyping 
Representative images of a PCR gel (A) performed to detect murine genotypes extracted from 
ear clips of mice and amplified using primers to detect wild type Cre recombinase expression. 
Wild type and knock bands are labelled. (B) A table showing the primers used to identify Cre 
recombinase in this colony and the internal controls. 
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2.10 Acute lung injury model  
Mice were placed into a plastic chamber and connected to an oxygen-driven 
nebuliser. Oxygen was delivered at 6 litres per minute through 3mg 
Lipopolysaccharide (LPS from E. coli, Sigma-Aldrich, L7018) suspended in 
sterile water creating a vapour that was delivered into the chamber. Once all 
LPS was vaporised (after approximately 20 minutes) the mice were then 
returned to their cages. In prior experimental work from my group and in the 
literature, it has been established that nebulised PBS does not result in lung 
injury but nebulised LPS induces a mild and predictable murine lung injury. 
This model has been is well characterised, widely used and publicised from in 
work from both my research group and others. 8,119,189,190  
2.11 Intratracheal instillation of exogenous Sema3F  
Mice were anesthetised with an intra-peritoneal injection of medetomidine 
1mg/kg and ketamine 76mg/kg. Then intratracheal instillation of phosphate 
buffered saline and Sema3F 1μM performed. Using a blunted metal hub 
needle (Harvard Apparatus, Cambridge) to cannulate the trachea under direct 
visualisation Sema3F 1μM in 50μl of PBS or PBS was then directly instilled. 
Following this, to induce recovery mice were given a subcutaneous injection 
of the reversal agent Atipamezole was used at 1mg/kg.  
The chimeric fusion protein Sema3F used in these experiments was prepared 
in keeping with future production of Sema3F as a therapeutic. Recombinant 
fusion proteins consisting of the extracellular domain of immunoregulatory 
proteins and the constant (Fc) domain of immunoglobulin G (IgG) represent a 
growing class of human therapeutics leading to higher yields and potentially 
an increased half-life of the protein. The murine IgG-Fc protein was used as a 
control and did not yield any alteration in neutrophil behaviour or measured 
parameters during these experiments. 
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2.12 Bronchoalveolar lavage of mice   
At specified time points mice were given an intraperitoneal injection of 
pentobarbital 100 μl of 40mg/ml.  The chest wall was exposed by opening the 
skin in the midline from the initial neck wound down to the abdomen. 
Pneumothoraces were introduced by carefully puncturing the inferior surface 
of the diaphragm and then the thorax was opened by carefully cutting along 
the lateral margins of the rib cage on each side exposing the lungs and heart. 
The trachea was exposed, cannulated and secured in placed with suture 
before the lungs were instilled with 5 x 0.8ml of Phosphate Buffered Saline 
(PBS). The recovered lavage fluid was maintained on ice before 
haemocytometer counts were performed. Cytospins of cells were stained with 
Re-stain Quick-Diff for differential cell counts. 
2.13  Histology sections from mice 
The mouse trachea was cannulated under direct visualisation and lungs 
inflated with 10% formalin and then harvested.  
2.14 Murine lung imaging 
2.14.1 Harvesting of Lung Tissue 
This work was done in collaboration with Dr Leo Carlin (Cancer Research UK, 
Beatson Institute, Glasgow), with animal work being done at the animal 
facilities at the University of Edinburgh and the final processing and imaging of 
the lung slices performed at the Beatson Institute. Mice were nebulised with 
1mg/ml of LPS) from E.Coli. For mice treated with Sema3F (1μM) or PBS intra-
tracheal instillation (IT) instillation was performed 24 hours post LPS. Mice 
were culled using a lethal injection of pentobarbital and then dissected to 
expose the thoracic cavity. Following this the trachea was cannulated and 
instilled with 2%(w/v) low melting point agarose gel (Life Technologies, 
UK16520050) maintained at 37°C. The cannula was secured with a drain-type 
suture, which was pulled closed once the lungs were fully inflated with the gel 
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to prevent leakage. The carcass was then cooled on ice allowing the agarose 
to set for >3mins. Lungs were then dissected en bloc and rinsed in PBS and 
placed in either 4% paraformaldehyde solution or RPMI media.  
2.14.2 Preparation of fixed lung slices 
Following harvesting lungs were rinsed in PBS and placed in 4% 
paraformaldehyde solution. To ensure total coverage of the tissue the attached 
suture was trapped in the lid of a universal container and the tube inverted 
ensuring total coverage of the air-filled lungs in the solution. The fixed lungs 
remained in the 4% Paraformaldehyde (PFA, 16% Paraformaldehyde (w/v) 
Methanol-free, Thermo Scientific Pierce, UK 28908) for 15mins at room 
temperature and then 1 hour and 45mins at 4°C. Lungs were then rinsed and 
re-submerged in a solution containing PBS, BSA 1% and Sodium Azide 0.05% 
(Scientific Laboratory Supplies Ltd, UK CHE3270). The left lower lobe was 
carefully isolated and attached to vibratome stage (Campden Instruments, UK 
5100mz) using Vetbond tissue adhesive (VWR International Ltd, M1469SB). 
Using the highest oscillation amplitude and speed (1mm/sec advancing speed 
for fixed tissue, 0.5-1mm/sec for non-fixed) 300μm slices were made into a 
4°C solution of PBS/BSA 1%/0.05% Sodium Azide.191 
2.14.3 Staining protocol for fixed lung slices 
All incubation steps and washes were performed on a rocker. In the well of 
standard 12 well culture plate individual fixed lung slices were blocked and 
permeabilised in 300 μl of PBS with10 % normal goat serum (NGS) (Sigma 
Aldrich G9023), 1% BSA, 0.3% Triton-X 100 (Sigma Aldrich, UK RES9690T-
A101X) and 0.05% sodium Azide (PBS/10%NGS/1%BSA/0.03%TX-
100/0.05%Azide) for 30 mins at room temperature. The lung was washed in a 
PBS/1%BSA/0.01% TX-100/0.05%Azide solution and transferred to 24 well 
culture plate. The slices were incubated with the primary antibodies 
unconjugated Anti-S100A9 (1:200 Hycult Biotech, Netherlands, HM1102) and 
unconjugated Anti-CD31 (1:250, Armenian hamster monoclonal [2H8] to CD31 
monoclonal, Abcam ab119341) in 250 μl of PBS/10%NGS/1%BSA/0.01%/TX-
The Role of Semaphorin3F in Neutrophilic Inflammation 
Chapter 2 Materials & methods  62 
100/0.05% Azide for 2 hours at room temperature. One rinse and 3x2min 
washes were then performed using a PBS/1%BSA/0.01% TX-100/0.05%Azide 
solution. The slices were incubated on a rocker for a further 1 hour at room 
temperature with the secondary antibodies Cy™3 AffiniPure Donkey Anti-Rat 
IgG (1/250, Jackson ImmunoResearch Laboratories, Inc. USA, 712-165-150), 
Goat anti-Hamster IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa 
Fluor 488 (1/250 Thermofisher, A-21110) and DAPI 1:2000 in a 
PBS/10%NGS/1%BSA/0.01%/TX-100/0.05%Azide solution. Finally, 
3x2minutes washes were performed using a PBS/1%BSA/0.01% TX-
100/0.05%Azide solution, with a final rinse in PBS alone. They were then fixed 
in 2% PFA for 2 minutes at room temperature and washed twice with PBS.191 
2.14.4 Mounting of fixed lung slices 
Plastic gantries were attached to clean glass slides. To unfold the lung slices 
and for easy mounting, lung slices were placed in a beaker of distilled water 
and then wound around a small spatula they were then floated on the water 
droplet placed within the gantry. The water was then aspirated and replaced 
with Mowiol with 2.5% DABCO (1,4-diazabicyclo-[2,2,2]-octane; Sigma 
Aldrich, UK D27802) (Mowiol Hard set media see Appendix IX) using 
approximately 100-150 μl of Mowiol mounting media. Slices were then 
carefully covered with a glass slip and dried in the dark. 
2.14.5 Preparation of lung slices for culture and ex-vivo imaging 
Harvesting of lungs from CatchupIVM_RED;Lifeact-GFP mice were performed at the 
animal facility at the Beatson institute by Dr Leo Carlin. Sema3F WT and KO 
lung tissue was collected by myself from the University of Edinburgh animal 
facilities and transported on ice to the Beatson institute within 1.5 hours. 
Following en bloc dissection lungs were rinsed in PBS and placed in RPMI 
media. In an identical manner to the fixed lung the left lower lobe was carefully 
isolated and attached to vibratome stage (Campden Instruments, UK 5100mz) 
using Vetbond tissue adhesive (VWR International Ltd, M1469SB). Using the 
highest oscillation amplitude and speed (1mm/sec advancing speed for fixed 
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tissue, 0.5-1mm/sec for non-fixed) 300μm slices were made into a 4°C RPMI 
1640 media with 1% FCS. 
2.14.6 Mounting of cultured lung slices 
The treated and control slices were placed into a double glass bottomed plastic 
chamber (Thermo Scientific™ Nunc™ Lab-Tek™ Chambered Coverglass, 
Thermofisher UK, 155361) with 800 μl RPMI 1640 media at room temperature. 
A metal tissue harp was placed over each slice and weighted down with a 
titanium washer overlaying a tissue harp (both from: Warner Instruments, UK). 
The chamber was then placed inside an environmentally controlled chamber 
on a Zeiss LSM 880 Airyscan (with Fast module). The temperature was 
maintained at 37°C with normal atmospheric oxygen and 5% CO2. 
Temperature of the media and slice were allowed to equilibrate for up to 1 
hour, this also allowed the slices to settle reducing movement artefact. At the 
beginning of this resting period Alexa Fluor® 647 anti-mouse CD31 Antibody 
(Biolegend, 102415) and Alexa Fluor® 488 anti-mouse S100A9 Antibody (47-
8D3, Novus, NBP2-47980AF488) 10µl of each were directly added to the 
media surrounding each slice. At the appropriate timings the treatments were 
also added to the media. 191  
2.14.7 Lung slice Image acquisition and analysis 
Laser scanning confocal microscopy was performed using an inverted LSM 
880 Airyscan ‘Fast’ microscope (Carl Zeiss). The Airyscan Fast detector has 
advantages of increased resolution, increased signal-to-noise ratio, and faster 
image acquisition (the ‘Fast’ module essentially allows the microscope to 
obtain four image scanning ‘lines’ simultaneously). The latter was important in 
the cultured lung slices when imaging moving neutrophils. The Airyscan 
detector is comprised of 32 individual detectors arranged in concentric circles. 
With this detector arrangement, some of the unfocused signal usually rejected 
when using a standard confocal microscope, can be used to increase 
signal:noise without decreasing resolution. In fact, combining the signal 
detected by an array of sensitive sub-airy detectors allows a maximum 
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resolution that moderately improves what is normally possible in diffraction 
limited microscopy, i.e. ‘super-resolution’. Acquisition for both cultured and 
fixed slices used a Zeiss 20x objective (0.8 N.A. Plan Apochromat Air). During 
live lung imaging pre-programmed automated time-lapse acquisition of 
cultured lung slices was used. Sequential alternating imaging of the control vs 
treated lung slice over the experiment approximated simultaneous recording. 
Z-stacks where acquired and projected using Imaris (Bitplane; Oxford 
Instruments) for analysis. Image stiching was performed  using Zen ‘black’ or 
‘blue software (Carl Zeiss) and represented an area of 1mm x 1mm of tissue 
imaged at 1 time-point/position. Analysis of imaging using IMARIS V 9.1 
software is detailed within the description of the corresponding data in results 
chapters 1 and 2.   
2.15 Murine neutrophil isolation 
Peripheral blood murine neutrophils were isolated by negative magnetic 
selection using commercially available kit from EasySepâ. Once adequately 
anaesthetised, a laparotomy was performed, and the inferior vena cava was 
exposed by blunt dissection. Blood was collected using a 23G needle and 1ml 
syringe. The syringe and needle were heparinised (10% solution, StemCell 
Technologies, UK 07980). Between 0.5 and 1ml of blood was collected from 
each mouse and transferred to a 15ml falcon on ice. Mice were then culled by 
cervical dislocation following venesection. The red blood cells were then lysed 
using 9 parts of an ammonium chloride solution (StemCell technologies, 
07800) to every 1part blood. This solution was then incubated in the dark for 
10 minutes. The leukocytes were then pelleted at 300g for 10 minutes at 4°C 
and the supernatant removed. Pellets were re-suspended in 10ml of a PBS 
buffer solution containing 2% foetal bovine serum and 5nM EDTA (RoboSepä 
buffer, StemCell Technologies, 20104) and spun again at 300g for 10 minutes 
at 4°C. Typically leukocytes from 2 or 3 mice were pooled to obtain sufficient 
numbers for neutrophil isolation.  
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Leukocyte pellets were re-suspended in 150µl of RoboSepä buffer and 
transferred into a 96-well non-tissue treated U-bottom plate (Corning, 
10739314). The EasySepâ neutrophil enrichment antibody cocktail labels a 
maximum concentration of leukocytes of 100x106 per ml. Typically 3 mice 
were pooled to provide an optimal number of cells. Rat serum (7.5µl per 150µl 
sample) and neutrophil cocktail (7.5µl per 150µl sample) were added and the 
plate incubated at 4°C for 15 minutes. RoboSepä buffer (100µl) was then 
added to each sample and the plates centrifuged at 300g for 7 minutes. The 
supernatant was aspirated, and the cell pellets re-suspended in 150µl of 
RoboSepä buffer. A biotin selection cocktail was then added (7.5µl per 150µl 
sample) and plates were incubated for a further 15 minutes at 4°C. Magnetic 
dextran-coated iron particles (D particles) were added (20µl per 150µl sample) 
and plates incubated for 10 mins at 4°C. RoboSepä buffer was added to each 
well to give a total volume of 250µl and the plate then placed on an EasyPlateä 
EasySepâ magnet (StemCell technologies) for 10 minutes at room 
temperature. The tetrameric antibody complexes bound to contaminating cells 
were attracted to the magnet and settled at the bottom of the wells leaving the 
unlabelled neutrophils in the supernatant. This supernatant was carefully 
transferred into 15ml falcon tubes and topped up with RoboSepä buffer to a 
final volume of 500µl. A haemocytometer count was performed, and cells 
washed in excess PBS before being spun at 300g for 10 minutes. The cells 
were then ready to be suspended in media or the appropriate lysis solution. 
2.16 Ultra-purification of murine BAL neutrophils 
Following murine LPS nebulisation and bronchioalveolar lavage with PBS the 
extracted fluid samples were kept on ice at 4°C, then spun at 300g for 10 mins. 
Ultra-purification was achieved using Percoll gradients optimised by Dr Emily 
Watts, Clinical Fellow, Walmsley Lab Group. Using 10x PBS, a 90% Percoll 
solution was made and % gradients made as described in Appendix X. The 
gradients were layered, starting with the 3ml of 78% layer, then the 3ml of the 
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69% layer and finally the sample pellet reconstituted with 52% Percoll. The 
samples were then centrifuged at 1200rpm for 30 min with an acceleration 
setting of 1 and deacceleration setting of 0. The two layers of cells were 
aspirated with the first containing the monocyte/macrophage population and 
the second containing >95% purity of neutrophils. The samples were topped 
up with PBS and then centrifuged and counted using a haemocytometer. A 
representative image is shown in figure 2.16-1.  
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Figure 2.16-1 Example of ultra-purified neutrophils 
Following bronchioalveolar lavage neutrophils obtained were subject to another discontinuous 
Percoll gradient to improve the purity of neutrophils in the sample. The image in this figure 
shows a pure sample of neutrophils. Original magnification x10. 
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2.17 Murine Neutrophil RNA extraction 
Murine peripheral blood or bone marrow neutrophil RNA was extracted using 
the mirVanaä total RNA isolation protocol (Ambion, USA AM1560). Cells 
(1x106 per condition) were lysed in 300µl of mirVana lysis/binding buffer and 
stored at - 80°C if not being extracted immediately. To extract the RNA, miRNA 
homogenate (1/10th of the lysates volume) was added to the lysate to stabilize 
the RNA and inactivate the RNases. Samples were vortexed to mix and 
incubated on ice for 10 minutes. Volumes of Acid-Phenol Chloroform (Ambion 
AM9720) equivalent to that of the initial lysate was added, mixed using a vortex 
mixer and spun at 13400 rpm (Eppendorf Mini Spin Hamburg, Sigma Aldrich, 
Z605220) for 5 minutes at room temperature. The upper aqueous layer was 
carefully removed and transferred to clean RNase-free 1.5ml Eppendorf tubes. 
The volume removed was noted to enable 1.25 volumes of ethanol to be 
added. Samples were vortexed and a maximum of 700µl of this aqueous 
layer/ethanol mixture was transferred into a filter cartridge within a labelled 
mirVana kit collection tube. The tubes were spun for 15 seconds at room 
temperature at a 10000 rpm. The flow through was discarded and any 
remaining aqueous/ethanol mixture was added to the filter cartilage. Once all 
the aqueous/ethanol mixture had been spun over the cartridge, 700µl of 
miRNA wash solution 1 was added to the filter cartridge. Tubes were again 
spun for 15 seconds at room temperature at a 10000 rpm, the flow through 
discarded and washing of the filter cartridge was repeated a further two times 
using 500µl miRNA wash solution 2/3, discarding the flow through after each 
wash. After the final wash, the tubes were spun for a further 60 seconds to dry 
the cartridge. Cartridges were then placed into clean labelled collection tubes 
and 30-50µl of RNase free water pre-heated to 95°C was added to the filter 
cartridge. Tubes were spun again for 20-30 seconds at 13400rpm. The flow 
through containing the RNA was then used using the NanoDropä 1000 
spectrophotometer (Fisher Scientific Ltd., UK).  
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2.18 cDNA Synthesis 
Avian myeoblastosis virus (AMV) reverse transcriptase and random primers 
were used to generate cDNA from RNA aliquots. Every 1µg RNA was made 
to 12.4µl with RNase-free water and a cocktail of primers, enzyme and dNTP 
was added. Samples were run on a ³Prime Thermal Cycler (Teche Ltd., 
Staffordshire, UK) at 23°C for 5 minutes, then 42°C for 2 hours, followed by 
99°C for 2 mins to heat inactivate the enzyme and stored at -20°C. 
Regents were from Promega (Promega, Southampton, UK). The following 
master mix was added to 500ng of murine RNA in water: 8µl 5 x AMV RT 
Buffer, 16µl 10mM dNTPs, 1.2µl RNasinâ, 1.2µl random primer and 1.2µl AMV 
reverse transcriptase. 
For future use with customer designed Sema3F primer probe set from Primer 
Design, the Precision nanoScript2 Reverse Transcription Kit was used (Primer 
Design, UK). For the annealing step 0.5µl Oligo-DT and 0.5µl random primers 
were added to RNAse/DNAse free water along with up to 2µg of RNA template 
to a final volume of 10µg. Using ³Prime Thermal Cycler these samples were 
heated to 65°C for 5 min then immediately cooled in an ice water bath. The 
10µl of the following solution added to each sample: 5µl nanoScript 4x buffer, 
1µl dNTP mix 10mM, 3µl RNAse/DNAse free water and 1µl nanoScript2 
enzyme. Samples were vortexed followed by a pulse spin and incubated at 
25°C (room temperature) for 5 minutes and then at 42°C for 20 minutes. The 
reaction was heat inactivated at 75°C for 10 minutes and stored cDNA samples 
at -20°C until use 
2.19 TaqManâ and PerfectProbeä  protocol 
TaqManâ commercially available primer probe sets were obtained from 
Applied Biosystems for the target assay (Sema3F) and the endogenous 
control assay (b-actin) (Applied Biosystems, USA). To prove knockdown of the 
Sema3F gene at the mRNA level customised PerfectProbeä primer sets were 
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obtained from Primer Design targeted to the deleted region containing the 
Sema3f Tm1d allele (critical region between the LoxP sites and validation of 
primer probes see Appendix XI). Each product contained sequence-specific 
primers and a 6-FAM dye labelled probe. b-actin was selected as the 
endogenous control as it is highly expressed, and expression is not altered by 
inflammation or hypoxia. This enables relative quantification following RT-PCR 
reactions. cDNA samples from wild type murine BAL or brain tissue were 
diluted to give standards in order to create a standard curve for each gene of 
interest. For TaqManâ primers the PCR mastermix consisted of 10µl 2 x qPCR 
MasterMix II with UNG, 8µl RNase free water, 1µl Primer probe set1µl of cDNA 
was added to 19µl of mastermix per reaction. On the same opaque 384-well 
plate cDNA was added to the master mix in duplicate or triplicate and covered 
with a sealed plate lid. 
Standard thermal cycle conditions were used. 2 minutes at 50°C, 10 minutes 
at 95°C, then 40 cycles of 15 seconds at 95°C to denature and 1 minute at 
60°C to anneal and extend. 
In the case of PerfectProbeä primers the PCR master mix consisted of: 10µl 
PrecisionPLUS qPCR Master Mix, 1µl primer probe mix, 5µl [25ng] of cDNA 
template, 4µl RNAse/DNAse free water. Thermal cycling conditions required a 
hot start with 10 min at 95°C, then 50 cycles of denaturation 15 seconds at 
95°C and 60 seconds at 60°C.  
Average threshold cycles were obtained for each sample using SDS2.4.1 
software (Applied Biosystems). Standard curves were plotted using an 
arbitrary value of 10,000 for the top standard followed by the appropriate 
dilution series against average threshold cycle values. Samples were then 
quantified using the standard curve. The values obtained were normalised to 
b-actin expression in the same samples using the following equation: 
Normalised value=Gene-of-interest expression/b-actin expression. 
Alternatively, for the previously validated custom primer-probe sets (Appendix 
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XI) values were analysed using delta-delta Ct method to calculate the relative 
fold gene expression of samples. 
2.20 Lung digest and analysis using flow cytometry 
Knockout Sema3Fflox/flox MRP8Cre+/- and wild type Sema3Fflox/flox MRP8Cre+/- 
mice were nebulised with LPS at 2, 6 and 24 hours post nebulisation mice 
were culled and lungs were harvested in RPMI 1640 media at 4°C. A lung 
digest cocktail of: [all sigma] Collagenase V (C9263), Collagenase D 
(11088858001), DNase I (10104159001) and Dispase (Thermofisher, UK 
17105-041) was made in RPMI 1640 media and warmed to 37°C. Once the 
cold media had been removed, 2mls of the cocktail was added to each lung in 
a 5ml bijou. Each lung was then sectioned in 1-2mm pieces using stainless 
steel scissors. The bijous were then placed on a heated (37°C) shaker for 
40mins and vigorously agitated by hand every 10mins. Following this, digested 
cells were run through a 100µm cell strainer and excess of cold FACS buffer 
(~15mls) (PBS without Ca2+/Mg2+, 1 % bovine serum albumin, 2 mM EDTA)  
into a 50ml falcon and centrifuged at 300g for 5 minutes at 4°C. Cell pellets 
were then re-suspended in 2mls of red cell lysis buffer (Sigma-Aldrich, UK 
R7757) for 2-5 minutes at room temperature and excess of FACS buffer added 
to stop the reaction. Following this, cells were spun at 300g for 5 minutes at 
4°C and re-suspended in in fluorescence-activated cell sorting (FACS) buffer 
and centrifuged at 300g for 5 minutes at 4°C. Following this the cell pellet was 
resuspended in 5mls FACS buffer and the suspension was passed through a 
40µm cell strainer. Cell number was counted using the live/dead stain trypan 
blue (Sigma Aldrich, T8154) and a haemocytometer. A maximum of 2x106 cells 
were placed in a V-bottom FACS 96-well staining plate (VWR, UK 
ANIC20.20.18EMV) for each lung and controls. The plate was then spun at 
300g for 5 minutes at 4°C, re-suspended in PBS and spun again at 300g for 5 
minutes at 4°C. Excess fluid was then removed and 25µl of fixable live/dead 
aqua dye (Applied Biosystems, USA L34957) 1:100 in PBS was added to each 
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well apart from the unstained and the plate incubated in the dark for 15 minutes 
at room temperature. The plate was blocked with Fc block (Biolegend, UK 
101319) 1:100 in PBS with mouse serum 1:10, this was added to each well for 
a 15-minute incubation at 4°C. A master mix of the flow markers to be used 
was prepared in FACS buffer (as detailed in the table below) and 50µl added 
to each well except the unstained condition, the single aqua and the control 
FMOs (fluorescence minus one). FMOs for each Ab used were made. The 
plate was then incubated in the dark at 4°C for 30mins. All antibodies are listed 
in Appendix XII. 
Comp beads (Thermofisher, UK 01-1111-41) were used for single controls for 
each fluorochrome at the same concentration as the master mix. Following 
staining, the plates were washed with FACs buffer and samples transferred, 
through a final 40µm cell strainer into glass flow tubes. Following this, samples 
were analysed using the LSR II 6 laser Fortessa (BD Biosciences, UK). The 
gating strategy is shown in figure 2.20-1.  
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Figure 2.20-1 Gating strategy for lung neutrophils and macrophages 
Doublets were excluded using FSC-H and FSC-A and the live population of cells selected as the aqua 
negative population. CD45 was used to highlight the leukocyte population. A granulocyte gate was 
applied, and macrophages were identified through their expression of CD64 and further subdivided into 
alveolar macrophages and interstitial macrophages based on their expression of Siglec F and CD11c. 
Interstitial macrophages were further subdivided into Ly6C+ or MHCII+ cells. Neutrophils were gated 
upon as Ly6G+ cells. 
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2.21 Flowcytometry analysis of neutrophil surface expression of 
Sema3F receptors 
Blood was obtained from healthy controls recruited locally from the Centre for 
Inflammation Research (CIR) Blood Resource database (AMREC, 
15/HV/013). Whole blood was immediately added to 3.8% sodium citrate 
(Sigma Aldrich, 1613859). The sample was prepared as described in section 
2.1 Human neutrophil isolation, however after the dextran sedimentation the 
cells were removed and decanted into a 50ml falcon then pelleted. To induce 
red cell lysis the cell pellet was re-suspended in 1 ml of a 0.2% NaCl hypotonic 
solution and then a further 9 mls of 0.2%NaCl was added and the falcon 
inverted 10 times. Next, 10 mls of 1.6% NaCl hypertonic solution was added 
to achieve isotonicity and the falcon inverted once.  The cells were centrifuged 
at 1500 rpm for 6 minutes and the pellet re-suspended in PBS and countered. 
A maximum of 3x105 cells were placed in a well of a V-bottom FACS 96-well 
staining plate for each condition and for controls. The plate was then spun at 
300g for 5 minutes at 4°C, re-suspended in PBS and spun again at 300g for 5 
minutes at 4°C. Excess fluid was then removed and blocked with Fc block 
(1:100 in PBS) with mouse serum 1:10. This was added to each well for a 15 
minute incubation at 4°C. A master mix of the flow markers to be used was 
prepared in FACS buffer (as detailed in Appendix XII) and 50µl added to each 
well except the unstained condition. FMOs for each Ab used were made. The 
plate was then incubated in the dark at 4°C for 30mins. The antibodies are 
listed below. Following this, samples were analysed using the LSR II 6 laser 
Fortessa (BD Biosciences, Oxford, UK). Results were processed using FlowJo 
software (version 10.0, Tree Star Inc., Ashland, US). 
2.22 Neutrophil surface expression of L-Selectin and CD11b 
Following 4 hours incubation with LPS, neutrophils were washed with ice-cold 
FACS buffer (PBS plus 0.5% BSA) and stained with anti-mouse antibodies at 
4°C. Cells were single-stained with PE-anti-CD62L (-selectin) (8 μg/ml, BD 
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Pharmingen™) and PE-anti-CD11b (8 μg/ml, BD Pharmingen™). Isotype 
matched controls (PE-IgG2a and PE-IgG2b respectively) were used to set 
baselines. Antibody binding was detected using a BD FACS Calibur™ flow 
cytometer (BD Biosciences, Dickinson Ltd., Oxford, UK). During analysis 
specific geometric mean fluorescence was calculated by obtaining geometric 
mean fluorescence intensity values for each antibody and subtracting the 
geometric mean fluorescence of the isotype control.  
2.23 Measurement of neutrophil respiratory burst 
Human neutrophils were isolated using a discontinuous Percoll gradient and 
cultured in RPMI 1640 media with 1%FCS at a density of 5x106 cells/ml in 96 
well plate at 37°C in an incubator with 5% CO2 as previously described. Those 
conditions requiring treatment with Sema3F, the recombinant Sema3F protein 
[10, 100nM] (R&D Systems), was added prior to re-suspension of the cell 
pellet. Following culture in media, or media with Sema3F for an hour, the 
general oxidative stress indicator CM-H2DCFDA (DCF) (Life Technologies, 
USA C6827) was added at concentration of 5 µM for 30 minutes at 37°C in an 
incubator with 5% CO2. The stimulus N-formyl methionyl peptide, formyl-
methionyl-leucyl phenylalanine (fMLF) [100nM] (Sigma Aldrich, 59880-97-6) 
was added for further 30 minutes returning the plate to the incubator. The 
entire plate was cooled in an ice bath and the conditions rapidly aspirated into 
cooled Eppendorfs which were centrifuged at 2000rpm for 5 minutes, rinsed 
once in cold FACS buffer and placed in glass flowcytometry tubes then 
analysed immediately on an LSR II 6 laser Fortessa (BD Biosciences, Oxford, 
UK).  
2.24 Measurement of neutrophil myeloperoxidase activity 
Neutrophils were cultured in RPMI 1640 with 1% FCS at a density of 1x106 per 
well. At time 0, 100nM of Sema3F or 15µl PBS vehicle control was added to 
wells. Following a 1-hour incubation at 37°C  with 5% C02 a further 10ng/ml 
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granulocyte-macrophage colony stimulating factor (GM-CSF, Pepro-Tech, UK 
300-03-5) or 15µl of RPMI 1640 media was added to wells. The plate was 
returned to the incubator and the neutrophils were treated with 100nM of FMLF 
or PBS vehicle control after 30 minutes for another 10 minutes. The plate was 
centrifuged at 350g for 5mins at 4 and 10µl removed from each technical 
replicate and pipetted onto a 96 well ELISA assay plate (CoStar, Corning, 
USA, 3590). To each 10µl of sample 80µl of H2O2 0.75mM pipetted onto all 
wells using a multi-channel pipette in addition 110µl of 3,3',5,5'-
Tetramethylbenzidine (TMB, Thermofisher, UK) substrate added to each well. 
The plate was covered to protect it from light and incubated for 5 mins at 37°C  
with 5% CO2. Finally, 50ul of 0.16M sulfuric acid stop solution was pipetted 
into the wells and the plate read on plate reader at 450nm (Synergy HT, Biotek, 
UK). 
2.25 Measurement of neutrophil elastase 
Elastase activity in cultured neutrophil and BAL supernatant was measured 
using the Enzcheck kit procured from Life Technologies and the supplied 
protocol adhered to (Enzcheck elastase, Life technologies, E12056). Cell 
supernatant was prepared as described in methods section 2.24 and the 
measurement of neutrophil elastase activity in response to pre-treatment with 
Sema3F[100nM] determined. Standard curves were made from DQ Elastin 
with 1:2 serial dilutions in triplicate. Neat neutrophil supernatant was used; 
samples and standards were incubated at room temperature for 20-30 minutes 
with the reaction buffer and then analysed using a plate reader 
(excitation/emission 485/530, Synergy HT, Biotek, UK). 
2.26 Statistical Analysis 
Data were analysed using Prism 7.0 software (GraphPad Software Inc, San 
Diego, CA). For comparison of two sample means when cells from the same 
subject were used, paired t-tests were performed. Unpaired t-tests were used 
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for comparisons between control and patient or wild type and transgenic 
sample means. If multiple time points or concentrations were used, repeated 
measures ANOVA with the relevant post tests were performed. If many 
comparisons between genotypes or controls and patients were required in 
these experiments, two-way ANOVA. Bonferroni or Šídák post-hoc tests were 
used when a selected set of means was to be compared. The Šídák method 
was used when each comparison was independent of the others. If this 
assumption of independence could not be supported, the Bonferroni method 
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3 Results chapter: Neutrophil Sema3F expression is 
upregulated following inflammation and regulates 
neutrophil migration in the injured lung 
3.1 Introduction 
3.1.1 Class 3 Semaphorins in disease 
As previously shown by Walmsley et al. (2011), in hypoxic neutrophils deficient 
in the PHD3 (a regulator of HIF pathway), the transcript for Sema3F was highly 
up regulated.192 This suggested that Sema3F has a role in the neutrophil 
response to hypoxia and inflammation. Certainly, it is known that Semaphorins 
have key roles in immune signalling and have been shown to act as a 
neutrophil chemorepellent in the context of chronic lung allergy by Movassagh  
et al. (2016).193 More widely Semaphorins have been demonstrated as having 
a role in lung cancer as a tumour-suppressor gene.194,195 Higher abundance of 
its co-receptor NRP2 is associated with increased metastasis in lung 
cancer.194,196 Moreover class 3 Semaphorins appear to regulate cell behaviour 
in an autocrine manner.160,197 Therefore neutrophil Sema3F could plausibly 
regulate neutrophil behaviour during the innate immune response in an 
autocrine manner. 
3.1.2 Lipopolysaccharide induced lung injury 
In order to investigate Sema3F in the context of acute lung injury a murine 
model of acute lung injury was used. This model is generated by the delivery 
of nebulised LPS to mice. LPS is a pathogen-associated molecular pattern 
(PAMP) which through interaction with TLR4 releases pro-inflammatory stimuli 
and recruits leukocytes to the injury site. LPS induced lung injury is an 
approximation of acute lung injury seen in humans, both produces a largely 
neutrophil-dependent response. The LPS-induced lung injury has a well  
characterised course and duration which is well tolerated by mice.189  
3.1.3 Neutrophil responses to TNF-a  and IL-1b 
TNF-a and IL-1b have both been shown to be important signals in lung 
inflammation and elicit characteristic neutrophil responses. They are useful 
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experimentally, as part of a reductionist strategy, to stimulate neutrophils to aid 
understanding of neutrophil behaviour in the inflammatory niche. TNF-a has a 
key role in myriad of respiratory diseases ranging from ALI to asthma and lung 
cancer. It is also prominent in the pathophysiology of conditions affecting other 
systems, including rheumatoid arthritis and inflammatory bowel disease. 
Monoclonal antibodies against TNF-a are now used as therapeutic agents in 
some of these illnesses.198-201 TNF-a has been shown to prime neutrophils and 
can enhance the respiratory burst through cytoskeletal rearrangements.202 In 
terms of apoptosis a bimodal effect is observed whereby, following cell culture,  
TNF-a inhibits apoptosis in neutrophils aged 6-20 hours but after 20 hours it is 
pro-survival.203 This is in contrast to most cytokines and chemokines which 
promote neutrophil survival in the inflammatory niche. TNF-a  has also been 
shown to promote neutrophil adhesion alongside inhibiting neutrophil 
polarisation and migration thus retaining the neutrophil in situ.204 The 
pleiotropic affect of TNF-a diverge at the level of its two receptors Tumour 
necrosis factor receptor (TNFR) 1 and 2. An inhibitor of TNFR1 was shown to 
reduce pro-inflammatory effects of TNF-a favouring the protective effect of 
TNFR2 signaling. This gives rise to the inhibition of neutrophil adhesion 
molecule expression and a reduction in lung inflammation and neutrophilia in 
non-human primates and healthy volunteers following an endotoxin lung 
challenge.205 
IL-1b has also been shown to recruit neutrophils and has a role in ALI.206 More 
generally IL-1b  is involved in auto-immunity and is a target for emerging 
therapies in rheumatoid arthritis.207 IL-1b deficient mice are hypersusceptible 
to group B streptococcal infection due to a reduction in neutrophil but not 
macrophage influx to the infective site. This occurs through a reduction in the 
neutrophil production of CXCL 1 & 2, which promotes neutrophil release from 
the bone marrow and is reflected in the neutropenia (defined as a neutrophil 
count of less than 0.5 ×109/l) found at baseline in these animals.208 
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3.1.4 Clearance of neutrophils in the resolution of inflammation 
Following recruitment to the injured lungs neutrophils are either disposed of 
through apoptosis and subsequent phagocytosis by macrophages or a 
significant number of neutrophils and macrophages will be cleared through the 
mucociliary escalator after which they are either swallowed or 
expectorated.25,114 These routes of clearance may not be mutually exclusive. 
It is highly improbable that neutrophils undergo reverse migration from the lung 
alveolus due to the complexity of the barriers to reverse transmigration. In 
effect this location represents loss to the external environment and therefore 
is final and to-date there is no evidence this can occur. However, there could 
be a degree of reverse migration from the pulmonary vasculature to the wider 
circulation.75 For example the lung has been posited as a de-priming station 
for neutrophils and a repository of neutrophils ready for rapid response. Also, 
as a mid-way station for neutrophils as they relocate back to the bone marrow 
following up-regulation of C-X-C chemokine receptor type 4 (CXCR4). 20,21,23 
There is an interplay between signals which control neutrophil survival during 
resolution. The majority of inflammatory stimuli present during the 
inflammatory response potentiate neutrophil survival. 8 7,209-211 For example, 
hypoxia, which is inextricability linked to the inflammatory niche, has been 
shown to promote neutrophil survival through neutrophil hypoxia-inducible 
factor (HIF)-1α.8 Thus a reduction in inflammatory signals may herald 
resolution and neutrophil death. As described, some inflammatory stimuli have 
opposing effects on neutrophil apoptosis which is timing-dependent203 
Apoptosis is regulated through a complex network of signals which include 
anti-apoptotic protein myeloid cell leukemia 1 (Mcl-1), Bcl-2 family member 
Bax (bcl-2-like protein 4), and the caspase family of proteases.212-214 Once 
apoptosis is engaged neutrophil functions are reduced but cell integrity is 
maintained and phagocytosis by macrophages clears the dying cells 
preventing their harmful contents being inappropriately released.114 Not only is 
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the amount of neutrophil apoptosis important but the rate of apoptosis over 
time will in part determine resolution.115 
More recently resolvins and protectins have been identified which further 
control the inflammatory response. These terminating signals are pre-emptive 
and begin prior to resolution.215 Influx and efflux of neutrophils to the injury site, 
in addition to apoptosis, will facilitate the inflammatory response. Other 
molecules that control neutrophil recruitment such as LTB4, may modulate 
neutrophil swarming behaviours at the injury site itself.36 Within this cacophony 
of signals there could be cues that instruct neutrophils to remain, and through 
antagonising opposing stimuli, maintain a helpful balance of neutrophil 
recruitment and loss working alongside established mechanisms of neutrophil 
clearance. 
I propose that Sema3F is a neutrophil autocrine retention signal that controls 
neutrophil transit to the lung and can differently regulate the inflammatory 
response with wider implications for host defense response and tissue 
damage. 
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3.2 Sema3F expression 
3.2.1 Human neutrophil expression of Sema3F is regulated by 
inflammatory mediators  
To investigate the regulation of Sema3F expression in human neutrophils, 
western blot analysis of neutrophil lysates was performed following culture with 
pro-inflammatory cytokines. The Sema3F detected in human neutrophil 
lysates was seen at 60 kDa and not the predicted 120 kDa. Sema3F 
possesses an RXRR furin recognition site in its C-terminus and can be 
proteolytically processed. 216 To prove that the 60 kDa represented a cleaved 
portion of the Sema3F protein, a blocking peptide to the Sema3F antibody (LS-
C135015-50 antibody) was used. When the blocking peptide was incubated 
(in excess) with the antibody only 120 kDa band was seen in the murine brain 
sample (figure 3.2.1-1 A & B). This shows that the antibody is specific for the 
Sema3F and detects the protein (or a portion of it) at 60 kDa in human 
neutrophil lysates. The signal seen in the murine brain sample may result from 
non-specific binding of the antibody. This antibody was then used to 
investigate Sema3F protein expression in human neutrophils. An example 
western blot is shown in figure 3.2.1-1 C and P38 was used as a loading control. 
Subsequently densitometry was performed, and protein expression is shown 
in (D), sample expression was adjusted according to the corresponding 
loading control. P38 MAPK (mitogen-activated protein kinases) was used in 
these experiments as it is detected at an ideal kDa for comparison with the 
protein of interest – Sema3F (60 kDa). P38 MAPK is both abundant and there 
is little  variation in neutrophil expression overtime or with stimuli 190. Tubulin 
and actin are unsuitable alternatives being detectable at 55 kDa. Neutrophil 
GAPDH is altered by hypoxia and therefore inflammation. 8 This demonstrates 
human neutrophils express the protein Sema3F at baseline (cultured for 4 
hours without treatment). There is a significant increase in Sema3F protein 
expression following treatment (one-way ANVOA, **P=0.0019). When 
comparing individual treatments, stimulation with LPS results in a significant 
up-regulation of Sema3F protein expression after 4 hours (4 hours culture vs 
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LPS *P=0.0058, n=3). There is an increased trend in the level of Sema3F 
expression seen following TNF-a. Following IL-1b stimulation there is no 
difference in Sema3F expression compared to the control group.  
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Figure 3.2.1-1 Sema3F differentially expressed in human neutrophils in 
response to inflammatory stimuli 
The Western blots shown in A represent neutrophil lysate samples and the controls 
recombinant Sema3F (R Sema3F) and murine brain tissue. Sema3F expression was detected 
using the polyclonal rabbit antibody LS-C135015-50, an anti-P38 antibody was used to provide 
a loading control. The membrane was cut below 50 kDa prior to incubation with the primary 
antibodies. The bands shown in the right blot (image A) are specific to this antibody, whereby 
following the addition of a paired blocking peptide (image B) there is a loss of bands at 
approximately 60 kDa in both the neutrophil lysates and controls. Using this antibody, the 
amount of neutrophil expression of Sema3F following culture with TNF-a, IL-1b and LPS [all 
at 100nM] is shown in the representative blot (C). The densitometry is represented in graph 
D, this is shown as a fold change of the time-matched control. There is a significant treatment 
effect and increase following LPS stimulation in Sema3F protein expression. Data shown are 
mean ± SEM, n = 3 performed as 3 independent experiments. Analysed using a one-way 
ANOVA (**P<0.01) with post test analysis using Fisher’s test to compare individual treatment 
groups (**P=0.0058). 
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3.2.2 Neutrophil Sema3F expression is seen in the inflamed 
airways of patients with COPD  
To test the relevance of Sema3F expression in the context of human 
respiratory disease, patient samples were obtained from the NHS Research 
Scotland (NRS) biorepositories and Sema3F expression identified using 
immunohistochemistry. To test whether that Sema3F expression is seen in 
transmigrated human neutrophils, lung sections were taken from patients at 
the time of lung resection with concomitant COPD; tissue samples were used 
from non-tumour areas. The sections were stained for Sema3F (dark brown 
staining) which is present in the myeloid population found in the airspaces of 








Figure 3.2.2-1 Sema3F expression is seen in the myeloid population in the alveoli of patients with COPD. 
Lung sections taken at time of tumour resection from non-tumour regions of patients with moderate severity COPD were stained for Sema3F (B-D). An 
isotype matched control is shown in (A). Positively stained cells are indicated by the black arrows. These images were obtained using a x40 optical lens. 
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3.2.3 Murine neutrophil Sema3F mRNA levels rise acutely 
following lung injury 
To further explore the expression profile of neutrophil Sema3F, qPCR was 
performed for Sema3F transcript in murine neutrophils recruited to the lung 
following LPS induced lung injury. Following nebulized LPS, mice were culled 
at 6, 24 and 48 hours and bronchioalveolar lavage (BAL) performed; 
neutrophils were isolated from the cellular infiltrate found in the BAL. 
Neutrophils were further purified using negative selection. From the cell pellets 
mRNA was extracted and cDNA made, using a Taqman assay quantification 
of the mRNA was detected. Beta-actin was selected as the endogenous 
control as it is highly expressed in neutrophils and is not influenced by 
inflammation. 8,217 To assess transcript expression 2DdCT was determined for 
the experimental conditions relative to unstimulated wild-type bone marrow 
derived neutrophils. The fold change of Sema3F mRNA compared to 
peripheral blood neutrophils (time 0) was calculated and is shown in figure 
3.2.3-1. The amount of Sema3F mRNA rises acutely at 6 hours (mean 
0.31±0.007 n=4, ***P<0.001) following recruitment of the inflammatory 
neutrophil to the injured airway and is sustained at 24 & 48 hours at slightly 
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Figure 3.2.3-1 Murine Sema3F mRNA levels rise acutely following LPS induced 
lung injury 
Fold change in Sema3F mRNA expression following acute lung injury with LPS. Mice were 
sacrificed at 6, 24 and 48 hrs post installation, bronchoalveolar lavage performed (BAL) 
neutrophils collected, and cDNA extracted. TaqMan analysis of cDNA was performed with 
data normalized to beta-actin (ACTB) expression and 2DdCt calculated (control: wild-type 
unstimulated bone marrow derived neutrophils). Data show mean± SEM of fold change 
compared to peripheral blood neutrophils (PB T0), n=4-6 analysed by one-way ANOVA, 
***P<0.001. 
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3.2.4 Murine neutrophils express Sema3F  
Wild type mice were nebulised with 1mg/ml of LPS and sacrificed at 24 hours. 
Serial sections stained for a Sema3F isotype control, Ly6G (neutrophils) and 
Sema3F respectively are shown in figure 3.2.4-1 in images A, B & C; image D 
is of murine brain tissue used as a positive tissue control. For details of the 
primary antibodies used for immunohistochemistry see appendix VI. In image 
A there is an infiltration of neutrophils to the injured lung at 24 hours post LPS 
induced lung injury. At this time >90% of the infiltrating population would be 
neutrophils.218 In image A no non-specific staining was seen in the isotype 
control supporting the specificity of the staining seen in images B, C and D in 
the figure. The murine brain tissue in D has positive staining located most likely 
on purkinje cells and on a subset of cells in the Inner Granular Layer as 
expected for Sema3F and provides a positive tissue control.219 In image A, 
there is only nuclear staining, this highlights the unique morphology of the 
neutrophil multi-lobar nucleus and draws a sharp contrast to the surrounding 
cells, clearly identifying the neutrophils (identified by the black arrow) shown 
in the representative paired image to the right of A. Ly6G (Lymphocyte antigen 
6 complex locus G6D) is a 21-25kD glycosylphosphatidylinositol (GPI)-linked 
differentiation antigen that is expressed by myeloid-derived cells in a tightly 
developmentally-regulated manner. Monocytes express Ly6G transiently 
during maturation within the bone marrow. In terms of recruited myeloid cells 
Ly6G is exclusively expressed by neutrophils.220,221 In figure 3.2.4-1 image B 
there is an abundance of neutrophils in the injured lung, these cells are positive 
for Ly6G staining confirming they are neutrophils shown in the representative 
image to the right of C. In the sequential serial slice C the neutrophils positive 
for Ly6G are also positive for Sema3F. 
The progression of Sema3F protein production during acute lung injury in the 
lung tissue is shown in figure 3.2.4-2. Sema3F expression is seen at 6 hours 
following LPS induced lung injury in wild-type mouse lung tissue image A. The 
black arrows indicate epithelial cells (*E) and neutrophils (*N) that are 
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positively stained for Sema3F at 6 hours post injury. At 24 hours post injury 
Sema3F is also seen in the macrophages (*M). Later at 48 hours, the level of 
Sema3F staining is subjectively reduced when compared to both 6 and 24 
hours and there is no staining seen in the epithelial cells (image C).  
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Figure 3.2.4-1 Following LPS induced lung injury recruited murine neutrophils express Sema3F 
An acute lung injury was induced by LPS nebulisation, mice were sacrificed at 24 hours and serial lung sections stained for expression of the neutrophil 
marker Ly6G (B) and Sema3F (C). The negative isotype control is shown (A) and positive tissue control, murine brain tissue (D). To the right of each lung 
section image (A, B & C) there is an example of a neutrophil from the parent image. For image D a blown-up image highlights the positive staining in both 
purkinje cells and a subset of cells in the Inner Granular Layer. Example neutrophils and blown-up tissue areas were achieved using digital magnification 
with black arrows indicating an individual neutrophil. Original magnification x40. 
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Figure 3.2.4-2 Following lung injury Sema3F protein expression is seen acutely 
in both the myeloid cell population and the epithelial layer  
Images shown are of stained lung sections from wild type mice following acute lung injury. At 
6 hours (A) there is evidence of Sema3F within both the recruited neutrophils (black arrow *N) 
and the airway epithelial cells (black arrow *E). At 24 hours staining is also seen in the 
macrophage population (black arrow *M). At 48 hours there is no Sema3F staining found within 
the epithelial cell layer (black arrow *E), however there are some macrophages (black arrow 
*M) and neutrophils (black arrow *N) that show positive staining. Original magnification is x40.  
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3.3 Co-receptor NRP2 expression 
3.3.1 NRP2 is expressed by recruited lung neutrophils in COPD 
To ascertain whether it is possible for neutrophil Sema3F autocrine signaling 
to occur in vivo and ensure that this is relevant to human lung disease, patient 
samples were obtained from the NHS Research Scotland (NRS) 
biorepositories and NRP2 expression identified using immunohistochemistry. 
Neuropilin NRP2 expression is seen in transmigrated human neutrophils. Non-
tumour containing lung sections were taken from patients at the time of lung 
resection with concomitant COPD. The sections were stained for NRP2 (dark 
brown staining) and similar to Sema3F staining this is associated with the 
myeloid population found in the airspaces of the lung (figure 3.3.1-1, Images 
B and C). For details of the primary antibodies used in immunohistochemistry 
see appendix VI. 
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Figure 3.3.1-1 COPD lung neutrophils express NRP2 
Lung sections taken at time of tumour resection from non-tumour regions of patients with 
COPD were stained for NRP2 (B&C). An isotype matched control is shown in (A). Positively 
stained cells are indicated by the black arrows. These images were obtained using a x40 
optical lens. 
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3.3.2 Human neutrophil NRP1 and NRP2 co-receptor expression 
can be detected by flow cytometry 
To explore the surface expression of NRP1 and 2 in human neutrophils I 
optimised a flow cytometry panel of antibodies. Whole blood was taken from 
healthy volunteers and was subjected to a red cell lysis optimised for the 
preservation of the neutrophil and monocytes populations. Then, using a 
previously validated panel to identify neutrophils from whole blood, the 
neutrophil expression profile of NRP2 and NRP1 was evaluated.222,223 Figure 
3.3.2-1 demonstrates the gating strategy for the neutrophil populations (Panel 
A) and subsequently the NRP2 (B & C) and NRP1 (D & E) positive neutrophils. 
Monocytes provided a biological positive for NRP1 staining which is shown in 
a later figure 3.3.4-1.224  
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Figure 3.3.2-1 Surface expression of NRP1 and NRP2 co-receptors on human 
neutrophils analysed by flow cytometry 
Following red cell lysis human whole blood was analysed using flow cytometry to determine 
NRP1 and NRP2 surface expression. In panel A, plot 1 shows identification of cells over debris 
using FSC-A/SSC-A, single cells are selected rejecting doublets (A plot 2), plot 3 shows gating 
for CD66b positive granulocytes (43% of single cells) and plot 4 shows CD49d negative 
granulocytes which are the neutrophil population (93.7% of granulocytes). Plot B shows the 
gate for the NRP2 positive neutrophil population (10.4% of neutrophils) which is based on the 
C, the corresponding fluorochrome minus-one (FMO) for the APC conjugated NRP2 receptor 
antibody signal. D & E show similar for the NRP1 receptor antibody which was conjugated to 
FITC (0.16% NRP1 positive neutrophils). 
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3.3.3 Cell viability and fluorescence-activated cell sorting (FACS) 
of human neutrophils expressing NRP2   
In addition to the previously described panel to identify human neutrophils from 
lysed whole blood as shown in the figure 3.3.3-1 (panel A), a fixable live/dead 
stain was added. Using this it was evident that < 5% of identified neutrophils 
were dead at the time of fixation (plot, B). The panel was designed for FACS 
of NRP2 positive human neutrophils (with thanks to QRMI flow cytometry Unit 
and Dr Shonna Johnston). Cytospins were made of the resulting cell pellet, the 
neutrophils were identified by morphology. They were exclusively neutrophils 
and there was < 1% apoptosis seen; a representative image is shown in figure 
3.3.3-1, image C. Of the cells that appeared dead, using the viability dye in the 
flow cytometry panel, very few were identified as NRP2 positive neutrophils 
shown in plot D. 
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Figure 3.3.3-1 NRP2 positive neutrophils are viable and FACS sorted NRP2 
positive neutrophils morphologically confirm an accurate identification of a 
neutrophil subpopulation 
Following red lysis and fixation a fixable live/dead stain was used to identify dead cells. 
Neutrophils were identified as shown in panel A. The amount of neutrophil death using this 
protocol was consistently < 5% as shown in the representative plot in B (dead neutrophils 
3.18% of the neutrophil population). Using this panel cells underwent flow assisted cell sorting 
(FACS) and a representative cytospin of the resulting cell population is shown in C, by 
morphology this is a pure neutrophil sub-population. NRP2 positive neutrophils are not 
identified as dying or dead and are viable, shown in plot D. 
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3.3.4 NRP2 and not NRP1 is predominately expressed in human 
neutrophils 
In order to confirm that NRP1 staining was accurate other cell types were 
identified in the flowcytometry panel to use as biological controls. This included 
monocytes as show in figure 3.3.4-1, panel A and eosinophils in panel B. 
Following the gating shown in plots 1 and 2 of both panel A & B, monocytes 
were identified as being CD66b negative, then CD49d and CD14 double 
positive (14.8% of CD66b negative single cells). Eosinophils in contrast were 
CD66b positive, CD49d positive (6.14% of CD66b granulocytes). In the 
literature it has been previously shown that monocytes are NRP1 positive cells 
and have lower NRP2 expression.146 This was replicated using my flow 
cytometry panel as shown in graph C, where the relative percentage of NRP1 
and NRP2 positive monocytes and neutrophils are shown. In contrast 
neutrophils appear to be the reverse of this, having significantly more NRP2 
receptor expression than NRP1, (NRP2 expression, mean 9.61% vs NRP1 
expression, mean 2.93%). Monocytes in keeping with the literature have lower 
levels of Neuropilin expression, with more NRP1 (mean 3.85%) than NRP2 
(mean 1.73%). There are significantly more NRP2 positive neutrophils, than 
NRP1 positive neutrophils (***P=0.0009, n=3). 
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Figure 3.3.4-1 Human Neutrophils predominately express NRP2 and monocytes 
NRP1 
Whole blood from healthy volunteers was subjected to red cell lysis and stained for flow 
cytometry analysis. In panel A and B, flow plots 1 and 2 show identification of single cells. In 
A panel B, flow plot 3 the CD66b population is shown, of the CD66b negative sub-population 
the monocytes are defined as the CD14 and CD49d positive cells, 14.8% of the parent 
population. From the CD66b positive sub-population, eosinophils are identified as CD49d+ 
positive cells. (6.14% of the parent population). Graph C shows the relative expression of 
NRP1 and NRP2 on neutrophils and monocytes at baseline. There are significantly higher 
NRP2 positive neutrophils than NRP1 positive neutrophils. NRP2 is expressed at a low level 
on monocytes. Data shown are mean ± SEM, n= 3 performed as 3 independent experiments. 
P values were calculated using two-way ANOVA and Sidak multiple comparison test 
performed, ***P<0.001. 
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3.3.5 Neutrophil NRP2 expression increases in response to 
inflammatory stimuli  
Whether neutrophil NRP2 receptor expression is altered by the inflammatory 
environment remained a key question. To address this, I assessed the surface 
expression of NRP1 and NRP2 co-receptors on isolated human neutrophils 
following culture with inflammatory stimuli. Despite using a discontinuous 
Percoll gradient to purify the cells for culture, I applied an identical flow 
cytometry panel as used in the human whole blood experiments, in part, to 
ensure purity and also to allow comparison between this experiment and 
previous. Graph A in figure 3.3.5-1 shows NRP1 and NRP2 expression 
following 4 hours of culture. As seen in figure 3.3.4-1 neutrophils express 
significantly more NRP2 receptor than NRP1 following stimulation by the 
inflammatory mediators LPS, TNF-a and IL-1b for 4 hours. IL-1b treatment 
more than doubles the percentage of neutrophils expressing NRP2 from 
8.18% to 18.47%, with a mean difference of -12.85% (Graph B). In contrast 
neutrophil expression of NRP1 remains unchanged regardless of the culture 
condition (graph C). 
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Figure 3.3.5-1 Neutrophil NRP2 surface express is enhanced by the addition of 
inflammatory stimuli 
Isolated human neutrophils were cultured with LPS [10ng/ml], TNF-a and IL-1b [both 100nM] 
for four hours, then fixed and stained using the previously optimised Neuropilin flow cytometry 
panel. There was significantly more surface NRP2 than NRP1 expression seen following the 
addition of inflammatory stimuli; the highest significance is seen following IL-1b with a mean 
of 18.47% expression, Graph A. Data shown are mean ± SEM, n= 3 performed as 3 
independent experiments, P values were calculated using two-way ANOVA and a Sidak 
multiple comparison post-test, *P<0.05, **P<0.01 & ***P<0.001. Graph B shows the data for 
NRP2 receptor expression only, there was a significant increase in NRP2 receptor surface 
expression following stimulation with IL-1b. Graph C shows there was no significant difference 
in neutrophil expression of NRP1 following treatment with the same inflammatory mediators. 
Data shown are mean ± SEM, n= 3 performed as 3 independent experiments, P values were 
calculated using unpaired t-tests, **P=0.0034. 
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3.3.6 NRP2 is detected in murine neutrophils the injured lung 
Next, I evaluated the expression of NRP1 and NRP2 in murine neutrophils. 
NRP2 is an obligatory co-receptor for Sema3F and forms the receptor complex 
with a plexin (A1-A4), through which class 3 Semaphorins signal. Sema3F has 
higher affinity for NRP2 over NRP1. To evaluate the expression of NRP2, 
sections from murine lung taken at 6 hours following LPS induced lung injury 
were stained for NRP2 and NRP1. In figure 3.3.6-1 image A shows the isotype 
control which demonstrates no positive non-specific staining and in (B) positive 
staining for NRP2 is seen. Box C shows a blown-up area of positive staining 
from image B to highlight the positive staining for NRP2 of the neutrophil. There 
appears to be no staining for NRP1 in the murine lung section; the NRP1 
stained image E is similar to the negative isotype control in image D. 
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Figure 3.3.6-1 NRP2 is preferentially expressed over NRP1 in recruited 
neutrophils following acute lung injury in mice 
Images A to E show murine lung sections from mice culled 6 hours following LPS induced lung 
injury and stained for NRP2 and NRP1 respectively, where A is the isotype control for B, and 
D represents the isotype control for E. Image C is an exploded area using digital magnification 
to demonstrate positively stained neutrophils. Original magnification x40. 
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3.3.7 Neutrophil NRP2 mRNA increases following acute lung 
injury in mice 
To gain insight into the expression profile of NRP2 I looked for the neutrophil 
NRP2 mRNA transcript at 6, 24 and 48 hours following LPS induced lung 
injury, using cDNA collected as described in section 3.2.3. Here, beta-actin 
was again selected as the endogenous control, 2DdCT was calculated relative 
to unstimulated wild-type bone marrow neutrophils. The graph in figure 3.3.7-
1 shows the 2DdCT values and not a fold change of peripheral blood as, unlike 
Sema3F mRNA expression there is NRP2 mRNA expression seen at time 0. 
There is a significant increase in NRP2 mRNA acutely following lung injury at 
6 hours (*P<0.05) and a non-significant increase at 24 and 48 following the 
LPS insult. 
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Figure 3.3.7-1 Murine neutrophil NRP2 mRNA levels increase acutely following 
lung injury 
Mice were sacrificed at 6, 24 and 48 hrs post LPS installation, BAL neutrophils collected, and 
cDNA extracted. TaqMan analysis of cDNA was performed with data normalized to beta-actin 
(ACTB) expression. To calculate 2DdCT unstimulated bone marrow derived neutrophils were 
used. Data shown are mean ± SEM of fold change compared to peripheral blood neutrophils 
(PB T0), n=4-6 analysed by two-way ANOVA, *P<0.05. 
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3.3.8 Following lung injury in mice NRP2 expression is initially 
seen in the recruited neutrophil and later in the lung 
epithelium 
To ascertain whether surface expression of the NRP2 receptor correlated with 
mRNA levels immunohistochemistry was performed. LPS lung injury was 
induced in wild type mice. In images A, in figure 3.3.8-1 there is positive 
staining in the neutrophils, indicated by the black arrows (*N). At 24 and 48 
hours post ALI, shown in images C and D the patchy NRP2 staining is found 
only in the epithelial layer. This indicates that inflammatory neutrophils acutely 
express the Sema3F co-receptor NRP2 following lung injury. 
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Figure 3.3.8-1 NRP2 expression within the murine lung tissue changes with time 
following LPS induced lung injury 
Lung tissue was obtained following LPS induced lung injury from wild type mice. Mice were 
culled at times 6, 24 and 48 hours post LPS and lung tissue stained for NRP2. In images A 
neutrophils expressing NRP2 (black arrows *N). At the later time points patchy staining for 
NRP2 is seen only in the epithelium indicated by the black arrows *E. Original magnification 
was x40. 
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3.4 Exogenous Sema3F treatment in vivo increases neutrophil 
retention in a murine model of LPS induced acute lung injury  
3.4.1 Intra-tracheal instillation (IT) of Sema3F at 24 hours 
increases retention of neutrophils in a mouse model of LPS 
induced lung  injury 
To investigate the effects of exogenous Sema3F on neutrophil function in vivo 
C57BL/6 mice were treated with nebulised LPS, then after 24 hours 
intratracheal instillation (IT) of 1 µM of recombinant Sema3F was compared to 
phosphate buffered saline (PBS). The use of a higher dose of recombinant 
Sema3F (1 µM) was to ensure the delivery of the protein to the alveoli, a large 
percentage of drug will be lost in the airways proximal to this. 225 A summary 
diagram of the experimental protocol is shown in figure 3.4.1-1. Graph A shows 
the total cell counts at 48 hours. There are more cells in the BAL in the Sema3F 
treated mice (mean value 4.33x106 cells ± 0.45, n=8) compared to the PBS 
treated group (mean 2.94 x106 cells ± 0.34, n=8), this was found to be 
significant, *P=0.02. There is retention of neutrophils in the airway at 24 hours 
after IT Sema3F (mean 3.18 x106 neutrophils ± 0.26 n=8) compared to IT PBS 
(mean 2.32x106 neutrophils ± 0.3, n=8) *p=<0.05. At the later time-point of 72 
hours there was no difference seen in total or neutrophil counts between PBS 
control or Sema3F treatment. At both time points there was no difference 
observed in the neutrophil apoptosis counts performed by assessment of 
morphology.  
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Figure 3.4.1-1 Intra-tracheal instillation of Sema3F in a murine model of acute 
lung injury retains recruited neutrophils at the injury site 
Intra-tracheal recombinant Sema3F (1µM) was administered to C57BL/6 mice 24 hours post 
nebulised LPS challenge or phosphate buffered saline (PBS). Mice were then sacrificed after 
a further 48 hours and 72 hours and bronchoalveolar lavage performed; the protocol is shown 
in above the graphs. Some lungs were harvested without bronchoalveolar lavage and retained 
for lung slice imaging. Using the BAL obtained total, differential and apoptosis cell/neutrophil 
counts are shown for 48 hours in graphs A-C and 72 hours in D-E. Data shown are mean ± 
SEM n=4-8 analysed using an unpaired t-test, *P< 0.05. 
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3.4.2 Intra-tracheal instillation of Sema3F at 24 hours increases 
 cellular infiltration seen in murine  
H&E stained murine lung sections were obtained from mice that underwent the 
same experimental procedure detailed in the diagram in figure 3.4.1-1. In 
figure 3.4.2-1 images A and C are taken at x4 magnification. Further images 
at x20 magnification are of a representative area of A and C respectively. 
Following LPS then Sema3F or PBS treatment changes associated with lung 
injury including thrombi are seen in the post-capillary venules (images A & C, 
black arrows) alongside infiltration of neutrophils into the interstitial space and 
septal thickening (images B & D, black arrows). To provide further comment 
on these isolated samples the observed differences between PBS and 
Sema3F treated tissue were scored using the Matute-Bello lung injury scoring 
system. Image B (PBS treated lung) scored 7 compared to Sema3F treated 
lung which scored a 12 (where a higher score denotes more lung injury). 226  
For scoring system see appendix XV.  
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Figure 3.4.2-1 Intra-tracheal instillation of Sema3F at 24 hours increases post-
capillary thrombi, neutrophil infiltration and alveolar-septal thickening seen in 
murine lung sections  
Mice were sacrificed at 48 hours post LPS-induced lung injury after receiving intra-tracheal 
injection (IT) Sema3F 1 µM or PBS. Representative lung sections taken from the time of cull 
were fixed with 10% formalin at 20 cmH2O, paraffin embedded and stained with H&E. Images 
A and B show sections at x4 and x20 magnification respectively from a mouse receiving IT 
PBS. Images C and D show sections at x4 and x20 magnification respectively from a mouse 
receiving IT Sema3F. Original magnification was x20. The black arrows in A and B show post-
capillary venules with associated thrombi. The black arrows in B and D show areas of 
neutrophil infiltration and alveolar septal thickening. 
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3.5 Murine model of neutrophil specific knockdown of 
Semaphorin3F  
3.5.1 Proof of knockdown at DNA, mRNA and protein levels 
We wanted to explore how the loss of neutrophil Sema3F would alter 
neutrophil behaviour following LPS-induced lung injury in mice. Prior to using 
this murine model of neutrophil specific loss of Sema3F it was imperative to 
prove knockdown of the Sema3F gene, mRNA and protein in the neutrophils 
of this transgenic animal. The Sema3FfloxfloxMRP8CRE-/- (WT) and 
Sema3FfloxfloxMRP8CRE-/+ (KO) were previously crossed with a reporter strain, 
where green fluorescent protein is only expressed in tissues with Cre activity 
(Materials and Methods 2.9.2 and Appendix VIII). Following LPS induced lung 
injury, at 24 hours mice were culled, BAL cells extracted and stained for flow 
cytometry analysis. Granulocytes were identified based on FSC-A/SSC-A 
position and CD45 positivity, from this population both neutrophils (Ly6G 
positive) and monocytes (Ly6G negative) populations determined. In the KO 
animal the neutrophils were GFP positive. Seen in figure 3.5.1-1 flow plot A, 
there is a lack of GFP signal in the WT neutrophils and, in contrast there is a 
right shift in Geomean fluorescence intensity seen the KO neutrophils (plot C). 
The monocyte population has minimal GFP signal (plots C & D). Graph E 
shows the percentage of neutrophils and monocytes that express the GFP 
protein determined from flow cytometry analysis. In the KO animal 95% of 
neutrophils ± 1.1 (n=4) express the GFP reporter protein, this is compared to 
4.15% ± 0.830 of the WT neutrophils. The WT and KO monocytes express low 
levels of the reporter protein being 6.1% ± 0.8 and 3.18% ± 0.48 respectively. 
This demonstrates that there is Cre recombinase activity in the neutrophil 
population. 
To further validate the model, I looked at the expression of Sema3F mRNA 
and protein levels.  Using BAL cells obtained at 24 hours post LPS induced 
lung injury, I compared the Sema3F transcript level in WT and KO neutrophils. 
In order to do this, primers were generated to lie within the deleted region of 
the Sema3F gene found in my transgenic animal. Bone marrow derived 
The Role of Semaphorin3F in Neutrophilic Inflammation 
Chapter 3 Results  115 
neutrophils were used as the control as they are known to express low levels 
of Sema3F.227 In figure 3.5.1-2, the graph G shows a marked reduction in 
neutrophil Sema3F mRNA in the KO mouse compared with WT. Figure 3.5.1-
3 shows images A-F representing stained lung slice obtained from mice 
following lung injury at 48 hours. A-C and D-F represent sequential serial 
sections. The first image is the negative control for each set of serial sections, 
next is stained for Ly6G (neutrophils) and the final image stained for Sema3F. 
It is evident that in the WT lung sections the cells that are positive for Ly6G are 
also positive for Sema3F. In comparison in the KO animal there is loss of 
positive staining for Sema3F in the neutrophils. This supports that the model 
has achieved successful knockdown of neutrophil Sema3F at the protein level.  
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Figure 3.5.1-1 Neutrophil knockdown of Sema3F demonstrated by detection of 
a GFP reporter by flow cytometry 
Sema3FfloxfloxMRP8CRE-/- (WT) and Sema3FfloxfloxMRP8CRE-/+ (KO) underwent LPS induced 
lung injury and were sacrificed at 24 hours and bronchioalveolar lavage performed. Following 
identification of the neutrophils and monocyte cell populations in the BAL the geometric 
fluorescent intensity of the GFP signal was determined by flow cytometry (plots A-D). In the 
flowcytometry plots side scatter intensity is plotted against fluorescent intensity in the GFP 
channel (B525_50-A). The percentage of GFP positive neutrophils and monocytes is shown 
in graph E, the GFP reporter protein is only significantly expressed in Sema3F KO neutrophils. 
Data shown are mean ± SEM n=4 analysed using a two-way ANOVA, ****<0.0001. 
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Figure 3.5.1-2 Sema3F is successfully knocked down in the neutrophil 
population at the mRNA level 
Sema3FfloxfloxMRP8CRE-/- (WT) and Sema3FfloxfloxMRP8CRE-/+ (KO) underwent LPS induced 
lung injury and were sacrificed at 24 hours, BAL neutrophils collected, and cDNA extracted. 
TaqMan analysis of cDNA was performed with data normalized to beta-actin (ACTB) 
expression. The graph shows fold change in Sema3F gene expression following acute lung 
injury with LPS in both the WT vs KO neutrophil. Data show mean ± SEM of fold change 
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Figure 3.5.1-3 Sema3F is successfully knocked down in the neutrophil population at the protein level 
Sema3FfloxfloxMRP8CRE-/- (WT) and Sema3FfloxfloxMRP8CRE-/+ (KO) underwent LPS induced lung injury and were sacrificed at 48 hours and lung tissue 
taken, serial sections made and stained for Ly6G and Sem3F. Images and A and D represent the isotype controls. Images A-C and D-F are two sets of 
three serial sections from the WT and KO animals showing the staining for neutrophils (Ly6G) and Sema3F respectively. There is a reduction in the 
amount of staining for Sema3F seen in the neutrophils in the KO compared to WT animal.  
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3.6 Neutrophil specific knockdown of Semaphorin3F increases 
both recruitment and clearance of neutrophils without 
altering apoptotic responses  
 
3.6.1 Neutrophil Sema3F knockdown enhances recruitment and 
resolution 
To investigate the effect of neutrophil specific loss of the autocrine Sema3F 
signal an in vivo lung injury model was used. KO mice 
Sema3Fflox/floxMRP8Cre+/- and WT mice Sema3Fflox/floxMRP8Cre-/- were 
nebulised with LPS and culled at 6, 24 and 48 hours. Following BAL both total 
and differential cell counts were performed. In figure 3.6.1-1, In Graph A in the 
KO animal the peak recruitment is seen at 6 hours with a significant increase 
in the recruited neutrophil count KO compared to WT mice. Mean values for 
the knockout mice were 8.97x106 ± 0.8 and wild type were 5.51x106 ± 0.7. At 
24 and 48 hours counts were comparable between groups.  
The resolution of neutrophilic inflammation occurs between 24 and 48 hours. 
The rate of decline in neutrophils numbers is higher in the KO than WT animal 
during the period. In graph B hypothesised lines have been drawn between 
timepoints to graphically show the rate of change for the WT and KO mice. 
The T50 for each genotype was calculated by identifying the maximal neutrophil 
recruitment number and the time taken to achieve a 50% reduction in 
neutrophil count from this peak. The resolution of neutrophilic inflammation 
occurs 9.1 hours earlier in the KO than the WT animal. Therefore, neutrophil 
specific loss of Sema3F enhanced the resolution of neutrophilic inflammation 
in this model. 
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Figure 3.6.1-1 Neutrophil specific knockdown of Sema3F enhances both 
recruitment and resolution post LPS induced lung injury 
Sema3FfloxfloxMRP8cre-/- WT and Sema3FfloxfloxMRP8cre+/- KO were challenged with LPS, 
sacrificed at 2, 6, 24 and 48 hours and bronchoalveolar lavage fluid obtained. Cell counts were 
performed by haemocytometer and the differential cell count established using cytospins. 
Graph A shows the individual mice during the time course. Data are shown mean ± SEM, n=6-
12 over 3 individual experiments analysed using two-way ANOVA, **P=0.014. Graph B shows 
the time taken for a 50% reduction in the number neutrophils at peak recruitment calculated 
individually for each genotype (T50) occurring 9.1 hours earlier in the KO compared to WT. 
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3.6.2 Neutrophil Sema3F deficiency does not increase neutrophil 
apoptosis or  macrophage numbers following LPS induced 
lung injury 
Apoptosis is a route of neutrophil clearance following LPS induced lung injury. 
To determine if apoptosis was increased to account for the increased rate of 
resolution seen in the KO mice apoptosis counts were performed. Cytospins 
of BAL samples from the same mice were analysed and percentage apoptosis 
assessed by morphological changes. Examples of the features used to define 
an apoptotic neutrophil is shown in image B figure 3.6.2-1. Graph A shows 
that, at all three times points, there is no difference in the percentage of 
apoptosis between genotypes. 
Macrophages and neutrophils often have complementary and overlapping 
roles within the innate immune response. The behaviour and longevity of 
neutrophils are controlled, in part, by macrophage signals and the 
phagocytosis of dying neutrophils by macrophages. The neutrophil specific 
Cre driver used in the construct Sema3Fflox/floxMRP8Cre+/-  is described in the 
literature as having minimal expression in macrophages/monocyte population 
and I have confirmed this in the context of my transgenic model (figure 3.5.1-
1).187 To ascertain whether the neutrophil specific KO of Sema3F has a 
neutrophil specific phenotype in the context of the LPS induced lung injury 
model, I determined macrophage numbers from the BAL differential counts of 
the mice. The macrophage counts are shown in Graph C and are similar at all 
time points. This supports the conclusion that the phenotype seen when there 
is a deficiency in neutrophil Sema3F is neutrophil specific, as is not due to a 
change in either macrophage counts during recruitment or resolution. 
Differences between genotypes are only observed in the neutrophils counts 
during ALI. 
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Figure 3.6.2-1 Loss of neutrophil Sema3F does not increase neutrophil 
apoptosis or macrophage number during the course of acute lung injury 
Graph A shows apoptosis counts of BAL neutrophils performed by assessment of typical 
apoptotic morphology of cytospins at times 6, 24 and 48 following LPS induced acute lung 
injury. Image B shows a representative image demonstrating some of the characteristic 
features used to identify apoptotic neutrophils. These include blebbing of the cytoplasm, 
shrinkage and pyknosis of the multi-lobed nuclei and the formation of the apoptotic body (with 
thanks to Dr Rob Grecian). Graph C shows the macrophage differential cell counts at these 
times points. (A) n=6-12 (B) n=5-12, Data are shown mean ± SEM analysed using two-way 
ANOVA. 
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3.7 Discussion 
 
I have demonstrated that human neutrophils express Sema3F at the protein 
level (figure 3.2.1-1) and its expression is under the control of the inflammatory 
mediators LPS but not TNF-a or IL-1b. While LPS and IL-1b are both pro-
inflammatory signals that activate neutrophils there some differences. It has 
been postulated that LPS signalling through the Toll-like receptor 4 (TLR4)  
activates neutrophils but does not elicit a pro-survival response.209 LPS may 
enhance neutrophil survival in the presence of peripheral blood mononuclear 
cells producing IL-1b.209 In contrast IL-1b stimulation has been shown to both 
activate and extend the neutrophil life-span and is related to a later stage of 
sterile inflammation.228 In the murine acute lung injury model, following loss of 
neutrophil Sema3F, we did not see any differences in apoptosis (figure 3.6.2-
1). Sema3F mRNA and protein levels rise acutely following lung injury (mRNA: 
figure 3.2.3-1, protein: figure 3.2.4-1).  
It was important to relate Sema3F expression to inflammatory lung disease 
and to establish whether Sema3F may have role in the pathogenesis of such 
diseases therefore an evaluation of COPD patient samples was undertaken. 
As the aetiology of COPD and lung cancer share smoking exposure as a 
common and important risk factor, there is often a co-existence of these 
pathologies. Lung tissue was taken from non-tumour regions during resection 
for lung cancer (figure 3.2.2-1) and stained for Sema3F. The recruited 
inflammatory cells found in the airspace, consisting predominately of 
neutrophils and a smaller proportion of macrophages, stained positively for 
Sema3F. This indicates that Sema3F may have role to play in the regulation 
of these cell types in COPD.  
Following this it became clear that Sema3F, in the context of the regulation of 
lung inflammation, warranted further investigation. To this end, an in vivo 
model of lung acute injury was used to ascertain the role of Sema3F in the 
innate immune response. I looked at murine neutrophils to ascertain whether 
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they also expressed Sema3F following LPS induced lung injury. Sema3F 
mRNA rises acutely with the initiation of lung injury and is maintained at a 
slightly reduced level at 24 and 48 hours (figure 3.2.3-1). There is no 
expression of Sema3F mRNA found in unstimulated peripheral blood 
neutrophils. This supports the hypothesis that Sema3F is involved in the 
regulation of neutrophil inflammation and as consequence is not found in the 
quiescent blood neutrophil.  
Sema3F is detected in murine neutrophils at the protein level, (figure 3.2.4-1). 
The Ly6G positive neutrophils in the adjacent serial section stain positively for 
Sema3F within the cell cytoplasm. This is keeping with what is known about 
class 3 Semaphorins, that they are released as exogenous proteins. In figure 
3.2.4-2, images of lung sections from mice are shown for time points 6, 24 and 
48 following LPS induced lung injury, depicting the temporal-spatial staining 
pattern for Sema3F protein during lung injury. Throughout the time-course 
there is expression seen in both the neutrophils and macrophages. At 6 and 
24 hours following acute lung injury staining is also seen in the epithelial layer; 
this is not apparent at 48 hours. The highest level of staining level is observed 
at 24 hours. The Sema3F mRNA does not directly correspond to the protein 
expression, in that the acute uplift in mRNA are seen at 6 hours, whereas 
subjectively the highest levels of staining for Sema3F is seen at 24 hours post 
lung injury. There may be a lag phase between mRNA and protein translation 
to account for this. Similarly, the lowest Sema3F staining levels are seen at 48 
hours despite the maintenance of the mRNA levels. There may be other factors 
controlling mRNA and protein levels, these include the regulation of protein 
translation and mRNA/protein degradation, trafficking within the cell and 
release mechanisms. There is a clear dynamic co-ordination of Sema3F 
expression which correlates with the stage of lung injury. It appears that 
resolution is associated with overall lower levels of Sema3F mRNA and protein 
expression. The amount of intracellular Sema3F could have an inverse 
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relationship with the amount of the exogenous active Sema3F protein present 
in the inflammatory milieu, which is not accounted for by this data. 
In conjunction with the investigation into neutrophil Sema3F expression, I also 
examined the expression of the Sema3F co-receptors, Neuropilins 1 and 2 
(NRP1 and 2). It was important to establish that neutrophil Sema3F-Neuropilin 
signalling is relevant to the human system and that Sema3F autocrine 
regulation of neutrophils remained a credible hypothesis. COPD patient lung 
samples, as described previously, were stained for NRP2. As is the case for 
the Sema3F staining in these samples, the positive signal was seen in the 
myeloid population resident in the inflamed airways (figure 3.3.1-1). I went on 
to characterise the human neutrophil surface expression of NRP 1 and 2 in 
health. The receptors were identified through a validated flow cytometry panel 
(figure 3.3.2-1). The panel successfully identified neutrophils that express 
NRP2. These neutrophils are seen to be viable, following fluorescent assisted 
cell sorting using this panel and a detailed study of the morphology of the 
selected neutrophils (figure 3.3.3-1). Human neutrophils express significantly 
more NRP2 than monocytes, and as such, monocytes provide both a biological 
negative control for NRP2 expression and a positive control for NRP1 
expression (figure 3.3.4-1). Following stimulation with the inflammatory 
mediators LPS, TNF-a and IL-1b there are higher levels of NRP2 expression 
where NRP1 expression remains unchanged (figure 3.3.5-1). Interestingly, in 
contrast to human Sema3F protein expression seen in figure 3.2.1-1, it is IL-
1b treatment that induces a doubling of the percentage of neutrophils that 
express NRP2 and LPS has the least effect on surface expression. The 
opposite effect of these proinflammatory mediators on Sema3F protein 
expression and NRP2 surface expression suggests differential regulation of 
the Sema3F ligand and co-receptor NRP2 by the inflammatory environment. 
This may also relate to an overall temporal co-ordination of the innate immune 
response to lung injury involving Sema3F and its co-receptor NRP2. LPS and 
IL-1b induce individual neutrophil responses and are prominent during different 
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phases of lung injury. Thus, variation in the expression of the ligand Sema3F 
and NRP2 throughout lung injury, could be co-ordinated by inflammatory 
mediators such as LPS and IL-1b  and in turn alter the neutrophil behaviour. 
Equally, temporal co-ordination of the ligand and receptor could be required 
for successful signal transduction. Following Sema3F protein translation, 
release of exogenous Sema3F has to occur and the ligand and receptor must 
be in proximity to allow binding for signal transduction. The timing of each of 
these steps could provide a level of regulation. Another consideration is the 
evidence that soluble NRP2 can be secreted by alveolar macrophages adding 
another layer of complexity.149 While the exact relationship between neutrophil 
Sema3F and its receptors has yet to be established, it is clear that Sema3F 
autocrine signalling has a role throughout acute lung injury from recruitment to 
resolution. 
Using a murine in vivo model system was crucial to understanding the role of 
Sema3F signalling in greater detail. Likewise, it was imperative to establish the 
presence of the Sema3F co-receptors in murine neutrophils. At 6 hours 
following LPS induced lung injury murine neutrophils express the NRP2 
receptor but no NRP1 was identified (3.3.6-1). Unlike Sema3F mRNA, 
neutrophils express NRP2 mRNA at baseline (unstimulated peripheral blood 
neutrophils). Following injury there is a significant induction of NRP2 mRNA, 
at 24 and 48 hours levels are reduced but maintained above baseline (figure 
3.3.7-1). In the WT mice, at 6 hours, NRP2 protein expression is present in the 
neutrophil population, following this it appears to be exclusively located in the 
epithelial layer and cells adjacent to the blood vessels (figure 3.3.8-1).   
To investigate the effects of Sems3F in the context of an in vivo system, 
C6/BL57 wild-type mice were used, 24 hours following acute lung injury intra-
tracheal Sema3F [1µM] or PBS (experimental protocol, figure 3.4.1-1). 
Following Sema3F given at peak recruitment neutrophils were retained at the 
site of injury (graphs A & B, figure 3.4.1-1). Neutrophil retention was not 
sustained at 48 hours following Sema3F treatment (graphs C & D). Alongside 
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this, lung sections were taken from mice treated using this protocol and culled 
at 24 hours post treatment. As a general observation there is an increase in 
the features of ALI following Sema3F treatment although this is not quantified 
(figure 3.4.2-1). This may suggest that a more severe lung injury is sustained 
following Sema3F treatment due to the increase in retained neutrophil 
numbers. The thrombi seen in the post capillary venules in acute lung injury 
are not generally thought to be a hallmark of underlying thromboembolic 
disorders but related to acute and localised alterations in the coagulation 
pathway.229 Whether this Sema3F-retention of neutrophils is due to an effect 
on neutrophil migration or an alteration in the pattern of neutrophil recruitment 
over the time course remains unclear. Sema3F treatment could reduce the 
reverse migration of neutrophils from the pulmonary vasculature to the wider 
circulation so greater numbers are in close proximity ready to be recruited or 
impede loss to body through the mucociliary escalator. This experiment 
discounted the possibility that Sema3F acts as a potent pro-survival stimulus. 
No difference was observed in neutrophil apoptosis counts between PBS or 
Sema3F treated mice at either 48 or 73 hours post ALI. 
In view of the response to excess exogenous Sema3F I wondered if the 
converse would hold true. To begin to answer this I used a transgenic 
neutrophil specific KO of Sema3F (Sema3FfloxfloxMRP8cre+/-) to further explore 
the role of Sema3F in neutrophil migration and lung inflammation. Semaphorin 
signalling has been shown to be autocrine in both tumour and endothelial 
cells.160,195,197 As such the neutrophil specific knockout of Sema3F provided a 
precise construct with which I could begin to interrogate the role of neutrophil 
Sema3F as an autocrine signal in the context of lung injury. MRP8 acts a driver 
for Cre in this transgenic construct and is highly specific for neutrophils. MRP8 
(S100A8/Calgranulin A) Cre mice show specific deletion in neutrophils, with 
minimal expression in macrophages, monocytes, natural killer (NK) cells, mast 
cells, basophils, or eosinophils.187 As the MRP8-Cre transgene contains an 
IRES-GFP cassette, I can also follow Cre expression by flow cytometry (figure 
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3.5.1-1). I have also demonstrated knockdown of neutrophil Sema3F at the 
mRNA and protein level (figures 3.5.1-2 & 3.5.1-3). Following lung, the loss of 
neutrophil Sema3F leads to peak recruitment being seen at 6 hours and a 
significant increase in the number of neutrophils within the airspace (figure 
3.6.1-1, graph A). After 6 hours, between 24 and 48 hours there is no 
significant difference between the KO and WT mice. At 48 hours the neutrophil 
numbers are virtually identical between genotypes. The rate at which the 
numbers of neutrophils fall, between 24 and 48 hours, is greater in the KO 
animal. Whether this represents a resolution phenotype is not fully answered 
by my data in this project. However, the rate of change in neutrophil number is 
greater in the KO mouse (figure 3.6.1-1 graph B) and it is evident that both 
phases of recruitment and resolution are occurring at this faster rate. 
Calculating the T50 confirms this, whereby the time taken for a 50% reduction 
from the maximal number of neutrophils recruited into the lung is 9.1 hours 
earlier in the KO than the WT animal. Rather than being related to an absence 
of neutrophil Sema3F expression, the increased rate of resolution could 
represent an upregulation in tissue homeostasis mechanisms responding to 
the greater influx of neutrophils in the KO mouse. These findings point towards 
an overall increase in the speed of neutrophil transit during acute lung injury.   
Apoptosis is a route for the disposal of neutrophils during resolution and yet 
the numbers of apoptotic neutrophils are unchanged between genotypes 
(figure 3.6.2-1, graph A). It must be acknowledged that even small differences 
in percentage of apoptosis, at a single time point, can alter the rate of apoptosis 
and have a major effect on levels of neutrophil clearance.115,230 This finding 
suggests that neutrophil specific KO of Sema3F can increase neutrophil 
recruitment and resolution without altering apoptotic responses. Semaphorins 
are known to control cell motility and it may be that the Sema3F deficient 
neutrophils have an increased propensity to migrate, to and away from, the 
injury site which would yield differences in both neutrophil recruitment and 
resolution. Macrophages also play a crucial role in the regulation of neutrophil 
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numbers and neutrophilic inflammation by phagocytosis of apoptotic 
neutrophils. Macrophages can control the behaviour of neutrophils by the 
production of inflammatory mediators, which can modulate both neutrophil 
recruitment and apoptosis. In this transgenic model I did not see alterations in 
macrophage numbers (figure 3.6.2-1, graph B).  
Both in vivo and in vitro LPS switches on neutrophil Sema3F production which 
appears to act as a “brake” to neutrophil transmigration. Recruited neutrophils 
are retained following exogenous Sema3F treatment and neutrophils deficient 
in Sema3F show a pattern of enhanced recruitment and resolution following 
lung injury. The main co-receptor for Sema3F is expressed on both murine and 
human neutrophils under the control of inflammatory stimuli. Taken together 
this supports the hypothesis that Sema3F is an important signal in lung injury 
and may act in autocrine manner to differentially influence the magnitude of 
the inflammatory response. In this way neutrophil Sema3F production and the 
Sema3F co-receptor NRP2 are highly relevant to the development of new 
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4 Results chapter: Sema3F retains neutrophils in the injured 
lung by inducing neutrophil F-actin disassembly 
Introduction. 
4.1.1 Neutrophil migration in lung injury 
The response to tissue injury requires a complex communication network and 
signals such as Sema3F may direct the traffic of neutrophils, retaining or 
permitting emigration from the injury site. This could occur through reverse 
migration, or loss to body and clearance by the mucociliary-escalator of the 
lungs. Certainly, dysfunctional migratory neutrophil behaviour is seen in 
patients with COPD, where recruited and inflammatory neutrophils are 
retained in the injured lung and contribute to the ongoing tissue 
distruction.231,232 Another class 3 Semaphorin, Sema3A, has been shown to 
modulate the migration of cells including macrophages and endothelial cells 
and has also been shown to control growth through alterations in the 
cytoskeleton by promoting F-actin disassembly.233,234 Changes in the F-actin 
cytoskeleton structure will not only affect cell migration, but will have clear 
implications for the exocytosis of neutrophil granules (degranulation) and the 
subsequent release of their potent histotoxic contents, which includes 
enzymes such as myeloperoxidase and elastase.235 Likewise a retention 
signal could increase the number of neutrophils releasing granules which 
would have a direct effect on the amount of histotoxic agents in the 
inflammatory milieu potentiating tissue damage.  
Enhanced or reduced neutrophil recruitment to the injury site is defined both 
by the ability of the cell to migrate, therefore the speed and directionality of 
neutrophil locomotion, but also the physical barriers breached during 
transmigration. In this regard, the human lung has key differences from other 
organs. It has been proposed, that even in health, 51% of circulating 
neutrophils are found in the marginated pool within the lung vasculature, 
approximately 33.15x107 cells/kg.60 These marginated neutrophils are poised 
in close proximity ready to respond rapidly to lung injury. The lungs participate 
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in the first line of host defence and have an enormous alveolar surface area of 
~143m2 which is in contact with the external environment.236 The human 
pulmonary capillary bed is proportionally large, with between 51-72 million 1st 
order pulmonary arteries and a capillary blood volume of 95m3, the capillary 
vessels themselves are narrow with an average diameter of 6.3µm.237 In order 
to enter the pulmonary vasculature neutrophils are required to undergo shape 
change and appear elongated; in turn their transit time in the capillary network 
is extended compared to red blood cells.238 This results in generating a pool of 
marginated neutrophils within the pulmonary capillary network of a healthy 
lung which are ready for rapid recruitment.239 In lung injury the process of 
sequestration of neutrophils follows the recognition of damage within the lung. 
Unlike in other organs the narrow diameter of the pulmonary capillary does not 
allow rolling. Neutrophil migration into the lung parenchyma is selectin and, in 
certain contexts, b2-integrin independent.240  
Yipp et al. (2013) used intra-vital imaging of transgenic murine lungs to identify 
that neutrophils survey the pulmonary vasculature for bloodstream pathogens 
and from this position, capture bacteria from the blood stream.22 Human 
subjects responded to intra-venous LPS with a rapid 50% reduction in 
circulating neutrophil counts, as these neutrophils were sequestered to the 
lung, adding to the already existing marginated pool of neutrophils. In the mice 
the canonical recruitment pathway did not occur and only upregulation of 
CD11b through TLR4 and Myd88 activation was required for neutrophil 
crawling leading to successful bacterial capture. 241 Downstream of TLR4 and 
Myd88 Abl-kinase inhibition reduced neutrophil crawling; interestingly Abl-
kinase is responsible for inside out signaling and modulation of both the 
cytoskeleton and integrins. Similarly, Sema7A promotes neurite outgrowth 
through inside out integrin signaling and cytoskeletal re-arrangements.242 
L-selectin deficient mice have a normal marginated pool of neutrophils and P- 
and E selectin are not expressed on the capillary endothelium.243-245 The 
CD11/CD18 adhesion pathway accounts for 60-80% of neutrophil migration 
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from the pulmonary capillary bed to the distal airspaces in response to LPS; of 
note 20-40% of neutrophil migration is therefore independent.62,63,246 
Doerschuck et al. (1987) demonstrated that following an injection of 
complement fragments, neutropenia is observed in rabbits within 1 minute of 
the infusion, and there is a corresponding increase in neutrophils within the 
pulmonary capillaries. These sequestered neutrophils require the CD11/CD18 
adhesion to maintain accumulation in the lung after 7 minutes. Blocking of 
neutrophil recruitment using a CD18 specific monoclonal antibody mAb 60.3 
is successful only after 7 minutes and not prior to this.239,247 It is therefore likely 
that the marginated pool of neutrophils is initially controlled by the transit time 
of the neutrophil, which in turn is regulated by the neutrophil deformability.60 
Yoshia et al. (2012) directly link a decrease in neutrophil deformability and 
increased sequestration to the lung in a rat model of bacterial pneumonia.248 
Neutrophils with low-deformability were identified by the formation of an F-actin 
rim, this appeared to control sequestration independently of adhesion either 
through selectins or CD11/CD18. The deformability of the neutrophil is 
determined by changes in the neutrophil cytoskeleton. Neutrophil rigidity is 
altered by cytocalasin B and not directly by colchicine, which suggests that 
actin and not microtubules, is primarily responsible for changes in deformability 
and therefore lung sequestration.249 Dynamic actin re-structuring and 
distribution appears to affect not only deformability but also neutrophil shape. 
F-actin amount and distribution relates to neutrophil function and activation 
status. Circulating unstimulated neutrophils are mostly round with lower levels 
of F-actin distributed both centrally and at the periphery. In contrast to the 
circulating neutrophil, quiescent bone marrow (BM) neutrophils have more F-
actin and are almost exclusively round and spherical, with some F-actin 
centrally, but most is located at the submembrane region.250 In response to 
fMLF, circulating neutrophils undergo a dramatic shape change and F-actin 
levels increase and are distributed to the submembrane region.250,251 In BM 
neutrophils there is a less extreme response to fMLF and only small 
irregularities appear in the plasma membrane. Yet in both circulating and BM 
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neutrophils there is loss of central F-actin in response to fMLF. The BM 
neutrophils are stiffer due to the predominance of submembrane F-actin 
distribution and as a result sequester better than circulating neutrophils to the 
lung.24,26 The key regulators of the actin cytoskeleton include the Rho family of 
GTPases. Neutrophils deficient in the Rac2 had 20-25% less F-actin content 
at baseline and a reduction in F-actin increase in response to fMLF. Associated 
with this they have impaired directionality and chemotaxis.252 Dooley et al. 
(2009) found that following immune-complex mediated lung injury in Rac2 -/- 
mice there was increased neutrophil recruitment when compared to WT mice 
at 6 hours.253 The reduction in baseline F-actin, may promote neutrophil 
sequestration which translates into enhanced acute neutrophil recruitment 
post lung injury. The Rac2-/- neutrophils had normal expression of adhesion 
molecules CD11a, CD11b, CD11c, CD18, and CD61. 
Neutrophil deformability and cytoskeletal arrangements appear to define 
sequestration to the pulmonary vasculature which can occur independently of 
CD11/CD18 adhesion, however retention of sequestered neutrophils requires 
adhesion through the CD11/CD18 and L-selectin pathways. The next stage of 
transmigration requires transendothelial migration (TEM) or diapedesis and 
occurs in the absence of rolling, due to the small diameter of the pulmonary 
capillaries. Neutrophils migrate through the endothelial layer via the 
transcellular or paracellular route. The biomechanical changes required 
involve both actin and microtubules and are far more complex than the earlier 
stage of sequestration. Changes in the endothelial cell cytoskeleton are also 
required.91,254 Once across the endothelial cell layer, the neutrophil triggering 
receptor expressed on myeloid cells 1 (TREM-1) is essential for neutrophil 
transepithelial migration into the distal airspace.64 Prior to this neutrophils must 
migrate through the lung interstitium; less is known about the regulation of 
migration through this compartment of the lung.  
Lung transmigration may not represent a one-way system. Reverse neutrophil 
transendothelial migration (rTEM) has been shown to occur in other organs 
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where subsequent neutrophil accumulation in the lung is a secondary event.75 
There is not yet evidence that neutrophils undergo reverse migration 
originating in the lung itself.96 The neutrophil is key in instigating reverse 
transendothelial migration elsewhere and the LTB4 - elastase axis is critical to 
the process.96 While there remains uncertainty regarding the possibility of true 
rTEM in the lung, neutrophils do return from the pulmonary vasculature to the 
remaining circulation. It has been posited that the lungs act as a neutrophil de-
priming station. The activated neutrophils are recruited to the pulmonary 
vasculature but do not undergo TEM. Once de-primed they are allowed to 
enter the circulation again; if prior to the de-priming further activation occurs or 
de-priming fails, these primed neutrophils are recruited to the interstitial space 
and may cause lung injury.20 During sterile injury neutrophils leave the tissue, 
return to the blood stream then enter the lungs where CXCR4 is upregulated 
promoting the return of the neutrophils to the bone marrow.23,255 Adrenaline 
and exercise have been shown to mobilise neutrophils from the marginated 
pool in the bone marrow.256 
In a zebrafish model of reverse migration, neutrophils which have been shown 
to reverse migrate were significantly less spherical and this may suggest they 
have are activated and remained primed.85 If the lung is indeed a center for 
de-priming neutrophils after which they return to the bone marrow, this may 
explain why reverse migration of activated neutrophils is not observed. This 
observation highlights a link between neutrophil migration, activation status, 
neutrophil effector functions and neutrophil roundness and sphericity. 
4.1.2 Neutrophil functions and their relationship to the actin 
cytoskeleton 
Neutrophils are professional phagocytes. Phagocytosis has three distinct 
stages: 1) the particle binding 2) pseudopod extension 3) phagosome closure. 
As such it is evident that phagocytosis requires dramatic changes in the 
neutrophil actin cytoskeleton. The Rho family of GTPases differentially 
regulates phagocytosis. For example Cdc42 regulates the formation of the 
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pseudopod, while Rac1 controls the closure of the phagosome.257 Rac1 and 
Rac2 have been shown to have distinct roles in actin organisation within 
hematopoietic stem cells.258 Inhibitors of actin polymerisation such as 
Latrunculin or,  Cytocalasin B which prevents actin turnover, inhibit neutrophil 
phagocytosis.259,260 The pox virus and Semaphorin family member A39R both 
evade host defence by inhibiting neutrophil phagocytosis.168 
Neutrophils produce ROS as part of an oxygen-dependent antimicrobial 
system. Stimulated neutrophils consume oxygen to generate superoxide; 
neutrophils can also be primed and following this initial signal the generation 
of ROS is enhanced. The bacterial peptide fMLF can both prime and trigger 
low levels of ROS. Neutrophil NADPH oxidase (NOX2) generates superoxide 
which dismutates and is used by the heme enzyme myeloperoxidase to 
generate both ROS and hydrogen peroxide. Neutrophil ROS is found intra-
cellularly in phagosomes, ready to kill engulfed bacteria but can be found at 
other sites or released to the environment.261 The generation of NADPH 
oxidase dependent ROS has been shown to be reliant on cytoskeletal 
rearrangements and the small GTPase Rac2. 262 The depolymerisation of actin 
is enhanced by ROS.263 Levels of intracellular ROS have been shown to 
control neutrophil migration.264,265 
Myeloperoxidase is a hemoprotein contained within neutrophil primary 
(azurophilic granules) and can be released through exocytosis which is a 
process dependent on actin cytoskeletal dynamics.235 This enzyme forms 
hypochlorous acid (HOCL), hydrogen peroxide (H2O2) and chloride anions 
from radical oxygen species. This toxic cocktail is released as part of the 
neutrophils’ role in host defence against invading pathogens.266 Primary 
granules undergo exocytosis, by relocation to the internal neutrophil 
membrane granules then they tether, dock and fuse to the phagolysosomes or 
expel their contents into the extra-cellular matrix. Translocation of primary 
granules to the internal neutrophil membrane is largely through Rac2 signaling 
and the actin cytoskeleton.267 
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4.1.3 Semaphorins regulate the cytoskeleton 
Semaphorins have been shown to regulate cell migration and the actin 
cytoskeleton. Sema3E has recently been shown to act as a neutrophil 
chemorepellent in a murine model of allergic asthma.193 In results chapter 3 I 
described that neutrophil Sema3F deficiency resulted in enhanced recruitment 
and resolution in a murine model of acute lung injury. Furthermore, that 
following intra-tracheal instillation of Sema3F recruited inflammatory 
neutrophils were retained in the injured airway. This suggests that Sema3F 
has a role as a retention signal rather than chemorepellent, in the control of 
neutrophilic inflammation. This is possibly through the modulation of neutrophil 
migration from the blood to airspace by alterations in the neutrophil 
cytoskeleton. Semaphorins have been shown to regulate cell migration and 
axonal growth in an integrin dependent fashion.160,169,242 Class 3 Semaphorins 
have been shown to regulate integrin activation status and affect vascular 
morphogenesis.160 The interplay between Sema3F modulation of actin 
cytoskeletal dynamics and shape and potentially also adhesion pathways may 
begin to explain the mechanism of neutrophil retention and enhanced 
recruitment seen in response to Sema3F treatment or loss. This regulation of 
neutrophil function and behaviour could be harnessed to create new therapies 
to ameliorate the consequences of pathological neutrophilic inflammation. 
Neutrophil Sema3F autocrine signaling determines neutrophil transit to the 
lung during ALI. There are many aspects to neutrophil transit including 
neutrophil kinetics, intrinsic properties of the neutrophil (deformability, 
adhesion pathways, cytoskeletal arrangements) and clearance, through 
expectoration, cell death, phagocytosis and migration away from the lung to 
distant sites such as the bone marrow. Clearly there exists a complex interplay 
between all these factors. A single signal which might cut through this all this 
‘noise’, such as the retention signal Sema3F, could participate in the regulation 
of neutrophil recruitment and resolution by inducing a well-timed pause thus 
allowing the neutrophil to do its important work. 
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4.1.4 Neutrophil elastase in health and disease 
Elastase is a chymotrypsin serine protease and is responsible for the 
degradation of a variety of substances including: elastin, extracellular matrix 
proteins, collagen types I–IV, proteoglycan, fibronectin, platelet IIb/IIIa 
receptor, complement receptor, thrombomodulin, lung surfactant, and 
cadherins.268-270 Neutrophils contain large amounts of elastase approximately 
5 mM and up to 3 pg and as such are a major source of elastase in the injured 
lung .271 Elevated elastase levels promote inflammation and delays wound 
healing.272 Similarly, in the lung excessive elastase activity leads to destruction 
of the epithelial capillary barrier, pulmonary oedema and acute lung injury. 273 
It is a dysregulation of the balance between proteases (elastase) and-anti 
proteases that can lead to this type of lung damage.274 While elastase has 
been shown to be increased in the BAL of patients with ARDS, this has not 
been seen in all studies conducted using similar patient groups.275-277 Elastase 
has a very short half-life of 0.6ms which may account for a lack of correlation 
between elastase levels and the clinical picture.278 Likewise, elastase can 
remain bound to the neutrophil membrane and at this site is more resistant to 
inactivation by endogenous protease inhibitors. Detection of membrane bound 
elastase is prohibited when studying BAL fluid or supernatant samples.279-281 
In view of this, as levels of protease inhibitors correlate well with ARDS risk, 
they are potentially better biomarkers of lung injury.282 
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4.2 Neutrophil specific knockout of Sema3F does not alter 
neutrophil transit through the lung tissue  
4.2.1 Ex-vivo lung imaging shows exogenous Sema3F in vivo 
retains neutrophils external to the vasculature  
As shown in chapter 3 neutrophil transit time to the alveolus and neutrophilic 
resolution is manipulated by Sema3F signalling. To assess neutrophil transit 
during ALI the location of the neutrophil population needed to be determined. 
In order to delineate the location of the WT, KO or Sema3F treated neutrophils 
I collaborated with Dr Leo Carlin at the Beatson institute. Following ALI, mice 
were culled, and lungs instilled with agarose gel, fixed and sectioned. They 
were stained to identify the neutrophils (S100A9 red) and blood vessels (CD31 
green) and slices were imaged using confocal microscopy (figure 4.2.1-1, 
image A). Images were processed, and rendered in 3D by Imaris software, 
shown in the small blown up section of image A (B). Using the definitions 
shown in diagram C, neutrophils were identified and counted. Then locations 
were assigned to the neutrophils as shown in Figure 4.2.1-1: alveolar space 
D, peri-vascular E and vascular F. Following the protocol shown in figure 4.2.1-
2 A, it was observed that intra-tracheal Sema3F treatment at peak recruitment, 
24 hours post ALI, retained neutrophils in alveolar space. This supports the 
previous observation of elevated BAL counts following IT Sema3F treatment. 
There were more neutrophils in the Sema3F treated lung compared to PBS 
per µm3 (****P<0.0001, n=13) (figure 4.2.1-2, graph B). This was accounted for 
by a significant increase in neutrophils in alveolar space rather than those 
associated with vasculature (****P<0.0001, n=13).  
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Figure 4.2.1-1 Identification of the location of neutrophils with respect to the pulmonary vasculature in fixed murine lung slices 
Murine lungs were instilled with agarose gel and fixed, then stained for CD31 (green) to denote the endothelial cells and S100A9 (red) identifying the 
neutrophil population. Lungs were imaged using a confocal microscopy (Zeiss LSM 880 with Airyscan) (A). For each animal 2 x 1mm areas of lung were 
imaged and analysed using Imaris software (Imaris V 8.3). Each slice underwent 3D reconstruction of the vessels shown in the inner square in image B. 
Further to this, neutrophils were identified as being external to the vessel (>10µm from the vessel surface distance “a” and larger than internal neutrophils 
size “b”) or internal (smaller than external neutrophils size “b”) (diagram C). Where alveolar space (D) and vascular (F) neutrophils co-localised these 
were classified as peri-vascular neutrophils (E). 
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Figure 4.2.1-2 Exogenous Sema3F retains recruited neutrophils in a murine 
model of lung injury at 24 hours 
Intra-tracheal (IT) recombinant Sema3F (1µM) or phosphate buffered saline (PBS) was 
administered to wildtype C57BL/6 mice 24 hours post nebulised LPS challenge and were 
sacrificed at 48 and 72 hours (Experimental protocol A). Murine lungs were instilled with 
agarose gel, fixed and stained to identify the location of the neutrophil population. Lungs were 
imaged using a confocal microscopy and neutrophil location assigned using Imaris software 
(Imaris V 9.1) and neutrophil number per µm3 of lung tissue is shown. There are significantly 
more neutrophils in the lung tissue following IT Sema3F treatment compared to PBS and this 
is accounted for by a rise in neutrophils found in the alveolar space. Data are shown mean ± 
SEM, n=13 over 2 experiments. Analysed using two-way ANOVA, with a post-test correction 
for multiple comparisons (Sidak), ****P<0.0001. 
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4.2.2 Sema3F deficient neutrophils transit from blood to alveolar 
space faster than wild-type neutrophils in early acute lung 
injury  
Following on from the finding that neutrophils deficient in Sema3F are recruited 
more avidly into the injured murine lung 6 hours post ALI (Figure 4.2.2-1, graph 
A) I began to investigate the mechanism of this enhanced transit. Neutrophils 
transmigrate from the blood, through the adjacent endothelial layer and lung 
tissue to emerge, following transmigration of the epithelial layer, into the 
alveolar space (4.2.2-1, diagram B - red arrow). It has been demonstrated that 
in health the majority of circulating neutrophils form a marginated intravascular 
pool and further neutrophil sequestration occurs following an insult to the 
lungs.9,15 Neutrophil transit time through the cell layers is dependent on many 
processes. These include neutrophil shape, chemotaxis and adhesion. Also 
changes in the cell layer to be transmigrated play a part, for example 
alterations in junctional molecules of endothelial cells allow neutrophil 
passage.53 In order to narrow the list of potential candidate mechanisms for 
Sema3F regulation of neutrophil transmigration I investigated the relative 
proportion of neutrophils in each compartment: blood, lung tissue and alveolar 
space (4.2.2-2, diagram A-C).  
In parallel to differential BAL neutrophils counts at 2, 6, 24 and 48 hours shown 
in figure 4.2.2-2, graph A. I looked at both the blood and lung tissue 
compartments (figure 4.2.2-2, graphs B & C). Following lung injury WT and KO 
mice were culled at 0 and 6 hours and full blood counts conducted using the 
Coulter counter method. The differential neutrophil count is shown in graph C. 
There was no significant difference between WT or KO mice peripheral blood 
neutrophil counts (P=0.2337). Blood monocyte counts were also unremarkable 
(data not shown). I quantified the numbers of neutrophils within the murine 
lung tissue at 2 and 6 hours. Whole lung tissue was isolated from Sema3F KO 
and WT mice. Using this tissue, I performed a pre-optimised lung digest 
protocol and then stained cells with a validated antibody panel to identify the 
neutrophil population by flow cytometry. Total cell counts were also performed. 
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The data is shown in figure 4.2.2-2 graph C: there was no difference in 
neutrophil numbers between the WT and KO animal at any of the timepoints 
investigated. Unpaired t-tests were performed: 2 hours (P= 0.472) and 6 hours 
(P= 0.352) n=6. Despite a clear neutrophil recruitment phenotype seen in the 
Sema3F KO animal it was surprising there was no difference seen in the lung 
tissue neutrophil population between genotypes. The full blood versus lung 
tissue neutrophil counts has limited resolution. The full blood counts would not 
include the marginated or sequestered neutrophil population.91 Neutrophils 
that are marginated/sequestered to the pulmonary capillaries or adhered to the 
endothelium could be variably accounted for in the lung digest experiment thus 
the proportion of neutrophils spread across the compartments during 
transmigration cannot be fully understood from these experiments. 
I have previously demonstrated that neutrophil specific loss of Sema3F 
enhances recruitment to the airways at 6 hours following the initiation of the 
lung injury (4.2.2-1, graph A). Using the same method employed in 4.2.1, I 
focused on this 6-hour timepoint and neutrophil location data was collected for 
the WT and KO animals. The mean total neutrophil count for the WT lung was 
180.1 neutrophils per µm3 and 136.6 neutrophils per µm3 for the KO lung. From 
these raw counts there appeared to less neutrophils in the KO lung however 
there was no statistical difference between groups (t-test, P=0.5049 n=5). 
When looking at the relative percentage of neutrophils in each location by 
genotype there is a significant increase in the percentage of neutrophils found 
in the alveolar space in the KO animal (*P=0.0401, n=5). As a reflection of the 
increased neutrophil percentage in the alveolar space, there is a trend towards 
lower neutrophils percentages in both the peri-vascular and vascular 
compartments of the KO animal (P=0.727 and P=0.0844, respectively). 
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Figure 4.2.2-1 Investigating the transit of Sema3F deficient neutrophils 6 hours 
post-acute lung injury 
Graph A (also shown in figure 3.6.1-1) highlights that following ALI more Sema3F deficient 
neutrophils are found in the injured lung at 6 hours. Diagram B shows neutrophil transit (red 
arrow) from the pulmonary capillary where neutrophils crawl and undergo transmigration 
through both the endothelium (via either transcellular or paracellular route) and the lung 
interstitium to finally emigrate through the epithelial layer into the alveolus. Also identified are 
the experimental approaches to quantifying neutrophil transit at this time point. The blood 
count which identifies the circulating neutrophil count, the lung digest which demonstrates the 
neutrophil population in the lung tissue and the lung slice which pinpoints the location of the 
neutrophil with respect to the endothelium.  
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Figure 4.2.2-2 Loss of neutrophil Sema3F increases neutrophil transit from the 
blood to the alveolus 
The diagram relates each data set to the lung compartment examined: A. Lung slice 
[neutrophil relationship to endothelium] B. lung tissue and peripheral blood C. (A) WT 
(Sema3FfloxfloxMRP8cre-/-) and KO (Sema3FfloxfloxMRP8cre+/-) were challenged with LPS and 
sacrificed at 6 hours and lung tissue obtained. Murine lungs were instilled with agarose gel, 
fixed and stained to identify the location of the neutrophil population. Lungs were imaged using 
a confocal microscopy and neutrophil location assigned using Imaris software (Imaris V 9.1). 
The percentage of the neutrophil number per µm3 of lung tissue is shown (A). There is a 
significant increase in the proportion in the airway (alveolar space) in the KO animal compared 
to WT. Data are shown mean ± SEM, n=5 over 2 experiments. Analysed using two-way 
ANOVA, *P<0.05. (A) At 0, 2 and 6 hours following nebulised LPS, WT and KO mice were 
sacrificed. Venepuncture was performed and full blood counts analysed, neutrophils numbers 
are shown in graph B, data are shown ± SEM n=3 analysed by two-way ANOVA. (C) WT mice 
and KO murine lungs from 2 and 6 hours were harvested and enzymatically digested. Cellular 
populations were identified using flow cytometry. Data are shown ± SEM n=4-6, analysed by 
unpaired t-tests. (  
 
. 
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4.3 Sema3F modulates neutrophil function in vitro  
4.3.1 Sema3F treated neutrophils display blunted chemotactic 
responses  
In order to gain access to sites of inflammation neutrophils migrate through 
challenging microenvironments towards chemoattractants.283 I had 
established that acutely, neutrophils deficient in Sema3F migrate faster into 
the air space post lung injury. Previous data shown in this chapter did not 
highlight a significant corresponding decrease in Sema3F KO neutrophils in 
either the wider circulation or associated with the pulmonary vasculature which 
would be expected if adhesion pathways were altered, facilitating rapid transit. 
As such, it suggests that this recruitment phenomenon was probably due an 
intrinsic property of the cell rather than an interaction between the neutrophil 
and the barriers to transmigration. As such, I wished to determine the effect of 
Sema3F upon neutrophil migration. I isolated peripheral human neutrophils 
and observed chemotaxis in a simple Boyden chamber assay, where human 
neutrophils are co-incubated with Sema3F (top of chamber) and migration 
towards known chemoattractants (well of chamber) measured (figure 4.3.1-1, 
diagram of chamber A). Neutrophils were cultured in exogenous recombinant 
Sema3F [100nM] and chemotaxis was measured towards known neutrophil 
chemoattractants either IL8 [100nM] or fMLF [100nM] (figure 4.3.1-1). A 
positive control (incubation without Sema3F), negative control (no fMLF or IL8) 
and chemokinesis control (incubation with fMLF or IL8) were included. Whilst 
Sema3F is not a chemoattractant itself, incubation with sema3F inhibits ex-
vivo human neutrophils migrating towards both chemoattractants. Sema3F 
100nM reduced neutrophil migration toward both high dose fMLF [100nM] and 
dose IL8 [100nM] (**P<0.01 and ****P<0.0001 respectively n=4-6). Sema3F 
treatment modulated fMLF- and IL8-induced neutrophil chemotaxis in a dose-
dependent manner. 
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Figure 4.3.1-1 Sema3F treated neutrophils display blunted chemotactic responses.  
Diagram A shows Boyden-type transwell assay, neutrophils are incubated with Sema3F above 
the filter and chemoattractant is placed into the well. (B&C) Isolated peripheral blood 
neutrophils from healthy volunteers were incubated with recombinant Sema3F [100nM], and 
the chemotactic behaviour of neutrophils to both fMLF & IL8 [100nM] determined by Boyden 
chamber. ,Data shown are mean ± SEM, n=4-6 analysed using two-way ANOVA; **P<0.01, 
***P<0.001 & ****P<0.0001.   
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4.3.2 Sema3F acts as a neutrophil retention signal in vitro  
Transwell assays have significant limitations to assess neutrophil migration yet 
are relatively easy and therefore widely used. It gives an endpoint readout only 
and provides no further information on the pattern of cell migration. To 
investigate further the effect of Sema3F on neutrophil migration I collaborated 
with Dr Felix Ellett a Clinical Fellow at Harvard medical school. The 
chemoattractant LTB4 is loaded into the chamber and washed through the 
channels creating a stable gradient for up to eight hours.89 The narrow 8µm 
diameter channels replicate the pulmonary capillaries. A drop of whole human 
blood is placed on the opposing pole and only the neutrophil population are 
able to migrate to the start of the channels through the first section of the chip 
assay (figure 4.3.2-1, diagram A). Real-time light microscopy is used to monitor 
the neutrophil journey to the chamber and retrotaxis (against the preserved 
gradient, away from the chamber). Every ~5min the percentage of maximal 
recruitment to the chamber was calculated. The inflection point represents 
maximal recruitment; after this point declining percentages represent retrotaxis 
and not apoptosis as these cells can be viewed actively leaving the chamber 
against the maintained gradient.  
Graph B (figure 4.3.2-1) shows accumulative percentage of maximal 
recruitment to the chamber over time. With Sema3F pre-incubation, there is a 
significant dose-dependent reduction in recruitment. Untreated neutrophils 
moved to the chamber significantly faster than those pre-treated with Sema3F 
10nM (P**=0.0019). Increasing the dose of Sema3F to 100nM slowed 
neutrophil locomotion further (P****=0.0001). Maximal dose of Sema3F 
1000nM resulted in the largest reduction in neutrophil migration to the chamber 
over time (P***=0.0006). Moreover, after reaching the inflection point (where 
maximal recruitment is achieved) the highest dose of Sema3F, 1000nM (black 
line) retains the neutrophils in the chamber for 90 minutes. In contrast, the 
lower doses of Sema3F and untreated neutrophils appear to move away from 
the chamber and against the LTB4 gradient performing retrotaxis in a dose 
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dependent manner. The untreated group has the largest percentage of 
neutrophils that undergo retrotaxis. 
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Figure 4.3.2-1 Pre-treatment with Sema3F retains neutrophils with reduced 
chemotaxis and retrotaxis 
A chip assay was used to assay the migration of human neutrophils in response to LTB4 
[100nM] diagram A, where only neutrophils can exit the blood and progress to the migration 
channels. In graph B a significant dose dependent reduction in neutrophil migration seen 
following Sema3F pre-treatment [0-1000nM]. Data shown are mean ± SEM, n=3 analysed by 
two-way ANOVA with Dunnett’s post-test correction for multiple comparisons. LTB4 vs LTB4 
& Sema3F 10nM P**=0.0019 LTB4 vs LTB4 & Sema3F 100nM P****=0.0001 LTB4 vs LTB4 
& Sema3f 1000nM P***=0.0006. 
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4.3.3 Sema3F does not alter neutrophil expression of Cd11b or L-
selectin in response to LPS 
Loss of neutrophil Sema3F enhances neutrophil transit into the alveolus post 
LPS lung injury. Semaphorins have been shown to regulate integrin adhesion 
and expression in tumour cells, axons, dendritic cells and during 
angiogenesis.169,233,242,284 Following culture with LPS, CD11b expression 
increases in a dose dependent manner (figure 4.3.3-1, graph A) and L-selectin 
is shed (graph B). This is consistent with the literature and the well 
characterised neutrophil response to LPS, where CD11b surface expression 
is rapidly up regulated with concurrent loss of L-selectin.285 Sema3F treatment 
does not alter this pattern of expression, and Sema3F alone causes no change 
in neutrophil expression of either CD11b or L-selectin. 
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Figure 4.3.3-1 Sema3F does not alter the expression of CD11b or L-selectin following treatment with LPS  
Human neutrophils were cultured in the presence/absence of LPS (0, 10 or 100ng/ml) and Sema3F (0 or 100nm), then stained with PE-anti-CD11b (A) 
or PE-anti-L-selectin (B) and geometric mean fluorescence determined by flow cytometry and fold change from control (media and vehicle control) data 
are shown ± SEM, n=4 analysed by two-way ANOVA. 
 
L-Selectin expression CD11b expression 
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4.3.4 Sema3F treated neutrophils undergo cell rounding  
Neutrophil sequestration in the lung is closely linked to the property of 
deformability which is regulated by the F-actin cytoskeletal arrangements and 
is associated with submembrane F-actin deposition and neutrophil 
roundness.56,57 Similarly, the formation of pseudopodia and lamellipodia are 
integral for cell motility. Generalized loss of these protrusions leads to cell 
rounding.163 During the migration assays I observed that Sema3F treatment 
caused marked rounding of neutrophils. Images in figure 4.3.4-1 are examples 
of this observation, images A-C show untreated quiescent neutrophils, D-F 
show fMLF shaped changed neutrophils and G-I show hyper-round Sema3F 
treated neutrophils. While assessing Sema3F-treated neutrophils during 
multiple experiments this phenotype appeared clear to me as the observer, but 
exact quantification was required to establish objectively whether Sema3F 
causes cell rounding.  
To answer this question, I isolated neutrophils from healthy volunteers and 
cultured them in media with autologous serum and Sema3F [10nM, 100nM]. 
Following 40mins of incubation with Sema3F, cultured neutrophils were 
treated with 100nM of fMLF and fixed after 15 minutes. These neutrophils were 
then stained to differentiate the nucleus, cytoplasm and actin. Images were 
taken using the Operetta high content imaging system. Example images are 
shown in figure 4.3.4-1 these were taken at x40 magnification to show the 
morphology of the hyper-round Sema3F treated cells compared to control or 
fMLF treated neutrophils. Associated software was used to quantify cell 
roundness and the results are shown in the graph in figure 4.3.4-2. Images for 
the roundness analysis were taken at x20 magnification as this increased the 
number of cells analysed. Each well represents a treatment group and had a 
minimum of 4 replicates; within each well 23 fields were imaged and on 
average 1000 cells per field analysed. Roundness was determined by the 
sequential use of cell masks in an optimized algorithm and roundness values 
displayed between 0 and 1, where 0 represents a line and 1 a perfect circle. 
The Role of Semaphorin3F in Neutrophilic Inflammation 
Chapter 4 Results  154 
Neutrophils were rounder when co-incubated with Sema3F [10nM, 100nM] in 
a dose dependent manner (figure 4.3.4-2). The rounding effect was overcome 
by treatment with fMLF [100nM]. Untreated neutrophils in culture medium had 
a mean roundness value of 0.935 ± 0.005 compared to Sema3F treated 
neutrophils which had a significantly higher roundness value of 0.966 ± 0.005 
(****P=0.0003). 
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Figure 4.3.4-1 Sema3F treated neutrophils undergo cell rounding 
Isolated peripheral blood neutrophils from healthy volunteers were incubated with recombinant 
Sema3F [0-100nM] and fMLF 100nM. Neutrophils were cultured in media for 40 mins then 
treated with fMLF and fixed after 15 minutes. Cells were then stained with DAPI (4',6-
Diamidino-2-Phenylindole, Dihydrochloride), HCS CellMask™ Green stain and Alexa Fluor® 
594 conjugated Phalloidin. Images were obtained using an Operetta High-Content Imaging 
System. Representative images taken at x40 magnification are shown in the figure; DAPI (A, 
D & G), HCS CellMask™ Green (B, E & H) and dual staining (C, F & I). Images A-C show 
untreated neutrophils, images D-F show neutrophils treated with fMLF and images G-I show 
neutrophils treated with Sema3F 100nM. 
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Figure 4.3.4-2 Sema3F treated neutrophils are rounder 
Isolated peripheral blood neutrophils from healthy volunteers were incubated with recombinant 
Sema3F [0-100nM] and fMLF 100nM. Neutrophils were cultured in media for 40 mins then 
treated with fMLF and fixed after 15 minutes. Cells were then stained with DAPI (4',6-
Diamidino-2-Phenylindole, Dihydrochloride), HCS CellMask™ Green stain and Alexa Fluor® 
594 conjugated Phalloidin. Images were obtained using an Operetta High-Content Imaging 
System and analysis of roundness performed by Harmony® analysis Software. Data shown 
are mean ± SEM, n=4 analysed using paired t-tests, *P<0.05, **P<0.01 & ****P<0.001. 
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4.3.5 Human neutrophils treated with Sema3F have preserved 
phagocytosis 
Sema3F signalling alters neutrophil migratory behaviour. Phagocytosis is an 
important cytotoxic neutrophil function which is regulated by cell shape and 
actin dynamics. To determine whether Sema3F could also inhibit phagocytosis 
I examined the phagocytosis of both Zymosan granules and fluorescent 
labelled E. coli results are shown in figure 4.3.5-1, graph A. Neutrophils were 
co-incubated with opsonised Zymosan A particles and phagocytic index (PI) 
calculated, negative controls were included where Zymosan granules were 
absent [not shown]. There was no inhibition of phagocytosis in the neutrophils 
treated with Sema3F as shown in graph A. The mean PI for untreated was 
0.53±0.071 compared to Sema3F treated which was 0.585±0.071, P=0.58. 
Neutrophils were incubated with fluorescently labelled E. coli and 
internalization assessed by flow cytometry. Sema3F did not significantly 
reduce internalisation of the labelled E. coli, P=0.27, n=3 (figure 4.3.5-1, graph 
B).  
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Figure 4.3.5-1 Human neutrophils treated with Sema3F have normal 
phagocytosis 
(A) The phagocytotic index was calculated from cytospins of healthy human neutrophils 
treated with Sema3F and cultured with opsonised Zymosan particles for 30 minutes. (B) Flow 
cytometry analysis of intracellular AlexÒ 488 E. coli was undertaken following 30 minutes 
culture of human neutrophils. A cold control was performed, neutrophils were also incubated 
with AlexÒ 488 E. coli at 4°C to identify the energy dependent internalisation from external 
binding of the labelled E. coli to the neutrophils. Data shown are mean ± SEM, n=4 (A) and 
n=3 (B) analysed using unpaired t-tests, *P<0.05, **P<0.01 & ****P<0.001. 
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4.3.6 Sema3F reduces neutrophil myeloperoxidase activity 
While Sema3F treatment does not alter phagocytosis, I wondered if other 
neutrophil effector functions would be modulated by Sema3F. Given that the 
accumulating evidence suggested that Sema3F regulates the neutrophil 
cytoskeletal and, that the re-arrangement of the actin cytoskeleton is 
necessary for neutrophil degranulation I looked at the one of the functional 
consequences of neutrophil degranulation - myeloperoxidase (MPO) 
activity.235 The activity assay measures the peroxidase capacity of the 
myeloperoxidase enzyme released during neutrophil degranulation in culture 
supernatant. Neutrophils were cultured with and without Sema3F for 1 hour, 
then stimulated with GM-CSF for 30 minutes and fMLF for 10 mins ensuring 
maximal degranulation.286 The supernatant was immediately removed and 
promptly analysed. The myeloperoxidase-catalysed oxidation of 3,5,3‘,5‘-
Tetramethylbenzidine (TMB), which uses H2O2 as a substrate, results in a 
colour change and is analysed using spectrometry. In figure 4.3.6-1 A, the 
graph shows that following Sema3F 100nM treatment there is a significant 
reduction in MPO activity.  
In a similar manner, to elucidate whether Sema3F treatment can regulate 
neutrophil degranulation and enzyme activity I assessed the elastase activity 
(graph B). This was performed following the same conditions used for the 
myeloperoxidase assay. Elastase is another component of primary granules; 
unlike MPO it is a peptidase and breaks down proteins. In this way elastase 
driven enzymatic digestion of a quenched fluorochrome removes the 
quenching and produces a signal. This assay did not show any differences in 
elastase activity following Sema3F treatment (P=0.5146).  
These two enzymes were chosen for their important role in host defence and 
tissue damage. They may also have a role as biomarkers of ongoing lung 
inflammation and have been used as markers of lung injury throughout the 
literature. 11,268 Both are contained within the same neutrophil granule 
(primary/azurophilic granules) when released from activated neutrophils. 
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There exists debate over the relevance of granule specify to the pathogenesis 
of tissue injury. It is postulated that different neutrophil granules release a 
spectrum of enzymatic and toxic contents and as such may not form a useful 
experimental or biological distinction. These assays do not directly evaluate 
neutrophil granule exocytosis itself and would be an interesting future area of 
research beyond the scope of this current project. 2  
 
 




Figure 4.3.6-1 Pre-treatment with Sema3F does not alter neutrophil elastase activity in cell culture supernatant but neutrophil 
Myeloperoxidase activity is reduced 
Following culture with Sema3F for 1 hour, Granulocyte-macrophage colony-stimulating factor (GMCSF) was given for 30min and FMLF for the final 10 
min, then supernatant harvested. Either the peroxidase utilisation of 3,3′,5,5′-Tetramethylbenzidine (TMB, Sigma) by MPO was measured and fold change 
from control (media alone) shown in graph A or elastase activity in a fluorometric assay graph B.  Data shown are mean ± SEM, (A n=3, B n=4) analysed 
using one-way ANOVA, **p<0.001 & ***p<0.001. 
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4.3.7 Following stimulation with Sema3F neutrophils treated with 
N-formylmethionyl-leucyl-phenylalanine have increased 
radical oxygen species production 
Neutrophils generate radical oxygen species (ROS) through the enzyme 
NADPH oxidase as part of an antimicrobial defence strategy.4 Following on 
from the observed reduction in neutrophil MPO activity in response to Sema3F 
treatment, I hypothesised that other histotoxic agents would be similarly 
reduced or inhibited and ROS could be reduced by Sema3F treatment. ROS 
has a unique and direct relationship with the actin cytoskeleton and has been 
shown to dynamically alter the actin through reversible glutathionylation 
promoting depolymerisation.44,61-63 In addition ROS has also been implicated 
in the internalisation of receptors that detect chemoattractant cues and can 
arrest neutrophil migration.264 Given this, I investigated the effect of Sema3F 
on neutrophil ROS production. In figure 4.3.7-1 the graph shows DCF 
fluorescence (the ROS detector) following neutrophil culture with various 
conditions. For each n number, which formed an individual experiment, the 
values were normalised to the unstained sample to remove any variability in 
both signal and detection between each experiment.  In the media alone group, 
DCFH-DA was added to delineate a baseline value. As expected fMLF induced 
a positive in increase in DCF signal and therefore intracellular neutrophil ROS 
production (media alone vs fMLF *P=0.0131), surprisingly with the addition of 
pre-incubation with Sema3F 100nM the response to fMLF was increased by 
157% (% mean increase, *P=0.0135). There was no difference between fMLF 
alone and Sema3F 10nM/fMLF (P=0.9573). Sema3F alone at either 10nM or 
100nM did not induce ROS production (P=0.6234 & P=0.6429 respectively).   
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Figure 4.3.7-1 Pre-treatment with Sema3F enhances fMLF induced intra-cellular 
radical oxygen species in neutrophils 
Intra-neutrophil radical oxygen species (ROS) generation was determined following a 1-hour 
pre-incubation with Sema3F and treatment with fMLF for 30 minutes. The ROS detector 
substance DCF was measured by flowcytometry. Data shown are mean ± SEM n=3 analysed 
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4.4 In vivo Sema3F reduces neutrophil locomotion through 
reduction of F-actin content 
4.4.1 In vivo Sema3F treated neutrophils are slower but maintain 
directionality  
When investigating the effect Sema3F had on chemotaxis in human 
neutrophils it became apparent that real-time analysis of neutrophil movement 
was superior. During neutrophil chemotaxis directionality and speed are linked, 
however to some degree, they can be regulated independently.287,288 In order 
to begin to measure this, a live lung culture experiment was optimised in 
collaboration with Dr Leo Carlin, Beatson Institute, using CatchupIVM-RED;LifeAct-
GFP mice. In this transgenic model the murine neutrophils express both the 
reporter tdTomato and the peptide LifeAct-GFP; the latter facilitates the 
visualisation of neutrophil F-actin. This allowed accurate locating of the 
neutrophils in vivo and may be amenable to future F-actin quantification. In 
figure 4.4.1-1 the schematic shows the details of the experimental protocol. 
The unstimulated transgenic mice were culled, lungs instilled with agarose and 
sliced. The slice was then placed in RPMI (1% FCS) at 37°C in 5% CO2. The 
duration of real-time confocal image acquisition is shown in timeline A. Lung 1 
and lung 2 were treated simultaneously, with Sema3F treatment omitted and 
PBS treatment given to lung 1. Following this 10µM of fMLF was given; this 
higher dose promotes ROS production and neutrophil chemotaxis 
declines.63,64 Initially lung slice movement during imaging created substantial 
movement artefact which was reduced by: 1) allowing the slice to equilibrate 
fully to temperature for 1 hour before imaging within the chamber; 2) The tissue 
harp and steel washer was used to hold the tissue in situ when the stage 
moved allowing imaging of the other slice, however they did not interfere with 
either treatments or imaging (B). Image C and D represent the two lung slices, 
imaged sequentially at positions 1,2,3,4. Only one position can be imaged at 
a time, to compare conditions in real-time alternating positions were used. All 
4 positions were imaged within 60 seconds. Treatments were given in the 
assigned locations, as shown in diagrams C and D. Using this protocol imaging 
data was acquired over 110 minutes. Each section of the timeline was 
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analysed independently using Imaris software and the data is shown in graphs 
A - C in figure 4.4.1-2. Automated analysis of speed and directionality [track 
straightness] was used to avoid observer error and bias. The analysis was then 
manually checked for accuracy. In graph A, average track speed is shown 
[track length / time between first and last position] and there is no difference 
between lung 1 & 2 prior to treatments (P=0.21). Following application of 
Sema3F 100nM neutrophils are significantly slower compared with both the 
control lung 1 at baseline (***P=0.0003) and the PBS treated lung (lung 1 60 
mins vs lung 2 60 mins, *P=0.021). The average speed of the neutrophils in 
slice 1 at baseline compared to PBS treated slice is unchanged (P=0.112). 
There is a significant reduction in neutrophil mean track speed following fMLF 
in both the treated and untreated slices (lung 1 60 mins vs lung 1 30 mins; lung 
2 60 min vs lung 2 30 mins). There is no difference between lung 1 and 2 
following fMLF (lung 1 30 mins vs lung 2 30 mins). In parallel, track 
straightness was recorded (straightness=displacement [distance between first 
and last position]/length [of tracks]) where the value of 1 represents a straight 
line and < 1 an indirect path. The starting and endpoint needed to be visible 
throughout the recording, this did generate some variability in the numbers of 
neutrophils amenable to analysis per slice. As shown in graph B directionality 
[track straightness] is preserved following Sema3F treatment. Track 
straightness decreased in the PBS treated groups over time. As the track 
straightness decreases the number of track branches increase and the 
neutrophil must perform increasing numbers of “turns”. Each turn will require 
additional time and slow locomotion. Therefore, to confirm the effect of 
Sema3F on neutrophil speed I also analysed the maximal speed of each 
neutrophil, graph C. Following Sema3F treatment there is a significant 
reduction in maximal neutrophil speed compared to PBS treatment 
(**P=0.0084) but not compared to baseline [initial 20mins without either fMLF 
or vehicle control PBS] (P=0.1579). There was no significant difference 
observed at baseline during the initial 20 minutes of recording (P=0.1827). 
Following fMLF there is no difference between treatment groups. The maximal 
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speed is less significantly reduced following Sema3F & fMLF sequential 
treatment compared to PBS & fMLF treatment (lung 1 60 mins with PBS vs 
lung 1 fMLF ***P=0.0001 - lung 2 60 mins with Sema3F vs lung 1 fMLF 
*P=0.0120). The maximal neutrophil speed does not appear to decline with 
time, changes from baseline are only seen following treatments. 
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Figure 4.4.1-1 Experimental protocol for live lung imaging 
Timeline A shows the recording of the live lung imaging with the serial conditions indicated, in the first 20 minutes the tissue equilibrates to 37°C, following 
this either Sema3F or PBS is added for 60 minutes and finally fMLF is added and recording continues for another 30 minutes. Image B shows the system 
employed to hold the slice in situ during movement of the stage allowing for continuous and alternating imaging of lung slide 1 and 2. C and D are 
schematics of the parallel chambers, a 30-frame recording is made at site 1, 3, 2 and 4 throughout the duration of the recording. PBS or Sema3F is added 
to the central area of the slice and FMLF to the top right-hand corner. 
 
 




Figure 4.4.1-2 Sema3F signalling slows ex vivo neutrophils but directionality is unchanged  
CatchupIVM-RED;Lifeact-GFP were sacrificed and lungs were instilled with agarose gel. Lungs were sliced and imaged using a confocal microscopy for 110 
minutes. Neutrophil speed (A) and track straightness (directionality) (B) and maximum track speed (C) were measured and analysed using Imaris software 
(Imaris V 9.1). Data shown are mean ± SEM, biological replicate of 3, analysed using one-way ANOVA *P<0.05, **P<0.001, ***P<0.001 & ****P<0.0001 
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4.4.2 Sema3F increases neutrophil sphericity in the injured 
murine lung 
Many of the neutrophil behaviours and functions altered by Sema3F signaling 
are associated with modifications of cytoskeleton dynamics. I have shown that 
Sema3F affects neutrophil cell rounding in vitro and that, at 24 hours post ALI 
neutrophils treated with Sema3F, are retained in the injured airway. Therefore, 
I hypothesised that the Sema3F retained neutrophils would be rounder, or 
indeed more spherical, than those treated with PBS in vivo. Mice were culled 
at 48 hours post ALI and after receiving IT Sema3F, lungs were instilled with 
agarose gel, fixed, sliced, stained and neutrophils identified. Using Imaris 
software, the neutrophils number were counted, and sphericity assessed, 
where 1 is considered a perfect sphere and 0 would be an extremely polarised 
neutrophil. It may be expected that in this context recruited neutrophils would 
be very shaped-changed in response to the multitude of inflammatory 
signals.289 In figure 4.4.2-1, graph A is a representative histogram showing 
data from one pair of lung slices. In this graph frequency is the percentage of 
neutrophils of the total number of neutrophils (per standardised area imaged). 
Sema3F increases the frequency (percentage) of neutrophils that are highly 
round, evident in the right shift of the Sema3F treated population compared to 
the PBS. In graph B the mean sphericity value for the neutrophil population, in 
each pair of treated lungs, is shown. This mean is derived from counting > 270 
cells (the number of neutrophils contained per slice in the imaged area), two 
areas were imaged per lung and the data compared. To analyse this data, t-
tests were conducted using the n number and SEM for the data set. Graph B 
demonstrates that when neutrophils when are treated with Sema3F in vivo are 
significantly more spherical than those treated with vehicle control, PBS. Mean 
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Figure 4.4.2-1 Sema3F treatment of recruited inflammatory neutrophils increases neutrophil sphericity 
Intra-tracheal (IT) recombinant Sema3F (1µM) or phosphate buffered saline (PBS) was administered to wildtype C57BL/6 mice 24 hours post nebulised 
LPS challenge and were sacrificed at 48 hours. Murine lungs were instilled with agarose gel, fixed and stained to identify the location of the neutrophil 
population. Lungs were imaged using a confocal microscopy and neutrophil location assigned using Imaris software (Imaris V 9.1) and neutrophil sphericity 
analysed. Example A shows n=1, where all data points are represented in the histogram. Sema3F treatment affects a right shift in the histogram towards 
increased sphericity with a maximal value of 1. Graph B shows a summary, data are shown mean, n=3 over 3 experiments. Data: donor 1 - PBS, 
mean=0.71 ± 008 (297 cells) vs Sema3F, 0.77 ± 009 (307 cells); donor 2 - PBS, mean=0.69 ± 0061 (639 cells) vs Sema3F, 0.79 ± 0.0053 (475 cells); 
donor 3 - PBS, mean=0.818 ± 0.080 (270 cells) vs Sema3F, 0.903 ± 0.048 (301 cells); analysed using unpaired t-test, ****P<0.0001. 
 
The Role of Semaphorin3F in Neutrophilic Inflammation 
Chapter 4 Results  171 
4.4.3 Sema3F differentially regulates myeloperoxidase and 
elastase activity in bronchioalveolar lavage fluid during 
acute lung injury 
Neutrophil degranulation occurs through dynamic cytoskeletal arrangements 
which can be regulated by Sema3F. I have shown in culture that exogenous 
Sema3F treatment of human neutrophils results in a reduced in MPO activity 
in the cell-culture supernatant. Following IT Sema3F at peak recruitment (24 
hours), at 48 hours there is significantly less MPO activity in the BAL fluid 
(figure 4.4.3-1, graph B *P=0.0113). I wondered if the converse would hold true 
and hypothesised following recruitment of Sema3F deficient neutrophils to the 
injured lung there would be an increase in MPO activity. The graph A shows 
that at 24 hours following lung injury there is a significant increase in MPO 
activity in the supernatant (*P=0.0301). Loss of neutrophil Sema3F results in 
enhanced recruitment and significantly more neutrophils in the alveolus at 6 
hours and not 24. Therefore, while this increase in MPO activity does directly 
correspond to the timepoint where increased neutrophil numbers are seen this 
could relate to an increase in accumulated MPO from this prior timepoint.  
Neutrophil elastase was significantly reduced at 48 hours in the Sema3F KO 
animal compared to WT (*P=0.0249). This is the timepoint that follows the 
enhanced resolution period seen in the KO animal. The reduction in elastase 
could reflect this ‘enhanced’ resolution. There is no effect of IT Sema3F when 
compared to IT PBS on BAL levels of neutrophil elastase.  
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 (KO) or C57BL/6 mice were 
challenged with LPS. WT and KO mice were sacrificed at 6, 24 and 48 hours then 
bronchoalveolar lavage fluid obtained (A & C). C57BL/6 mice were given IT PBS or Sema3F 
at 24 hours and culled at 48 and 72 hours following this BAL fluid was extracted (B & D). BAL 
fluid was tested and the peroxidase utilisation of 3,3′,5,5′-Tetramethylbenzidine (TMB, Sigma) 
by MPO measured or elastase activity in a fluorometric assay graph. Quantities of MPO and 
elastase were derived using standard curve method. Data are shown mean ± SEM analysed 
using two-way ANOVA. Graph A, *P=0.0301 n=8 over 2 individual experiments. Graph B, 
*P=0.0113 n=5 over 1 experiment, graph C *P=0.0249 n=8 over 2 individual experiments and 
Graph D n=5-6 over 1 experiment. 
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4.4.4 Sema3F treatment reduces neutrophil steady state F-actin 
content but does not alter polarity 
Sema3F reduces the speed of neutrophil chemotaxis and transit in vivo and 
vitro. This could be through the induction of neutrophil F-actin disassembly. 
Following fMLF stimulation neutrophils undergo a well characterized response. 
Initially between 0 to 75 seconds there is an actin polymerisation phase, 
neutrophils appear round and this is not dependent upon fMLF dose. Following 
this there is depolymerisation to an intermediate level which leads into the 
stable state between 5 and 10 minutes. The depolymerisation phase is 
inversely dependent upon fMLF dose. It is only the maximal polymerisation 
point and the steady state that is dose dependent. 290  
I looked at the neutrophil F-actin content at key timepoints starting at 0, 75, 90 
seconds then 3,10,15 & 30 minutes as shown in figure 4.4.4-1, graph A. After 
pre-incubation with Sema3F, the neutrophil F-actin levels are significantly 
reduced only once the steady state is reached at 10 minutes shown in graph 
A (*P=0.0150). This is not surprising as the rapid polymerisation rate is not 
proportional to the fMLF dose and may be a fixed response. It is possible that 
Sema3F promotes an extended second phase of depolymerisation resulting in 
a reduced F-actin content. The F-actin distribution, shown in graph B by the 
co-variance of the pixel intensity, becomes increasingly disparate overtime to 
the same degree in both treatment groups. This infers that neutrophil 
polarisation is preserved and despite a reduction in total F-actin the distribution 
of F-actin is unchanged by Sema3F treatment. At 10 minutes the neutrophils 
have maximally polarised shown by the higher heterogenicity of their F-actin 
signal. This would support the ex vivo findings, that Sema3F does not alter 
track straightness and that neutrophil polarisation (F-actin heterogeneity) and 
directionality are maintained. Sema3F does reduce neutrophil speed in vivo 
with a corresponding reduction in F-actin neutrophil content in vitro. 
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Figure 4.4.4-1 Sema3F reduces steady state F-actin content in neutrophils while distribution is unchanged 
Isolated peripheral blood neutrophils from healthy volunteers were incubated with recombinant Sema3F [100nM] and then treated with fMLF 100nM. 
Neutrophils were cultured in media for 60 mins with and without Sema3F then treated with fMLF and fixed at the timepoints shown in graph A and B for 
15 minutes. Following permeabilisation cells were then stained with DAPI (4',6-Diamidino-2-Phenylindole, Dihydrochloride), and Alexa Fluor® 488 
conjugated Phalloidin. The characteristic of F-actin kinetics is marked in grey on graph A.  Images were obtained using an Operetta High-Content Imaging 
System and analysis of F-actin was performed by Harmony® analysis Software. Data shown are mean ± SEM, n=3 analysed using two-way ANOVA, 
*P=0.015. 
.   
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4.4.5 Intra-tracheal Sema3F retains neutrophils in the injured 
airway through F-actin disassembly 
I wanted to elucidate the mechanism by which Sema3F treatment retained 
recruited neutrophils in the injured lung. I hypothesised that neutrophils 
retained in vivo by Sema3F treatment would have less F-actin content. To do 
this I assessed the F:G actin ratio within each neutrophil. As filamentous F-
actin depolymerises into G actin the ratio declines figure 4.4.5-1, diagram B. 
Wild type mice were given nebulised LPS and I obtained neutrophils 48 hours 
following IT Sema3F or PBS treatment at 24 hours. The mice were culled, and 
lungs instilled with a gentle fixative to preserve the F-actin cytoskeleton in vitro 
(experimental protocol is shown in diagram A). The method of permeabilisation 
employed maintained the characteristic neutrophil FSC-A and SCC-A profile 
to assist analysis. Following staining with Phalloidin-conjugated and DNAse I 
conjugated probes, the ratiometrics were determined on a flow cytometer 
shown in graph C, in figure 4.4.5-1. A subset of the PBS and Sema3F treated 
neutrophils were neutrophils not immediately fixed and were first treated with 
Latrunculin A (Lat A) for 30 minutes. This is a potent effector of F-actin collapse 
and provided a positive control shown in graph B, where following treatment 
with Lat A the F:G ratio is extremely low. There was no difference observed 
between groups post Lat A treatment. The neutrophils treated with Sem3F 
have a significantly lower F:G actin ratio (**P=0.089) and less F-actin content. 
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Figure 4.4.5-1 Inflammatory neutrophils are retained in the injured airway by 
Sema3F induced F-actin disassembly 
Using the experimental protocol shown in diagram A, BALs were performed with fixative and 
neutrophils permeabilised. The F:G actin ratio is defined in diagram B; after intracellular 
staining for F and G actin, this ratio was determined for each neutrophil using flowcytometry. 
A subset of neutrophils was treated prior to staining with Latrunculin A [10µM] to collapse the 
F-actin cytoskeleton as a positive control. Data shown are mean ± SEM n=9 over two individual 
experiments, analysed using unpaired t-tests. **P<0.01 & ****P<0.0001 
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4.5 Discussion 
Neutrophil transit into the injured lung tissue is altered by both exogenous 
Sema3F and neutrophil loss of Sema3F. Analysis of the neutrophil location 
demonstrated that in the lung treated with exogenous Sema3F there were 
significantly more neutrophils per µm3 of lung tissue (as defined by the area of 
the capillary vessel network) (figure 4.2.1-2). This was largely accounted for 
by a significant increase in neutrophils found in the alveolar space. The 
retention of neutrophils to the alveolus may simply occur as this is the location 
where the neutrophil would sense the exogenous Sema3F signal. 
Alternatively, reduction in clearance of neutrophils from the distal airway would 
account for this. In this setting neutrophil clearance occurs partially through 
apoptosis and subsequent phagocytosis by macrophages.114 The neutrophil 
counts made in the lung slices may include neutrophils in early apoptosis. This 
is less likely as during this phase in the LPS induced lung injury model, 
neutrophil survival is enhanced and it is doubtful that this route of clearance is 
a significant contributor.9 While neutrophil reverse migration has been 
confirmed in other organs, this has not been observed from the alveolar space 
into the pulmonary vessels and remains unlikely due to the complexity of the 
barriers to migration.75 It has however been shown that neutrophils may return 
from a marginated state, where they are in close proximity to the blood vessel 
wall to the wider circulation.20 This would not account for the differences seen 
in alveolar space neutrophil populations. Once the neutrophil arrives in the 
distal airway it is permanently captured in the lipid rich mucus. The mucociliary 
escalator is a mechanism for the clearance of particles in the lung; this also 
extends to cells, including both macrophages and neutrophils.25,291 If the 
amount cleared is in excess and cannot be swallowed this results in cough and 
the generation of sputum. In health and following induction of sputum 
neutrophils represent 37% of the cell types found and this dramatically 
increases in inflammation to 80%.25 Another explanation is that PBS treated 
neutrophils are removed from the distal airway more efficiently than those 
treated with Sema3F. For example, neutrophils that are more amenable to 
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migrate, be captured and then propelled from the alveolus mucus, to the start 
of the “escalator” adjacent to the ciliated distal airway would be cleared faster. 
As mice swallow all sputum and do not have a cough reflex this is difficult to 
evaluate in a murine model.  
Following the discovery that neutrophils deficient in Sema3F are recruited into 
the injured airway in significantly greater numbers at 6 hours post ALI, it 
remained unclear whether this neutrophil specific phenotype due overall to an 
increase in circulating neutrophils in the KO animal or due to faster neutrophil 
transit to the distal airspaces. Neutrophil release from, and recapture in, the 
bone marrow partly regulates the numbers of neutrophils in circulation. In 
health the circulating pool of neutrophils is a small percentage (1-2%) of the 
total number of mature neutrophils present in the bone marrow (BM).60 During 
an inflammatory insult, stimulation by G-MCSF and inhibition of retention 
signals through the receptor CXCR4 ensures neutrophils are released from 
the bone marrow. Sema3A autocrine loops regulate BM endothelial cell 
behaviour.197 Likewise following sterile injury neutrophils move to the lungs 
and through CXCR4 relocate back to the BM.23 While no role has been 
described for Semaphorins in the regulation of neutrophil release from the BM, 
it was possible that the Sema3F deficient neutrophils could be released, 
retained or recaptured by the bone marrow differently from their WT 
counterparts. At baseline (0 and 6 hours), the circulating differential neutrophil 
count was similar between genotypes (figure 4.2.2-2, C). Baseline neutrophil 
blood counts were at the lower end of what is expected for the C57BL/6J 
background strain; mean counts between 0-6 hours range from 0.469-0.6983 
1x109/L.292 This suggests that loss of Sema3F did not alter the pool of 
circulating neutrophils in health. “Time 0” could occur up to 20 minutes 
following induction of ALI. Intravenous injections of bacterial peptide fMLF, 
complement factor C5, IL8, LTB4 have all been shown in animal models to 
induce neutropenia rapidly between 30 and 90 seconds.293 In humans 
intravenous LPS results in neutropenia within 30 minutes.22 Rapid neutropenia 
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occurs due to the sequestration of neutrophils following systemic circulation. 
While LPS in this case was delivered via nebulisation and not given IV, this 
delay could allow for the rapid sequestration of neutrophils to the pulmonary 
vasculature and the low normal counts between 0 and 6 hours. If this were true 
there is no identifiable difference in rapid sequestration between WT and KO 
neutrophils.  
To capture the neutrophil flux through the interstitium during ALI, lung digests 
were performed following LPS induced lung injury at 2 & 6 hours. Cell 
suspensions were counted and stained with an established antibody panel to 
allow identification of granulocyte populations, then flow cytometry performed. 
In figure 4.2.2-2 graph B shows the neutrophil count per ml of digest. There 
was no significant difference observed between genotypes. Overall, there is a 
decline in neutrophil numbers in the lung tissue, a trough is seen at 6 hours 
concurrent with the timing of enhanced neutrophil recruitment seen in the KO 
mice. Taken together the data regarding the relative neutrophil populations in 
the blood and lung tissue suggest that Sema3F regulation of neutrophil transit 
is independent of interactions with these compartments and points to 
regulation of an intrinsic neutrophil property.  
Sema3F may regulate neutrophil cytoskeleton, shape and deformability which 
are important determinants of neutrophil transit in ALI. Of circulating 
neutrophils 20% are found in the healthy lung and of these, 90% are found in 
the pulmonary capillaries. The airspace neutrophil population is dramatically 
increased following an inflammatory insult. The narrow diameter of  pulmonary 
capillaries requires neutrophils to deform in order to enter and neutrophil 
migration into the lung capillary bed is largely independent of P or L selectin 
adhesion, or integrin mediated rolling.62,245,294 In a rat model of E. coli 
pneumonia model, requiring CD11/CD18 mediated neutrophil adhesion, there 
was no reduction in neutrophil sequestration. Levels of selectin adhesion or 
neutrophil platelet binding also had no effect and it was the presence of 
neutrophil F-actin rims that largely accounted for neutrophil 
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sequestration.12,20,22,47 Cytocalasin D, an inhibitor of actin polymerisation 
inhibits sequestration into the lung; similarly increased deformability of 
neutrophils resulted in shorter transit times into the lung.248,293,295 Cytocalasin 
D reduces the overall turnover of the actin cytoskeleton and dynamic 
cytoskeletal arranges that probably increase cell deformability. The enhanced 
recruitment of KO neutrophils to the injured lung at 6 hours point to an early 
event in the transmigration of recruited neutrophils being adjusted, such as 
sequestration. There is strong evidence that it is the biomechanical properties 
of the neutrophil and the slow blood flow of the pulmonary capillaries that 
determine the rate of neutrophil sequestration into the lung over selectin or 
integrin interactions.296,297 The lack of disparity in neutrophil blood and lung 
tissue numbers between genotypes attests the hypothesis that the autocrine 
Sema3F signal regulates an intrinsic property of the neutrophil and not an 
interaction between the neutrophil and other cell types. 
In results chapter 3 I demonstrated that neutrophil specific loss of Sema3F 
results in enhanced recruitment to the injured airway at 6 hours. The circulating 
differential neutrophil count does not include the marginated/sequestered 
neutrophil population. Lung tissue digests will include neutrophils adherent to 
the endothelial layer, but as the pulmonary vasculature is washed out with PBS 
prior to resection, it will also not include the marginated population. Therefore, 
patterns of neutrophil transit may be obscured by a lack of resolution. To 
address this limitation, I looked at lung tissue taken from WT and KO mice at 
6 hours, to assess whether the recruitment phenotype was reflected by an 
altered location of the neutrophils (figure 4.2.2-2, graph A). There was no 
significant difference in the absolute number of neutrophils per µm3 between 
genotypes. I then calculated the percentage of neutrophils at each location 
from the total number of neutrophils in the slice. Using this method there were 
significantly more Sema3F deficient neutrophils found in the alveolus at 6 
hours post injury. Following bronchoalveolar lavage the KO animal had a 
statistically significant enhancement of neutrophil recruitment (figure 4.2.2-1 
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graph A). This discrepancy between lung slice and BAL counts could relate to 
the BAL fluid representing a more comprehensive airway neutrophil 
quantification. Neutrophils that are in the distal airways and larger airways, will 
not be captured by the lung slice which includes small airways and alveoli, 
whereas the entire bronchial tree would be reflected in a BAL count. If the 
mucociliary escalator is reached earlier by the faster KO neutrophils I would 
hypothesise that the larger airways would contain more neutrophils than the 
distal or alveolus. In conjunction with increased percentage of Sema3F 
deficient neutrophils in the alveolus there is a non-significant reduction in both 
vascular and peri-vascular neutrophils. These compartments probably 
represent the marginated (vascular) and those undergoing transendothelial 
and/or transepithelial migration (peri-vascular). This points to an increase in 
the neutrophil rate of transit, over a decrease in adhesive forces alone, as both 
marginated neutrophils and those undergoing diapedesis are affected. In 
addition, the total numbers of neutrophils per lung slice remain similar between 
genotypes; it is the portion of cells that have migrated to the finish line - the 
alveolar space, which is increased. In summary, in diagrams A & B, figure 4.5-
1, I have summarized the trends in neutrophil transmigration observed across 
multiple experiments in response to both exogenous Sem3F and neutrophil 
specific loss of Sema3F. What is clear from this diagram is that Sema3F signal 
is able to alter the pattern of neutrophil transit thus both recruitment and 
resolution. This appears to begin acutely and there is a suggestion that it is 
independent of adhesion pathways. The differences in recruitment at 6 hours 
in the transgenic animal and at 24 hours in the exogenous Sema3F experiment 
are not reflected in significant decreases in other compartments. It is possible 
that these neutrophils are recruited differently from a marginated pool of 
neutrophils which would not affect baseline circulating blood counts. 
Alternatively, the relative speed of neutrophil transit time may be enhanced 
following loss of Sema3F.  
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Figure 4.5-1 A comparison of trends in neutrophil distribution during LPS lung injury in the murine lung 
A summary of data from separate experiments to show neutrophil transit during ALI. Diagram A shows the increased neutrophils found in the alveolar 
space by lung slice imaging and by differential white cell counts performed on BAL fluid. Diagram B shows the changes in the KO mouse compared to 
WT in circulation (Blood) in the interstitium (lung digest) relative to the pulmonary capillary blood vessels (lung slice) and in the BAL (differential cell 
counts). Blue sideways arrows indicate where there is no significant difference. Green arrows indicate an increased count in the KO versus WT animal, 
red arrows indicate a relative decrease and blue arrows no difference. In the KO (compared to WT) animal an increase in neutrophil numbers is seen in 
both BAL and alveolar space at 6 hours. Not all experiments were conducted for each time point. 
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Semaphorins have been shown to control cell migration; rapid recruitment to 
the site of injury is a pre-requisite of neutrophils as the first responder of innate 
immunity.148,169,193,298-301 As such, I began to examine the effect of Sema3F 
behaviour on neutrophil migration. Human neutrophils were co-incubated with 
Sema3F for the duration of the transwell assay shown in the diagram A in 
figure 4.3.1-1. The chemoattractants fMLF and IL8 were placed in the well and 
the percentage of neutrophils that had successfully traversed the filter and 
chemotaxed to the well recorded. Sema3F significantly inhibited neutrophil 
chemotaxis towards both fMLF (figure 4.3.1-1, graph B) and IL8 (not shown). 
Chemokinesis for Sema3F was similar to that of media alone. Sema3F alone 
was not a chemoattractant as it reduced (rather than enhanced) chemotaxis 
towards the chemoattractant when co-incubated with neutrophils in the top of 
the transwell system. Sema3E, another class 3 Semaphorin, has been 
demonstrated in chronic allergy188 to act as a chemorepellent, Sema3F itself 
was initially described as chemorepellent293 in the nervous system and to 
human thymocyte migration148,193,302 Sema3F does not act as neutrophil 
chemorepellent in this assay. These initial results confirmed that Sema3F 
treatment slows the neutrophils ability to move from the top chamber into the 
well. This could be a result of changes in speed and/or ability to deform to 
migrate through the 5µm pore. Sema3F can signal through Neuropilin (NRP) 
1 or 2 and Plexins A1-A4, as shown in chapter 1 neutrophils express higher 
levels of NRP2 than 1 which is enhanced by inflammatory stimuli (figure 3.3.4-
1). The surface expression of Neuropilins and Plexins varies between cell 
types, for example human thymocytes express predominately NRP2 and this 
similar to neutrophils as shown in chapter 3. 193 This could, in part, determine 
specific role of Semaphorin signalling in this cell type. However, Neuropilin 
expression may not always be relevant. For example Sema3E is the only class 
3 Semaphorin that can signal directly through Plexins without requiring a co-
receptor.148,193 In this manner varied receptor expression may explain how 
Sema3F has diverse effects on cell behaviour.  
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As mentioned, the transwell assay has limitations and to overcome these a 
microfluidic chemotaxis assay was performed (figure 4.3.2-1). This 
demonstrated that Sema3F reduces neutrophil chemotaxis in a dose 
dependent manner to LTB4 and retains neutrophils in the chamber by a 
reduction in the speed/rate of retrotaxis. Following the maximal dose of 
Sema3F 1000nM the neutrophils remain in the chamber for 90 minutes, while 
the LTB4 gradient reduces by 70% after 2 hours. Yet there is still > 1% LTB4 
gradient maintained over 8 hours, the minimum for neutrophil chemotaxis or 
retrotaxis. It has been suggested that neutrophils can consume 
chemoattractant signals, thus creating self-generated gradients on a local 
scale.106 These neutrophil derived gradients would not occur in isolation and 
the environmental gradient may be more relevant in chemotaxis over longer 
distances. After maximal recruitment neutrophils could consume a large 
amount of the chemoattractant in the chamber, such that the chemoattract 
levels are then higher in the adjacent channel, promoting chemotaxis and not 
retrotaxis away from the chamber. In either case it remains evident that 
Sema3F, in a dose dependent manner, slows neutrophil chemotaxis.  
I have demonstrated that in vivo and vitro Sema3F slows neutrophil 
chemotaxis and acts as a retention signal. This begins to explain the increased 
neutrophil transit into the injured lung when the Sema3F signal is lost. In 
addition to regulating neutrophil locomotion I questioned whether Sema3F 
could regulate the expression of CD11b and loss of L-selectin in response to 
LPS. I found there was no effect of Sema3F treatment on integrin CD11b or L-
selectin surface expression and the characteristic response to LPS stimulation 
was preserved (figure 4.3.3-1).285 This supports the view that Sema3F 
increases neutrophil transit into the lung not through altering the surface 
expression of adhesion molecules. It must be noted that this simple experiment 
does not assess integrin activation state which is known to be altered by other 
Semaphorins. 242  
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During the migration assays I had observed the neutrophils treated with 
Sema3F were very round. A F-actin sub-cortical rims and neutrophil roundness 
have been identified as features that selectively promote the sequestration to 
the lung capillaries.296 Semaphorins themselves have been shown to affect F-
actin disassembly, growth cone collapse and reduce lamellipodia, all of which 
could give rise to neutrophil rounding.155,163,174 Neutrophils receiving Sema3F 
rounded up in culture (figure 4.3.4-2). Sema3F rounding was overcome by 
fMLF 100nM. This be may an effect of the dose of fMLF chosen, which may 
not reflect physiological conditions within the specific inflammatory milieu. 
Rounder neutrophils would have the potential to travel faster within fluids such 
as blood but may have reduced deformability which may limit sequestration 
and transmigration. Sema3F-induced changes in the neutrophil cytoskeleton 
could be manifold: a reduction in actin turnover, actin stabilisation, 
destabilisation of the existing F-actin structure or increased branching. A 
varying combination of these could yield the neutrophil phenotype observed.  
In human Glioma cells Sema3F-NRP2/Plexin A1 signalling has been shown to 
reduce F-actin stability and the formation of stress fibres, essential for the 
contractile forces behind locomotion.303 Inhibition of neutrophil production of 
LTB4 has been shown to reduce chemotaxis to fMLF.304 In a similar manner 
neutrophil chemotaxis could be regulated by neutrophil production of an 
autocrine retention signal, such as Sema3F, in the context of inflammation. 
Phagocytosis is another key neutrophil function that is dependent upon 
dynamic cytoskeletal changes. It represents a complex process with a large 
degree of redundancy.305 Therefore, it may be unsurprising that following 
treatment with Sema3F phagocytosis is preserved to both opzonised Zymosan 
granules and labelled E. coli (figure 4.3.5-1). The divergent effects of Sema3F 
on phagocytosis, chemotaxis and cell shape relate to the alternative pathways 
involved in each. These pathways are often discussed and portrayed as being 
separate whereas they are interconnected. There is significant overlap 
between the downstream regulators of the actin cytoskeleton in chemotaxis 
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and phagocytosis. They may appear to be mutually exclusive events, where a 
neutrophil is required to promote one function above all else. As such they are 
often studied in isolation, as is the case here. The migrating neutrophil is 
thought to pause to complete phagocytosis as this action requires changes in 
the cell cytoskeleton that are possibly inhibitory to cell chemotaxis. This is 
probably a limited view and there is data involving immunophysical single cell 
modelling which suggests that cells may phagocytosis on the move, as a 
specialised continuum of chemotaxis.306  
Polarisation is an initiating event that is common to both processes.180,305 In a 
zebrafish model of inflammation, following tailfin injury, Sema3F over-
expression had no effect on either neutrophil polarisation or PI-3K kinase 
activity as judged by PH-GFP disposition (unpublished data, Prof Sarah 
Walmsley). In other cell types (glioblastoma cells, melanocyte cells, Jurkat T 
lymphocytes and endothelial cells) Nakayama et al. (2015) demonstrated that 
Sema3F, through NRP2-Plexin A1 signaling, inhibited PI3-K activity within 20 
minutes.307 It is known that Plexins are linked to the Rho family of small 
GTPases. The Sema3F-Plexin signal transduction might involve redox 
enzymes such as Mical1 as a direct link to the actin cytoskeleton, or regulatory 
proteins such as GAPs or GEFs, which control GTPase activity.173 109 There 
are distinct roles for the Rho family members Cdc42, Rac1 and Rac2 in 
phagocytosis; their roles are related to the ‘stage’ of the process.26 The distinct 
spatial and temporal patterns of Rho GTPases and the interplay of divergent 
Plexin signalling pathways would allow for a single signal, Sema3F, to have 
disparate effects on multiple and concurrent cytoskeleton dependent 
neutrophil functions. 
Other neutrophil functions include generating the armament of histotoxic 
contents and their dispersal as part of a host-defense response. Neutrophil 
Myeloperoxidase is contained in primary (azurophil) granules and release is 
dependent upon actin remodeling. Myeloperoxidase is a peroxidase which 
produces the bactericide hypochlorous acid (HOCl) (or the equivalent from a 
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non-chlorine halide) from hydrogen peroxide (H2O2) and chloride anion 
(Cl−).308 It is an enzyme which is crucial for the bactericidal role of neutrophils 
but causes extensive tissue damage when inappropriately released.309 Mitchell 
et al. (2008) demonstrated that during exocytosis of granules cortical actin is 
redistributed to the primary sites of granule translocation involving Rac-
dependent cortical actin depolymerisation.235 While low doses of Latrunculin B 
(Lat B) and Cytocalasin B (CB) induce exocytosis, the actin stabiliser 
Jaspokinalide inhibits exocytosis as too did high doses of CB and Lat B.235 I 
observed that pre-incubation with Sema3F significantly reduced neutrophil 
myeloperoxidase activity in culture (figure 4.3.6-1, graph A). GM-CSF and 
fMLF sequential neutrophil stimulation was used to stimulate maximal granule 
release.310 While MPO activity assays cannot directly correlate to the 
exocytosis or degranulation rates, with suitable controls this assay can begin 
to describe the effect Sema3F has upon myeloperoxidase function. The 
amount of exocytosis/degranulation will still be a crucial rate limiting step. Yet 
it is improbable that Sema3F or downstream effectors have the potential to 
regulate the activity of myeloperoxidase, rather than the rate of release. This 
highly potent redox enzyme has proven difficult to inhibit therapeutically as it 
often oxidises many inhibitors.308 Inhibitors either disrupt the catalytic cycling 
of the enzyme or act as suicide inhibitor and by virtue of this are free radical 
containing acids or substances that covalently bind to the heme group. 
Therefore, there is little scope for Sema3F to directly affect MPO activity in 
culture. Furthermore, I have reported the fold change from baseline so known 
effects on MPO activity by gender, age and polymorphism are controlled for.311 
If we assume Sema3F does not directly affect myeloperoxidase activity then 
the likely the determinant of fold change in MPO activity in cell culture 
supernatant is exocytosis magnitude. This is supported by the finding that 
Sema3F only alters upstream of GM-CSF and fMLF exocytosis simulation. 
This suggests that Sema3F may regulate the neutrophil cytoskeleton such that 
exocytosis of primary granules is reduced. Rounder Sema3F neutrophils may 
represent an increase in sub-cortical F-actin, this may prevent normal levels of 
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exocytosis being achieved by disrupting the balance between cortical actin 
depolymerisation and redistribution to sites of granule translocation heralding 
exocytosis.235 
In contrast to Sema3F’s ability to alter neutrophil MPO activity, the amount of 
elastase in cell culture was unchanged following pre-treatment with Sema3F 
(figure 4.3.7, graph B). Low level readings were obtained in this assay which 
may suggest a submaximal degranulation response. This could also reflect the 
short half-life of elastase in the extracted supernatant. Alternatively a 
proportion of the total enzyme may remain bound to the neutrophil membrane 
and therefore not available in the supernatant. 278,279I280,281  
In a similar fashion following IT instillation of either Sema3F or PBS at peak 
neutrophil recruitment, there was no effect observed on the levels of elastase 
found in the BAL fluid (figure 4.4.3-1, graph D). Again, this could also represent 
a submaximal neutrophil degranulation or an artificially low elastase level due 
to inhibited detection. In this experiment the timepoints are much later in the 
LPS lung injury time course and represent the resolution phase. During 
resolution elastase levels would be expected to be lower. In terms of protease 
inhibitors, their presence in the BAL fluid could inhibit the elastase more 
effectively in vivo post-harvest than in vitro.  In the BAL and supernatant fluid 
there is no membrane bound elastase. This elastase is more resistant to the 
effects of protease inhibitors. In this setting there are also no neutrophils to 
replace the rapidly degraded elastase leading to an underestimate of the 
physiological level. Indeed, there are many other proteases that would be able 
to degrade the quenching structure in the fluorochromatic assay. These 
include: protease 3, cathepsin (G, L & S), macrophage elastase and 
gelatinase.272 In addition other cells such as monocytes and mast cells can 
produce elastase.312  
Despite all these caveats, the assay may still generate valid results. The 
variables affecting elastase measurement described would be present and 
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equal in all the in vivo elastase assays. So, it remains important that loss of 
neutrophil specific Sema3F reduces elastase activity at 48 hours post ALI. This 
may be a sequela of the enhanced resolution seen in the KO animal between 
24 and 48 hours. Neutrophil elastase itself is not just a protease but can also 
generate further chemoattractive signals such as GMCSF, IL-6 and IL-8.313 As 
such it has a pivotal role in ongoing lung injury and reduction of elastase could 
be very beneficial in the context of pathological inflammation and tissue 
damage. 
The neutrophil’s ability to produce ROS, the respiratory burst, is crucial to its 
function as a front-line responder to invading pathogens.3,4 As other histotoxic 
functions such as myeloperoxidase activity were reduced it may have been 
expected that neutrophil ROS production was also inhibited. I have 
demonstrated that neutrophils have a significant increase in ROS production 
in response to fMLF following pre-incubation with Sema3F (figure 4.3.7-1). The 
ROS detector Dichlorodihydrofluorescein diacetate (DCFH-DA) is a cell 
membrane permeable probe, that is widely used to detect ROS. Two-electron 
oxidation converts DCFH-DA into a fluorescent and therefore detectable 
signal. There are limitations to this method, the oxidation of DCFH-DA is not 
limited to one type of ROS and not directly with H202.  It may also take part in 
itself in redox-cycling and therefore enhance ROS. With stable culture 
conditions, controls and repeated measurements some of these concerns can 
be mitigated.314 The actin cytoskeleton and ROS have an intimate relationship. 
Leukocyte Rho GTPases and cytoskeletal dynamics have been shown to be 
involved in the production of ROS, and in turn are influenced by ROS. 
Leukocytes contain the inducible electron transport chain NADPH, reducing 
equivalents are transferred from NADPH to oxygen producing superoxide 
anions. NADPH exits in a dormant resting state in unstimulated neutrophil and 
upon stimulation is relocated to the cell membrane associating with 
cytochrome B. This relocation to facilitate NADPH assembly has been shown 
to be dependent on actin polymerisation.315-317 It has been suggested that Rho 
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family GTPases might be even more intimately involved with the NAPDH 
complex. Rac is required for the transfer of electrons from NADPH to 
cytochrome b-associated FAD, then to cytochrome b heme and finally to 
molecular oxygen.318 Leukocyte adhesion stimulated inhibition of ROS 
production is suggested to be specifically through Rac2, whereby integrins act 
to suppress both Rac2 activation and assembly into the functional membrane 
NADPH oxidase complex.319 NADPH oxidase-dependent generated ROS 
negatively regulates actin polymerisation through reversible actin 
glutathionylation.320 Glutathionylation of a critical cysteine, Cys374, in actin, 
has been shown to reduce the ability of G-actin to polymerise into F-actin 
polymers.263 Sema3F alone appears to have no effect on neutrophil ROS 
generation. Sema3F could have dual roles as a retention and neutrophil 
priming signal, similar to LPS and other inflammatory stimuli.320 It may be that 
the hyper-round Sema3F treated neutrophil with a lower predisposition for 
integrin mediated adhesion leads to a reduction in the inhibition of ROS 
production via Rac2 signaling, and this is only unmasked on further treatment 
with fMLF. Sema3F increases in intracellular ROS may result in higher levels 
of glutathionylation and thus reduce actin polymerisation, which could result in 
reduced neutrophil chemotaxis.263 Sema3F may not only act as neutrophil 
retention signal but it would appear it could also potentiate specific cytotoxic 
features such as increased intracellular ROS alongside a preserved 
phagocytosis ability.  
To explore whether Sema3F altered neutrophil locomotion in vivo I 
collaborated with Dr Leo Carlin. We constructed an experimental system 
where the movement of Ly6G labelled neutrophils & LifeAct-GFP labelled actin 
could be tracked in a live-culture lung slice (figure 4.4.1-1). Confocal images 
were taken as described throughout 110 minutes, at the allotted timepoints 
PBS verses Sema3F was given, this was followed by fMLF. As expected in the 
first 20 minutes there was no difference in neutrophil behaviour, after the first 
treatment there was a significant reduction in neutrophil speed in response to 
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Sema3F alone, with the addition of fMLF this was exacerbated (figure 4.4.1-2, 
graph A). Rather counterintuitively fMLF treatment also reduced the speed of 
neutrophils in the non-Sema3F treated lung slice perhaps related to the high 
dose of fMLF used generating ROS production. At this level the fMLF dose is 
inversely proportional to neutrophil locomotion speed.321 The effect of culture 
of the ex-vivo lung slice tissue and associated neutrophils may alter the 
neutrophil behaviour overtime and this could correspond to changes in 
neutrophil chemotaxis. The comparison between parallel lung slices, (lung 
1[control] and lung 2[Sema3F) helped to identify the specific effect of 
exogenous Sema3F. There is significant difference between lung 1 (PBS then 
fMLF) and lung 2 (Sema3F then fMLF), with slowing of the neutrophil 
movement following Sema3F treatment. The chemoattractant fMLF will 
disperse quickly through the media following its addition and there may not be 
a sustained differential chemokine gradient. Chemokines and cytokine 
gradients do not act in isolation and it has also been demonstrated that 
neutrophils can make their own gradients.322 So a lack of “true” fMLF gradient 
may be irrelevant to neutrophil migration in this context.  
In this experiment track straightness remained similar between PBS and 
Sema3F treated neutrophils (figure 4.4.1-2 graph B). Track straightness is the 
displacement of the neutrophils (distance between the first and last recorded 
position) divided by the length from the start to end position. A straight line 
would give a higher value, however as the length increases but the 
displacement does not this would reduce the value. Therefore, an increase in 
chemokinesis would reduce track straightness. There appears to be no effect 
in chemokinesis or track straightness between treatment groups, there does 
appear to be an effect with time and fMLF treatment. While fMLF has been 
shown to promote a convergent (direct) over divergent (exploratory) migratory 
pattern, without a sustained source of fMLF and a gradient, neutrophil 
chemokinesis would be increased and would further reduce track 
straightness.263 The track average speed is calculated based on the track 
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length divided by the time between the first and last positions. With a decrease 
in track straightness, an increase in chemokinesis and/or direction the average 
track speed could be lower despite the actual speed of the neutrophil 
remaining stable or increasing. Therefore, I also looked at the max speed 
recorded, as this measurement would overcome variation due to migration 
pattern. There was a significant reduction in neutrophil maximum speed 
following treatment with Sema3F compared to PBS (figure 4.4.1-2 graph C). 
Overall there was a reduction in speed following fMLF in both treatment groups 
and Sema3F treatment did not exacerbate this. In this case there was not a 
reduction seen over time (PBS: 20mins vs 60mins) in max speed and this 
supports the suggestion that the differences in track straightness and average 
speed seen with increased culture time is a function of a change in migratory 
pattern.  
As mentioned the slowing of neutrophil chemotaxis in response to fMLF has 
multiple explanations. In part it could be due to dysfunctional chemotaxis, as 
seen in the neutrophils of burns patient, whereby following fMLF stimulation 
there is a 75% reduction in neutrophil velocity.106 The absence or dwindling 
production of  other signals, for example GM-CSF may reduce fMLF neutrophil 
chemotaxis.304 Neutrophils also display environmentally dependent 
hierarchical chemotaxis, for example LPS may induce expression of the 
human FPR1 receptor and enhance chemotactic responses to fMLF.287,323 
These lungs were deliberately unstimulated as part of a reductionist strategy 
to assess the underlying mechanisms. Furthermore, desensitisation to the 
fMLF may occur following internalization of the FPR1 receptor. A higher dose 
of fMLF given was (10µM), required for the full response of murine neutrophil 
which will elicit ROS production. The effect of increased ROS could result in 
actin depolymerisation through increased glutathionylation and reduced 
maximal speed. Howard et al. (1984) demonstrated that up to 10nM 
concentrations of fMLF F-actin and mean rate of locomotion (mROL) of 
The Role of Semaphorin3F in Neutrophilic Inflammation 
Chapter 4 Results  193 
neutrophils increased simultaneously. At doses > 10nM while F-actin content 
did increase, there was a steady decline in mROL.324 
Neutrophil roundness is increased in culture by Sema3F treatment, in vivo 
measurements in 3D describe neutrophil sphericity. Increased sphericity has 
been linked to enhanced neutrophil sequestration, thus slowing neutrophil 
transit to the lung tissues.325 This shape change occurs as a rapid and transient 
first response to inflammatory mediators such as complement fractions.321 
Zebrafish with neutrophil specific mutant Rac2 had a rounder morphology 
compared to WT and were retained in haemopoietic tissues.296 The underlying 
change in the actin cytoskeleton requires redistribution of central actin to the 
sub-cortical regions and thus reduces neutrophil deformability.296 In the 
literature sphericity has been linked to neutrophil function and location, highly 
spherical neutrophils are less motile and are found on the luminal surface.326 
A hallmark of neutrophils that have undergone reverse migration is their lack 
of sphericity.296 In lung slices from mice treated at peak recruitment with intra-
tracheal Sema3F neutrophils are retained in the airway. They are significantly 
more spherical compared with PBS treated neutrophils (figure 4.4.2-1). This is 
in keeping with previous in vitro data where I demonstrated that cultured 
neutrophils following Sema3F treatment are rounder, which was overcome by 
fMLF treatment. The in vivo response to Sema3F signal occurs following LPS 
induced inflammation and is not overcome by inflammatory stimuli. This could 
be accounted for by the dose of Sema3F used in the in vivo experiment being 
1µM, compared to 100nM in culture. This is unlikely as it is expected that intra-
tracheal instillation will result in a delivery of considerably lower actual doses 
to the alveolus due to distribution and loss in the preceding proximal respiratory 
tract. Alternatively, LPS may not antagonise the effect of Sema3F rounding in 
a similar manner to fMLF, it is also possible that measurement of cell 
roundness is less sensitive than that of sphericity or indeed less specific. With 
these caveats in mind it still suggests that Sema3F inhibition of chemotaxis 
and neutrophil retention both in vivo and in vitro relates to increased neutrophil 
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roundness and sphericity as either a consequence or cause. This is in keeping 
with observations in the literature regarding the phenotype of highly spherical 
or round neutrophils, suggesting neutrophils in this shape-conformation have 
specific properties that determine both location and function. 
In both vitro and vivo I observed a significant reduction in neutrophil MPO 
activity following Sema3F treatment. IT Sema3F treatment at 24 hours 
following LPS resulted in less MPO activity in the BAL fluid at 48 hours (figure 
4.4.3-1, graph B). At 48 hours it is expected that MPO levels will be declining 
as this timepoint is during the resolution phase of the LPS lung injury model. 
Following IT Sema3F these levels are further reduced compared with IT PBS. 
In contrast loss of neutrophil Sema3F enhanced MPO activity in the BAL fluid 
at 24 hours compared to WT (figure 4.4.3-1, graph A). Whereas the increased 
neutrophil number in the KO animal is seen at 6 hours and WT and KO 
recruited neutrophil numbers are similar at 24 hours. Therefore, the increase 
in MPO does not relate directly to more neutrophils releasing the substance at 
24 hours. It could be an accumulation of MPO from the previous 6-hour 
timepoint. As the half-life of MPO is 10 hours, therefore 18 hours later there 
could still be active MPO produced during this previous timepoint.327,328 At 48 
hours there are similar lower levels of MPO in the BAL fluid in both WT and 
KO. Alveolar macrophages have been shown to scavenger MPO so that 
accumulation is limited.329 This suggests that Sema3F may regulate neutrophil 
degranulation taken alongside other data: reduced neutrophil 
chemotaxis/speed, neutrophil retention and the altered effector functions 
observed strongly suggest that Sema3F may regulate the neutrophil 
cytoskeleton as an overarching mechanism. 
Initially I looked at neutrophil F-actin content in vitro and identified that Sema3F 
reduced F-actin content during the steady state following fMLF stimulation 
(figure 4.4.4-1, graph A) while the polarisation or heterogeneity of the F-actin 
distribution was unchanged (figure 4.4.4-1, graph B). I then went on to test the 
hypothesis that F-actin disassembly is the underlying mechanism by which 
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Sema3F signaling results in these observations. If true there would be less F-
actin in the Sema3F retained neutrophils in vivo. I again used the murine ALI 
model, where IT Sema3F or PBS was given at peak recruitment and 
investigated the F:G ratio at 48 hours (figure 4.4.5-1). In solution monomeric 
actin or G actin will spontaneously self-assemble into polarised bi-helical 
filamentous actin, even in steady state these are dynamic structures and this 
process is ATP dependent.113,114 I assumed that neutrophil retention at 48 
hours would be the result of a lower F-actin steady state in these cells. An F: 
G actin ratio was derived by using conjugated labels: Phalloidin (F-actin) and 
Deoxyribonuclease I (G-actin). Phalloidin is considered the gold-standard for 
labelling endogenous actin in fixed samples.330 Phalloidin is a toxin which 
requires fixation and permeabilisation of the cell, it stabilises the F-actin 
structure by reducing the dissociation of G-subunits to zero. Methanol was 
avoided as this can create artifacts upon phalloidin staining within the 
cytoskeleton. Theoretically detection by phalloidin staining could 
underestimate F-actin, as binding can be inhibited by actin regulator proteins; 
this would be a consistent caveat in all treatment groups and experiments.331 
Likewise, DNase I has been shown to be specific for G actin when used with 
a detergent and paraformaldehyde fixation; it can also detect G-actin when 
bound to Latrunculin A.117,118 Flowcytometry ratiometrics (the ratio of 
decreasing signal over increasing signal) has been established as a method 
to quantify calcium flux in cells.332  I harnessed this system using Phalloidin 
Alexa 488 and DNAse I 594 to detect F: G actin ratio. These specific and 
sensitive probes attached to stable complementary fluorophores give a reliable 
signal. Determining the ratiometric value per neutrophil corrects for artifactual 
changes in fluorescence due to variations in dye loading, bleaching effects and 
changes in equipment. 
The F: G actin ratio per neutrophil was found to be significantly lower in the 
Sema3F treated group 24 hours following IT administration (figure 4.4.5-1). 
This demonstrates that the Sema3F treated neutrophils have less F-actin and 
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therefore have undergone relatively more F-actin disassembly, in concert with 
this G-actin is increased. Both PBS and Sema3F treated neutrophils displayed 
an extremely significant reduction in F: G actin ratio following treated with 
Latrunculin A (Lat A). This confirms the validity of the ratio as a measure of F-
actin disassembly. Lat A binds to the actin monomer (G-actin) and prevents 
incorporation to form a polymer or F-actin, it affects disassembly through 
preventing the continuing treadmilling of actin structures by promoting only 
disassembly.333 The Sema3F treated neutrophils have a less significant 
amount of F-actin disassembly compared with both the Lat A treated groups, 
suggesting that Sema3F (by this route and dose) does not inflict complete F-
actin disassembly. Therefore, it may only serve to modulate F-actin dependent 
functions rather than prevent them. This is in keeping with the in vitro 
phenotypes I have observed where neutrophil chemotaxis is inhibited yet other 
neutrophil functions, such as phagocytosis are preserved. A reduction in the 
F: G actin ratio indicates net F-actin depolymerisation this does not identify the 
specific mechanism. For example, this could be a result of alterations in actin 
turnover, F-actin stability, structure divergence (branching) or a combination of 
these. 
The effects of Sema3F signaling can be explained by alterations in the 
neutrophil cytoskeleton, more specifically a reduction in neutrophil total F-
actin. I have demonstrated that Sema3F treatment enhances ROS generation. 
The regulation of the neutrophil cytoskeleton by Sema3F will inform patterns 
of neutrophil migration but also the functional phenotype including ROS 
production. Equally, the increases in ROS seen in Sema3F treated neutrophils 
may go some way to explaining the mechanism by which Sema3F causes 
dynamic actin rearrangement. Terman et al. (2011) identify MICAL, a large 
multi domain flavo monooxygenase that directly links Sema3A-Plexin A1 
signaling to the actin cytoskeleton.334,335 Sema3A-Plexin mediated relief of 
autoinhibition of  MICAL allows this enzyme to oxidise actin at the methionine 
44 residue within the D-loop of the actin helix promoting decreasing 
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polymerisation.174 Sema3A, has also been shown to affect neurite growth cone 
collapse through F-actin disassembly mediated by sequential inhibition and 
activation through cofilin phosphorylation by LIM-kinase resulting in an actin 
severing.336 There appears to be a synergistic relationship between MICAL 
and cofilin, such that MICAL induced oxidation enhances cofilin binding and 
severing of F-actin ensuring instability and dismantling of the F-actin 
network.337,338 MICAL establishes a role for neutrophil redox reactions in the 
regulation of the cytoskeleton. Increases in ROS directly promote F-actin 
disassembly and balance actin dynamics320 Low levels of ROS also regulate 
actin. There is a deficiency in the generation of NADPH oxidase-dependent 
ROS in the phagocytes of patients with chronic granulomatous disease (CGD). 
Neutrophils from these patients have defective migration, with an increase in 
the frequency of pseudopodia and reduction in directionality and speed. This 
has been recapitulated with siRNA inhibitors of NADPH and in murine models 
of CGD.265,339 
An extract of green tea, epigallocatechin gallate (EGCG) flavoprotein 
monooxygenase inhibitor, neutralised Sema3A axonal repulsion in culture.340 
EGCG is a non-specific inhibitor of flavoproteins. As MICAL cannot be 
selectively inhibited and genome editing through transfection is not effective in 
neutrophils it is difficult to ascertain whether MICAL is involved in Sema3F F-
actin disassembly. I have demonstrated that Sema3F signaling results in F-
actin disassembly in neutrophils, the upstream regulators of this process 
remain unclear. Certainly, we known that neutrophils express the MICAL 1 
protein (unpublished data, Prof Sarah Walmsley) and thus it could link the 
Sema3F-Plexin-actin pathway. ROS and the regulators of neutrophil ROS 
production could also be candidates.  
The lack of availability to me of a non-functioning blocking antibody for the 
Sema3F binding site on the NRP2 co-receptor means I cannot confirm the 
direct effect of Sema3F by this method. But considering the concordance 
between my varied model systems showing in vivo and vitro data. Alongside 
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what is already known about class 3 Semaphorins, there is little doubt that 
these results are due to Sema3F and its signaling pathway. Future work will 
focus on this pathway to delineate the key players and identify novel 
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5 Discussion 
The regulation of neutrophil migration and retention has implications for the 
magnitude of the inflammatory response. In pathological neutrophilic 
inflammation there is an exaggerated response with the sequelae of tissue 
damage leading to disease. Signals that curtail excessive inflammation are 
directly relevant to the generation of novel anti-inflammatory therapies.  
5.1 Summary of findings 
Human neutrophils express Sema3F and its co-receptor NRP2 and are 
therefore amenable to autocrine regulation by Sema3F. Expression of both 
ligand and receptor are under the control of the inflammatory mediators. 
Sema3F mRNA and protein are up regulated in response to LPS and 
neutrophil surface expression of NRP2 is significantly increased by IL-1b (see 
table 5.1-1).
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Neutrophil Expression of: 
Sema3F 
Stimuli/disease mRNA expression Protein expression 
LPS UP **P<0.001 (6 hours Murine fig 3.2.3-1) IHC – present (murine fig. 3.2.5-1) 
 WB- UP **P=0.0058 (human fig.3.2.1-1) 
TNF-a ? WB-present (human fig.3.2.1-1) 
IL-1b ? WB-present (human fig.3.2.1-1) 
COPD ? IHC – present (human fig. 3.2.2-1) 
NRP2 
LPS UP *P<0.05 (6 hours Murine fig 3.3.7-1)  IHC – present (murine fig. 3.2.5-1) 
 FlowC-present (human fig 3.3.5-1) 
TNF-a ? FlowC-present (human fig 3.3.5-1) 
IL-1b ? FlowC-UP **P=0.0034 (human fig 3.3.5-1) 
COPD ? IHC – present (human fig. 3.3.1-1) 
Table 5.1-1 The regulation of Sema3F and NRP2 expression 
A summary of results detailing Sema3F and NRP2 expression as determined by immunohistochemistry (IHC) Western blot (WB) and Flow cytometry 
(FlowC)  
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Both Sema3F and the co-receptor NRP2 are expressed by recruited COPD 
neutrophils in the inflamed lung.  Murine neutrophil Sema3F is induced acutely 
following ALI and persists throughout injury. Temporal differences between 
Sema3F and NRP2 murine neutrophil expression, at both the mRNA and 
protein level, were noted during the course of ALI. This suggests that a level 
of regulation of the signalling pathway occurs through Sema3F and NRP2 
expression. In a murine model of LPS induced ALI exogenous Sema3F acts a 
in vivo retention signal to neutrophils following peak recruitment. Whereas loss 
of neutrophil Sema3F generates the converse phenotype, with increased 
neutrophil transit resulting in enhanced recruitment to the lung and resolution 
of neutrophilic inflammation. This occurs without alterations in neutrophil 
apoptosis, macrophage populations or disruption to the characteristic 
neutrophil surface expression of adhesion molecules CD11b and L-selectin in 
response to LPS.341 
Following deletion of neutrophil Sema3F no differences were observed in the 
baseline circulating neutrophil counts. The phenotype was only uncovered 
following the induction of LPS induced lung injury. On induction of lung injury 
prior to, or at 6 hours both circulating and lung tissue neutrophil counts were 
similar for both genotypes. Loss of neutrophil Sema3F did lead to an increased 
BAL count and an earlier peak in neutrophil recruitment occurred at 6 hours in 
the KO animal. The observed increase in the neutrophil count was exclusive 
to the alveolar space. As such neutrophil Sema3F does not alter neutrophil 
adhesive interactions with constituents of the blood or lung tissue 
compartments namely: the lung endothelium, interstitium or epithelial layers 
allowing rapid neutrophil transit. It is more probable that Sema3F controls an 
intrinsic neutrophil property resulting in differential neutrophil transit times. This 
supports the view that following neutrophil sequestration, transmigration into 
the lung can be through an adhesion independent pathway.82,240 Sema3F 
treatment inhibits convergent chemotaxis and acts as a neutrophil retention 
signal both in vivo and vitro. Neutrophils become rounder and more spherical 
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in response to Sema3F and this can be antagonised by fMLF. The effect of 
Sema3F on neutrophil histotoxic related functions is divergent. On one hand, 
ROS generation is promoted, and phagocytosis preserved, but in contrast 
MPO activity is reduced both in vivo and vitro. For MPO activity the converse 
holds true where loss of neutrophil Sema3F enhances MPO activity in the BAL 
fluid following ALI. There was no effect observed on neutrophil elastase activity 
following Sema3F treatment in vitro. In vivo the Sema3F KO animal had 
reduced elastase levels in the BAL fluid at 48 hours. This was associated with 
a period of enhanced resolution of the neutrophilic inflammation seen in the 
KO animal. This identifies a potential anti-inflammatory role for an antagonist 
of Sema3F signalling. This divergent behaviour of neutrophils in response to 
Sema3F in the context of inflammation could reflect a) the specific activation 
status of the Sema3F treated neutrophil or b) provide mechanistic insights. For 
example it is known that neutrophil ROS, which is up regulated by Sema3F 
treatment, is intimately related to the F-actin cytoskeleton.263 
Sema3F pre-treatment reduces the level of neutrophil F-actin achieved during 
the steady state following the initial rapid polymerisation and depolymerisation 
phases characteristic of the neutrophil response to fMLF. Neutrophils that are 
retained by Sema3F in vivo have a decreased total F-actin. They are also more 
spherical and are slower with persevered directionality correlating with the in 
vitro chemotaxis data. These data taken together establish that Sema3F acts 
as a neutrophil retention signal by slowing down neutrophil migration through 
the induction of F-actin disassembly leading to more spherical neutrophils with 
altered effector functions. What remains to be elicited is the link between the 
Sema3F signal and downstream F-actin disassembly. Candidates include the 
observed increase in intracellular ROS resulting in a promotion of F-actin 
depolymerisation or redox enzymes such as MICAL which directly link 
Semaphorin-signalling to F-actin disassembly.  
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5.2 Limitations 
I identified the presence of the receptors NRP1 and 2 using both flow cytometry 
and immunohistochemistry on neutrophils. The NRP2 receptor is the 
preferential co-receptor for Sema3F and a focus of this project as this 
presented a potential future therapeutic target.342 I demonstrated that NRP2 
expression is under the regulation of inflammation and is present on 10-18% 
of circulating human neutrophils. This is less than I expected given the size of 
the neutrophil response to both exogenous Sema3F and loss of neutrophil 
Sema3F. These methods would not identity NRP2 if it was either released as 
a soluble form in vivo, lost prior to fixation, or following fixation during sample 
processing. While this may result in an underestimate of the levels of NRP2 
neutrophil surface expression, the relative ratios of the receptor expression 
between conditions would remain constant. Certainly, we know that murine 
neutrophil NRP2 mRNA is seen to rise acutely following LPS induced lung 
injury. Reassuringly, NRP2 is then observed at the protein level in recruited 
murine neutrophils in the injured lung. This supports the hypothesis that NRP2 
is involved in Sema3F signalling and the generation of the phenotypes 
observed during this work. This project did not attempt to address which Plexin 
A1-A4 is expressed by neutrophils, as the NRP2 is an obligatory co-receptor. 
NRP2 is an ideal therapeutic target as it has no intracellular component and 
blocking agents are less likely to affect downstream pathways.  
Having said this, NRP2 can bind other ligands, although at a separate binding 
site to Sema3F. This includes the vascular endothelial growth factor (VEGF) 
and antagonism between VEGF and Sema3F has been observed.343,344 This 
interplay could be relevant to the Sema3F autocrine regulation of neutrophils. 
In the context of both a plethora of ligands, varied receptor combinations and 
expression profiles and the potential for receptor solubility, a reductionist 
strategy was employed in the first instance. This does not preclude the 
existence of further layers of complexity regarding Sema3F signal and its 
detection by neutrophils. In terms of the specificity of the Sema3F signal in 
these experiments it cannot be stated that they are a direct effect of Sema3F-
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NRP2 binding. One constraint was the lack of a commercially available NRP2 
non-functioning blocking antibody. In the context of the receptor complexity I 
have described this, single blockade would not have been sufficient to ensure 
that this was indeed due to a direct effect of Sema3F-NRP2 signalling. My 
hypothesis is further supported as the converse phenotype is seen in the 
neutrophil specific KO murine model. This result suggests that Sema3F does 
impact on neutrophil migration as predicted from extrapolations of both the in 
vitro and exogenous Sema3F murine experimental results. Therefore, it is 
highly likely that this is a result of direct Sema3F signalling. 
It remains unknown whether the Sema3F signal in the injured lung is only from 
neutrophils. I observed that Sema3F was produced in epithelial cells in the 
injured airways of mice. The contribution to the overall Sema3F signal by cell 
type was not quantified. To address this the neutrophil specific knockout of 
Sema3F identified the impact of the neutrophil contribution to overall Sema3F 
signal by the resulting alteration in neutrophil behaviour. Semaphorins have 
been shown to affect integrin conformation and cell adhesion.284,345 While I 
looked at neutrophil expression of CD11b and L-selectin I did not look at the 
activation status of these adhesive molecules or the ability of the neutrophil to 
adhere following Sema3F treatment. Neutrophil migration in the pulmonary 
vasculature can be adhesion pathway independent. The location and transit 
profile of the Sema3F deficient neutrophil suggests that the differences 
observed are likely due to adhesion pathway independent mechainsims.240  
Finally, in the situation of neutrophil Sema3F loss the resolution of neutrophilic 
inflammation occurred at a faster rate. What this data cannot say is the route 
of enhanced neutrophil loss. I did not investigate either neutrophil reverse 
migration or loss to body through expectoration. There are significant 
challenges with measuring both of these potential routes of neutrophil loss and 
this fell beyond the scope of this current project. I did not observe alterations 
in apoptosis at individual timepoints which gave no indication that Sema3F 
alters neutrophil survival. 
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5.3 Future work 
As identified in the limitations of this work there are many potential avenues to 
explore. The temporal regulation of neutrophil Sema3F expression is not 
known. How Sema3F production is switched on in the neutrophil and other cell 
types is crucial to understanding the signal during ALI and lung disease. In a 
similar manner I have not identified the Sema3F receptor profile over the injury 
course, or how the Sema3F autocrine loop functions; both would be essential 
in understanding this process in greater detail. It may be possible to use 
techniques such as mass spectrometry or Cytometry by Time of Flight 
(CyTOF) for detailed phenotypic analysis of the cells types implicated in the 
neutrophil Sema3F signalling pathway.346 This method is able to use a far more 
extensive panel of antibodies than standard flowcytometry and is directed at 
both extra-and intracellular components. Using this it would be interesting to 
observe the production and release of Sema3F in neutrophils, macrophages 
and endothelial cells. This assessment would describe the contributions of 
various cell types to the total Sema3F signal and the individual cell-types 
response to Sema3F. This could be done by way of expression patterns of 
adhesion molecules and changes in cytoskeletal proteins. I could use this 
information to define how neutrophil transit is up and down regulated in 
response to Sema3F. It has been shown that myeloid specific ablation of NRP2 
increased leukocyte infiltration into LPS injured lungs and delayed resolution149 
Similarly, loss of neutrophil Sema3F also enhanced leukocyte infiltration but 
resolution was not delayed. This may suggest Sema3F from a non-neutrophil 
source, or another antagonist of NRP2 is an important regulator of the myeloid 
population during resolution. To this end I have also begun work on a LysmCre 
driven Sema3F floxed mouse line to delineate the role of 
monocytes/macrophages in this signalling pathway. I also have preliminary 
immunohistochemistry data to describe the Plexin profile of the lung tissue 
during ALI. To further this I will generate a new flow panel to assess the 
neutrophil expression of the Sema3F Plexin receptors A1 to A4. 
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In the situation of loss of neutrophil Sema3F there is a causal relationship 
between increased neutrophil transit and enhanced resolution, but the 
mechanism remains unknown. Experiments to investigate neutrophil kinetics 
in this system might unmask the route of enhanced neutrophil clearance. My 
hypotheses are that enhanced clearance is due to: 1) greater loss to the body 
and the mucociliary escalator; 2) a reduction in the adjacent sequestered pool 
of neutrophils through reverse migration to the wider circulation resulting in a 
reduction in the availability of neutrophils to recruit to the airspaces; or 3) 
increased homeostatic clearance mechanisms engaged by the earlier peak in 
neutrophil recruitment seen in the Sema3F KO animal. When the mucociliary 
escalator fails the alveoli fill with mucus and gaseous exchange is reduced. 
This is seen in chronic lung diseases such as primary ciliary dyskinesia and 
cystic fibrosis. A role for the mucociliary escalator in acute lung injury cannot 
be completely discounted as there is no evidence to refute that clearance of 
neutrophils via this route would not influence the level of local inflammation in 
the alveoli following injury. Experimentally neutrophils could be followed 
through this journey and loss measured, for example monitoring labelled 
neutrophils in alveolus, small and large airways and sputum over a time 
course, this would begin to describe the fate of Sema3F deficient neutrophils 
following acute lung injury in mice. While ARDS It is known that reverse 
migrated neutrophils upregulate ICAM 1, CD54 and are CXCR1Low.61,323 
Neutrophil surface expression of these markers could be assessed by flow 
cytometry to identify reverse transendothelial migrated neutrophils.  
I would like to maintain the focus of research on potential therapeutic agents 
that could be used in the treatment of respiratory diseases. As such the 
Sema3F-NRP2 signalling pathway is pivotal. Two arms to this future work 
would include focusing on the receptor NRP2 and investigating the 
downstream effects of Sema3F signalling on the F-actin cytoskeleton. This 
would include investigating the consequence of NRP2 neutrophil specific 
knockout in an animal model, to recapitulate the Sema3F phenotype and 
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investigate the autocrine signalling loop. In addition, using NRP2 blockade by 
a non-functioning antibody to demonstrate that Sema3F-NRP2 binding is an 
initiating step in the pathway activation. The antibody could also be used in an 
animal model as an in vivo therapy, where nebulised NRP2 would be 
hypothesised to enhance neutrophil resolution and lessen lung tissue damage. 
Lung damage would be assessed through measurements of markers 
associated with progressive disease elastase, such as myeloperoxidase and 
albumin alongside immunohistochemistry of lung tissue. 
It would be vital to establish the role of neutrophil Sema3F in host-pathogen 
responses in order to assess whether this pathway could yield a viable 
treatment for inflammatory lung conditions. In part, this is because sterile lung 
inflammation often occurs concurrently with infection either super-imposed on 
the inflammation or as a preceding injury to the lung leading to inflammation. 
As such, investigating the response of the Sema3F KO mouse to pneumonia 
or hypoxia would further deepen our understanding of the role of Sema3F as 
a retention signal and the potential for exploiting this to modify disease. In this 
situation the timing of the exogenous Sema3F or NRP2 blockade could dictate 
whether this treatment is harmful or helpful to the host. For example, delivery 
of the NRP2 blockade early in a pneumonia model may reduce the helpful 
neutrophil responses, as recruitment and resolution are both enhanced, 
resulting in a detrimental persistence of the infective agent. Equally, the 
enhanced peak recruitment could be sufficient to clear the pathogens and 
recovery from pneumonia expedited. Likewise, exogenous Sema3F given at 
peak recruitment or before could enhance the neutrophil response and 
bacterial clearance. It is unclear whether this would result in damage to the 
host as neutrophilic resolution is subsequently delayed. 
In concert with interrogating the physiological effects of Sema3F in the context 
of lung disease, elucidating the underlying mechanism is required. To 
investigate the F-actin cytoskeletal changes in relation to Sema3F I would use 
the ex-vivo lung slice set-up with real-time imaging. By using Ly6G-LifeAct-
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GFP neutrophils I can heat-map the F-actin distribution in real-time in response 
to treatment and stimuli. Other ways to address this could include high-
resolution con-focal microscopy of neutrophils with staining for F and G actin 
or fluorescent speckle microscopy.347 This may highlight which downstream 
actin associated regulators are involved and these could be targeted to control 
neutrophil migration downstream of Sema3F.  
As discussed, the redox protein MICAL and intracellular ROS are candidates 
which could link Sema3F-Plexin signalling to the cytoskeletal.173,263,338,348,349 F-
actin disassembly can be the result of multiple cytoskeletal re-arrangements 
and modifications involving proteins such as: cofilin and ARP2 complex 
promoting actin severing and branching respectively, or other such as fascin 
an actin bundling protein and formin an actin nucleation factor. Directionality is 
preserved in the Sema3F deficient murine neutrophils and supported by 
unpublished zebrafish data from my lab group. We know the Sema3F signal 
alters the actin cytoskeleton downstream of the formation of the leading edge 
which excludes actin associated proteins upstream of this. This suggests the 
family of Rho GTPases, in particular Rac1 and 2, could be involved in the 
generation of the divergent effects on neutrophil effector functions seen in 
response to Sema3F. An understanding of the downstream mechanisms in the 
Sema3F signalling pathway may guide the generation and application of future 
therapeutic interventions based on this science. 
5.4 Therapeutic targeting of Sema3F signalling pathway in 
neutrophils 
I have eluded to the use of NRP2 blockade as a way to regulate neutrophilic 
inflammation. This poses the danger of altering an essential innate immune 
response and could potentially render the patient susceptible to infection. If the 
NRP2 blocker was given too early this could enhance neutrophil recruitment 
and exacerbate the problem. As yet, we do not fully understand how the 
Sema3F signal causes enhanced recruitment and later resolution, or the 
interplay with other key signals. Manipulating the actin cytoskeletal responses 
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downstream of the Sema3F signal appears attractive. This could negate 
effects on VEGF binding and off target effects of NRP2 receptors on other 
cells. This is a risky proposal as these are ubiquitous targets and modulators 
of actin cytoskeleton are often cytotoxic, such as phalloidin and the 
chemotherapy agent Paclitaxel.  
It may be that NRP2 blockade could be used in conjunction with other 
therapies. The beneficial anti-angiogenic effect of the VEGF-A monoclonal 
antibody (bevacizumab) on patients with glioblastoma is short lived. This is 
associated with NRP1 down regulation due to internalisation following binding 
transforming growth factor βs (TGFβs).350 In this case dual therapy with NRP1 
blockade could give a better response to anti-cancer therapy. SEMA3F is a 
known tumor suppressor in lung cancer; this is downregulated by TGFβ1 but 
NRP2 is upregulated during TGFβ1-driven epithelial-mesenchymal 
transitioning.351 This suggests NRP2, in this context, is transducing a pro-
cancer signal which is antagonised by Sema3F. In this manner, rather than 
non-functioning blockade of NRP2, Sema3F treatment itself may have a role 
in cancer therapy. Overall there are many promising therapeutic applications 
for Sema3F and its co-receptor NRP2 in respiratory disease. It is with greater 
knowledge of the ligand and receptor we can produce both targeted and 
personalised therapies for our patients with enhanced efficacy and improved 
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7 Appendices 















  M/L g/M M g/L ml mg ml 
Tris pH 7.8 1M 1 - 0.1 - 10 - 100 
EDTA   372.24 0.0015 0.5584   55.84 100 
KCl   74.56 0.01 0.7456   74.56 100 
DTT   154.25 0.0005 0.0771   7.71 100 
Na 
orthovanadate   183.91 0.001 0.1839   18.39 100 
Tetramisole   240.76 0.002 0.4815   48.15 100 
dH2O         90   100 
Add 50ul of protease-inhibitor containing water per 1ml of sonication buffer 
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II. Human 2XSDS Lysis buffer (hypotonic lysis buffer) 
SDS lysis buffer 
Stock 
Conc. FW Molarity  Conc. % Required Volume to add Mass to add 
Final 
volume 
  M/L g/M M g/L   ml Mg ml 
DTT 1 154.25 0.2 30.8500     308.50 10 
SDS 20%       4% 2   10 
Glycerol 100% 100%       20.00% 2   10 
Tris-HCl pH 6.8 0.5   0.1     2   10 
Bromophenol Blue 2%       0.04% 0.1   10 
Protease inhibitor cocktail           0.2   10 
H2O            3.7   10 
 
Protease-inhibitor containing water: To 1ml ddH20 add 1 tablet of cOmplete™, EDTA-free Protease Inhibitor Cocktail (Sigma-
Aldrich). Store at -20ºC. PMSF (phenylmethylsulfonyl fluoride): 100mM stock made up in isopropanol Fw = 174.20 i.e. 87.1 mg 
in 5 ml isopropanol = 100 mM. Store in foil at 4ºC. 
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III. Running buffer for Western blots 
10 X Running Buffer 
Glycine 190g 
Tris Base 30.3g 
20% SDS 50ml 
dH2O to 1 litre 
IV. Transfer Buffer for Western blots 
10 X Transfer Buffer 
Glycine 145g 
Tris Base 29g 
dH2O to 800ml 
1 X Transfer Buffer: Made immediately before use 
10 X Transfer Buffer 10ml 
Methanol 20ml 
Water 70ml 
V. Primary Antibodies used in Western Blotting  












Anti-NRP2 1/100 Atlas Antibodies HPA054974 
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VI. Primary Antibodies used for immunohistochemistry 




1/75 Sigma-Aldrich SAB2700501 
Anti-Neuropilin 1 
Rabbit Polyclonal 
1/100 R & D Systems AF3870 
Anti-Neuropilin 2 
Rabbit Polyclonal 
1/100 Santa Cruz H300 
Anti-Ly6G 
Rat monclonal 
1/250 Abcam ab25377 
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VII. Pipeline used to measure neutrophil roundness 
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VIII.  Genotyping for murine colonies 
2% gels were used. 
Mastermix 
DNA                          2ul 
5xbuffer                   2.4µl 
MgCl2                      0.96µl 
dNTP (2.5mM)       0.96µl 
Primer 1084           0.6µl 
Primer 1085           0.6µl 
Primer 7338           0.6µl 
Primer 7339           0.6µl 
Taq polymerase    0.03µl 
dH20                       3.25µl 
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PCR cycling conditions 
Step Temp. ºC Time Repeat 
1 94  3 min.  
2 94 30 sec.  
3 51.7 1 min.  
4 72 1 min Steps 2-4 for 35 
cycles 
5 72 1 min.  
6 10 Hold  
IX. Mowiol mounting medium; hard set  




• Mowiol 4-88 (Sigma 81381) 
• Glycerol (Sigma G5516) 
• Tris-Cl (0.2 M, pH 8.5; see below)  
• DABCO (1,4-diazabicyclo-[2,2,2]-octane; Sigma D27802) 
Method: 
1. In a 50 ml Falcon, add 2.4 g of Mowiol 4-88 to 6 g of glycerol. Stir to 
mix.  
2. Add 6 mL of dH2O and leave for several hours at room temperature.  
3. Add 12 mL of 0.2 M Tris-Cl (pH 8.5) and heat to 50°C in rotating 
hybridization oven for up to 5 hrs. After the Mowiol dissolves, clarify by 
centrifugation at 5000g for 15 min.  
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4. Aliquot in airtight containers and store at −20°C. 
5. To use for fluorescence detection, thaw, then add DABCO (antifade) 
to 2.5% (w/v) and dissolve on roller (approx. 45 mins), then stand 
upright at 4°C for approx. 30 mins before use to let bubbles rise.  
6. Store excess at 4°C for a few weeks then discard if not used. 
X. Percoll gradients used for Ultra-purification of Neutrophils 
Concentrations For 10ml (3 
gradients) 
For 20ml (6 
gradients) 









78% 8.7ml 1.3ml 17.3ml 2.7ml 26ml 4ml 
69% 7.7ml 2.3ml 15.3ml 4.7ml 23ml 7ml 
52% 5.8ml 4.2ml 11.6ml 8.4ml 17.3ml 2.7ml 
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XI. Critical region used as reference for Primer design 
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Primer Design quality control data for custom made Sema3F primer-probe set 
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XII.  Antibodies used in Lung Digest 
Stain Concentration Supplier Code 
PE-CF594 
Siglec F 0.00125 Biolegend 562757 
BV450 
CD11b 0.002 Biolegend 101239 
FITC Ly6C 0.005 Biolegend 128005 
PE Lys6G 0.0025 Biolegend 127607 
PerCP Cy5.5 
MHC 11 0.005 Biolegend 107625 
PE Cy7 
CD11c 0.005 Biolegend 117317 
APC CD64 0.005 Biolegend 139305 
AF700 CD45 0.005 Biolegend AF700 CD45 
BV450 
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XIII. Antibodies used in Neuropilin 1 and 2 surface expression 
panel 
Antibody Concentration Supplier Code 
Anti-NRP2 1/25 R&D Systems 









Anti-CD66b 1/100 BD Biosciences 
Oxford, UK, 
562940 
Anti-CD49d 1/250 BD Biosciences 563645 
CD14 1/125 BD Biosciences 301835 
 
XIV. Exclusion Criteria for healthy blood donors 
 
Exclusions criteria:  
Healthy donors were not eligible to be participate and be registered on the 
generic database if affected by any of the following:-  
• Infection with any blood borne diseases (e.g. HIV, Hepatitis B or 
Hepatitis C)  
• Previous or current intravenous drug abuse  
• Current anaemia  
• Blood clotting disorders  
• Current anticoagulant (blood thinning) drug therapy  
• Regular use of steroids  
• Under the age of 16, or unable to give informed consent 
 
For this piece of work further information was obtained by a trained physician 
to exclude the following: 
• Recent use of anti-inflammatory medicines (including steroids, 
ibuprofen or similar)  
• Active inflammatory conditions 
• Known eosinophilia 
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• Current smoker 
• Sex and age were anonymously recorded for each sample and used 
for matching purposes 
 
 
XV. Matute-Bello lung scoring system 
 
 
 
 
 
 
 
 
 
 
